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ABSTRACT
The stereochemical determination of the non-steroidal anti-inflammatory 
agents ibuprofen sodium and flurbiprofen sodium in biological media using !H and 
19F NMR respectively has been attempted. Initial studies showed that chiral 
recognition of resonances in aqueous solutions of drug were achieved in the 
presence of cyclodextrin. When equivalent solutions were used to spike samples of 
human or rat urine, however, such discrimination was either altered or eliminated. 
This observation was thought to be a consequence of structural changes in the 
complex formed between drug and cyclodextrin brought about by endogenous 
urinary metabolites. The effect of a number of experimental variables such as pH, 
temperature and the presence of ionic salts on the chiral discrimination process 
was investigated.
Complexes of p-cyclodextrin with ibuprofen sodium and flurbiprofen 
sodium and a number of structurally related 2-arylpropionates were further 
examined using a range of NMR methods. Chemical shift, J coupling and Job plot 
data recorded in D20  and dg-DMSO allowed structures for the inclusion complexes 
to be proposed.
The nuclear Overhauser effect (nOe) has also been used to provide 
information relating to the structure of the cyclodextrin inclusion complex. 
Correlation times of complexes necessitated use of the ROESY experiment 
TOCSY correlations present in ROESY spectra hindered their inteipretation 
through the possible additional presence of false cross-peaks. Methods were 
therefore examined to effect their elimination.
Preliminary measurements of 13C longitudinal relaxation times for the p- 
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Introduction to NMR Bio-fluid Analysis and its Application to Studies of the 
Enantioselective Metabolism of the Profens
1.1 Introduction
The analysis of biological fluids by high-field FT NMR in the study of drug 
metabolic processes is now relatively commonplace. It has been estimated, 
however, that approximately 25% of drugs currently available have a chiral centre 
as part of their structure and are formulated as the racemate [1]. Except in rare 
examples of self-discrimination, NMR spectroscopy is unable to distinguish the 
two enantiomeric forms of such a drug (or its metabolites). With increasing 
awareness of the importance of enantioselective metabolism and the need in drug 
metabolic studies to be able to effect such a distinction, there would appear to be a 
serious limitation to the applications of NMR bio-fluid analysis in this area. We 
envisage that this may be remedied by the addition to the bio-fluid of an 
appropriate chiral shift reagent prior to analysis, and have investigated such a 
possibility with regard to the 2-arylpropionic acid series of non-steroidal anti­
inflammatory drugs (NSAIDs). By way of introduction, this chapter considers our 
interest in this particular series of drugs, general features of NMR bio-fluid 
analysis and the results of previously-reported studies relevant to this work. 
Finally, the choice of an appropriate chiral NMR shift reagent is considered.
Chapter 2 describes the results of our studies of the enantioselective 
metabolism of the 2-arylpropionic acid NSAIDs using NMR bio-fluid analysis. 
These results prompted further examination of the nature of the interaction 
between the drug and the chiral NMR reagents of choice, the cyclodextrins. 
Results of solution state NMR studies of this interaction are given in Chapter 4. 
The preceding chapter introduces relevant properties of the cyclodextrins and their
1
complexes and NMR methods used to examine them. Finally, Chapter 5 describes 
experimental methods appropriate to the results discussed in Chapters 2 and 4.
1.2 The Profens as Non-steroidal Anti-inflammatory .Drugs
The 2-arylpropionic acid or profen series of NSAIDs are widely used as 
analgesics and in the treatment of a range of inflammatory conditions [2]. Their 
action is associated with the inhibition of the cyclooxygenase enzyme responsible 
for the conversion of essential fatty acids, stored in the phospholipids of cell 
membranes and other complex lipids, to prostaglandins [3], although other 
mechanisms of action of as yet unknown clinical significance have been reported 
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Figure 1.1 The general structure of the profen series of NSAIDs
The compounds have a chiral centre at C2, and therefore exist in both R 
and S enantiomeric forms (although a few examples with an additional asymmetric 
substituent of the aryl group, and consequently a total of four stereoisomers eg 
loxoprofen are also known). As therapeutic agents, the profens are generally 
formulated as the racemate, except in the case of naproxen, where a single
2
enantiomer, (S(+)), is used. The significance of drug stereochemistry with regard 
to biological action and consequences is becoming increasingly recognised [1,5- 
11].
1.3 Stereoselectivity in Profen Metabolism
Optical isomers have identical physical and chemical properties in an 
achiral chemical environment. In a chiral environment, however, this equality does 
not necessarily remain. Biological systems present such an environment, because 
of the chiral building blocks, such as amino acids and sugars, which Nature 
employs. Thus, the administration of a racemic drug to the body inevitably leads to 
differentiation between the two enantiomers which make up the mixture. The 
importance of this and other stereochemical considerations in the action of 
xenobiotics has recently received much attention.
Recognition processes involving chiral molecules are involved in many of 
the stages which together form the whole of the metabolic process [12-14]. These 
stages, together with their relevance to the metabolism of the profens, are now 
considered.
1.3.1 Stereoselectivity in Drug Absorption
Most routes of drug administration (excepting injection) require the 
absorption of the drug across a lipophilic membrane before it can enter the body. 
Both passive diffusion and carrier- mediated processes are possible. Passive 
diffusion depends on differences in aqueous and lipid solubility and as such does 
not differ for a pair of enantiomers. Carrier-mediated processes require interaction 
with chiral bio-macromolecules and are therefore associated with stereoselectivity. 
Carrier mechanisms are, however, only seldomly implicated in the absorption of 
drug molecules, since these systems were evolved to enable the absorption of 
essential nutrients, which often bear little structural resemblance to drug
3
molecules. Differential changes in membrane permeability brought about by the 
two enantiomers of a drug have also been suggested as a possible mechanism of 
enantioselective drug absorption [15].
Studies of the enantioselectivity in the absorption of the profen series of 
drugs have not been reported. The gut has, however, been implicated as a possible 
site for the stereoselective bio-transformations some of these drugs undergo 
(Section 1.3.4), so that consideration of route of administration is obviously of 
importance.
1.3.2 Stereoselectivity in Drug Distribution
Following absorption, a drug is circulated around the body in the blood 
supply. The effective concentration available is dictated by the extent of binding to 
proteins which are present in the plasma. Albumin and alphar acid glycoprotein 
are the major plasma proteins, which bind predominantly acidic and basic species 
respectively. The degree of stereoselectivity in binding to such proteins varies 
considerably with drug, but is generally considered small.
The profens are highly bound to plasma proteins, predominantly albumin , 
Table 1.1. The data in this table, taken from the review of Lin et al. [16], refer to 
formulated drug, which for all but naproxen is the racemate.






Table 1.1 Clinical pharmacokinetic properties of some NSAIDs [16]
4
More recently', studie s have addressed the stereoselectivity of this binding 
process, and have fouJnd smaill but significant differences for the two enantiomers 









2-Phenylpropionic acid yes [23]
Table 1.2 Stereoselectivity in the plasma protein binding of some profens in 
various species
Whilst detailed examination of the consequences of such differential 
binding in terms of the pharmacokinetics and therapeutic effects of these drugs 
have not been studied, competitive binding has been suggested as a possible 
explanation for differences in pharmacokinetic properties when these drugs are 
administered as individual enantiomers rather than the racemate [24,25].
Possible stereoselectivity in the uptake of drug from the blood by the 
tissues remains relatively unexplored in general. The profens are, however
exceptional in this regard.
Xenobiotic carboxylic acids, when converted to their coenzyme A (CoA) 
thioester in vivo, may replace natural fatty acids in the formation of
triacylglycerides. Possible consequences of such hybrid triglyceride formation are 
the accumulation of tissue residues of xenobiotics, disturbance of lipid
biochemistry and disruption of normal membrane function with possible
5
concomitant toxicity |[26]. Ass carboxylic acids, the profens are possible substrates 
for this pathway, anid indeed Fears et al. [27] have reported the presence of 
ketoprofen, ibuprofen and fenoprofen in such hybrid triglycerides in in vitro 
studies with rat liver slices. Interestingly, flurbiprofen was not incorporated, 
presumably because of its inability to form a CoA derivative [28], More recent 
studies with ibuprofen [29] and fenoprofen [30] have shown that the uptake of 
these drugs into adipose tissue in the rat occurs stereospecifically for the R 
enantiomer. Such stereospecificity may be associated with enantiospecific 
formation of the CoA thioester of these drugs (Section 1.3.4).
1.3.3 Stereoselectivity of the Drug-Receptor Interaction
The enantioselectivity of the drug-receptor interaction has been more fully 
characterised. The therapeutic action of a drug generally results from the 
interaction of a drug molecule with one or more specific receptor sites. The 
chirality of a receptor site allows stereoselective distinction between enantiomers 
to be made. For any particular action, therapeutic or toxic, the differential 
responses produced by each of the enantiomers may be expressed in terms of the 
eudismic ratio. The most active enantiomer at a receptor site is termed the eutomer, 
and the less active the distomer; the eudisimic ratio is the activity ratio o f eutomer 
to distomer. Obviously, the higher the eudismic ratio, the greater the drug 
enantioselectivity: eudismic ratio values of the order of one hundred are not 
uncommon for drug substances [5]. Where eudismic ratios differ considerably 
from unity, the therapeutic action resides almost completely in the eutomer. At 
best the distomer may be regarded as biologically inactive, at worst it  may give 
rise to a range of undesirable effects, not necessarily related to those of the 
eutomer, which may include non-competitive antagonisitic and toxic responses 
[1,5-11].
6
Eudismic ratios for the profen NSAIDs in vitro hive recently been 
reviewed by Caldwell et al. [31] and are summarised in Table 13, taken from that 
paper. It is readily apparent that it is the S enantiomer which is responsible for the 
anti-inflammatory action of these drugs.










Table 1.3 Stereoselectivity of action of profen NSAIDs at putative sites of action 
in various species [31]
1.3.4 Stereoselectivity in Drug Metabolism
Enantioselectivity may also be apparent in the bio- transformations initiated 
by metabolizing enzymes, as a consequence of differential enzymic affinity and 
rates of metabolism. The metabolites so-formed may thus show differences in 
molecular structure and stereochemistry depending on the enantiomer from which 
they were derived, and may therefore elicit different biological responses, 
including toxicity. It is generally the case, however, that differences in the 
metabolism of enantiomers is often considerably less than might be expected on 
the basis of differential receptor binding. This may be related to poorer enzyme 
specificity, or, more probably, as a result of averaging of any preferences over a 
number of steps catalysed by a number of isoenzymes [12,13].
7
The metabolic^ pathways of the profens will be influenced by the nature of 
the aryl substituent cof each individual drug and by the species to which it is 
administered [32-39]. A common metabolic pathway is the formation of the 
glucuronide conjugate, a well-known mechanism for the detoxification of 
xenobiotic carboxylic acids [40], and it is the enantioselectivity of the 
glucuronidation process which has received most attention. El Mouelhi et al. [41] 
have shown, for example, the enantioselective glucuronidation of racemic 
naproxen, ibuprofen and benoxaprofen in vitro, using immobilized enzyme 
preparations which avoided complications from competing metabolic routes. The 
preferred enantiomer and its extent of preference were found to depend on both 
drug substrate and species. Nakamura and Yamaguchi [42] have similarly 
suggested the stereoselective glucuronidation of (S)-2-phenylpropionic acid and 
























Figure 1.2 Proposed mechanism for the uni-directional metabolic inversion of the 
profens, illustrated for ibuprofen [54]
8
In addition to studies of glucuronidation, studies of ibuprofen metabolism 
in vivo in man show a laclk of stereoselectivity in formation of the carboxy 
metabolite [43].
Most interest in the stereoselectivity in profen metabolism has, however, 
centered on an unusual transformation which inverts the chiral centre at the C2 
atom [44]. The reaction is essentially uni-directional, with the R enantiomer 
converting to the S, Figure 1.2, although small amounts of the R enantiomer 
formed from the S have been observed in studies of 2-phenylpropionic acid 
metabolism in rat kidney slices [42] and in vivo [45],of ibuprofen metabolism in 
the rat [46] and possibly in man [24], and also of cicloprofen in the rat [47]. The 
extent of this chiral inversion depends on both drug substrate and species, and has 
recently been reviewed by Jamali [48].
The biological consequences of this conversion of inactive to active isomer 
is readily apparent from comparisons of the eudismic ratios of these drugs 
measured in vivo compared with in vitro data, Table 1.4, and has lead to 
considerable research into its mechanism and site of occurrence.
Drug Eudismic ratio S/R 









Table 1.4 Differential stereoselectivity of action of profen NSAIDs in vitro and in 
vivo [31]
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An initial study of thie metabolism of deuterium-labelled (R)-ibuprofen in 
man suggested that reaction iproceeded via the action of fatty acid dehydrogenase 
on the CoA thioester of (R)-ibuprofen [49]. Subsequent studies have shown, 
however, that the CoA thioester formation leads to increased acidity of the H2 
proton, and that in fact reaction proceeds via deprotonation, as opposed to 
elimination, and subsequent racemization. There is much evidence to suggest that 
stereospecific action of the acyl- CoA synthetase enzyme on the R enantiomer 
gives rise to the uni- directional nature of this inversion (and to the enantiospecific 
uptake of these drugs into adipose tissue, Section 1.3.2). Thus, for example, 
enantioselective thioester formation has been demonstrated in vitro for (R)- 
ibuprofen [50] and (R)-fenoprofen [51] and, Porubek et al. [28] have shown that 
once formed, the CoA thioesters of flurbiprofen are both able to readily epimerize 
in vitro.
Deprotonation of the CoA thioester could occur either by enzymic or 
chemical means. The pKa of 10.3 observed for the ibuprofen N-acetylcysteamine 
thioester model compound [46] suggest that chemical deprotonation is unlikely 
and, indeed, the NMR deuterium exchange experiments of Mayer et al. [52,53] 
show that although chemical deprotonation may be possible under extremely non- 
physiological conditions, even so the rate of reaction is not sufficient to explain 
those observed in vivo. The failure to observe a detectable deuterium kinetic 
isotope effect in the isomerization of ibuprofen gives some insight as to the 
identity of the enzyme system responsible [54], although it remains unknown at 
present.
The distribution of the epimerizing enzyme in the body also remains 
unclear. Proposed sites have included the gut (Section 1.3.1), where inversion of 
(R)-benoxaprofen in the rat [55] and of (R)-ibuprofen in man [56-58] have been 
observed. A small amount of (R)- to (S)-2-phenylpropionic acid interconversion 
has also been reported in rat small intestine in vitro, although not in the lung,
10
testes, heart or spleeni [42]. The predominant sites for inversion in this study were, 
however, the liver anid kidney, the importance of these organs subsequently being 
demonstrated in vivo [45]. Inversion of (R)-ibuprofen has also been demonstrated 
in perfused rat liver [59] and in isolated liver preparations [60,61]. Knadler and 
Hall [62] have also reported inversion of fenoprofen in liver preparations.
1.3.5 Stereoselectivity in Drug Excretion
Both drugs and metabolites are susceptible to enantioselective excretion as 
they are eliminated from the body in the urine and bile. The kidney employs 
secretory and reabsorption mechanisms in the tubules which form part of its 
structure to allow removal of waste products in the urine. Both mechanisms may 
be carrier-mediated, and as such enantioselectivity may be anticipated, although it 
has not as yet been demonstrated for xenobiotic excretion. Carrier systems have 
also been implicated in the biliary excretion of several drugs and metabolites, but 
no enantioselectivity has been established.
The difference in biological fate of the enantiomers of chiral drug 
compounds has thus been demonstrated at stages throughout the metabolic 
pathway. These differences may be either pharmaco-dynamic or -kinetic in origin, 
and raise many questions concerning the propriety of the administration of drugs as 
racemates, without thorough testing of the metabolism of the individual 
enantiomers. The profens are particularly interesting in this regard: 
enantioselectivity has been demonstrated at many stages of their passage through 
the body and they exhibit a highly unusual, essentially uni-directional chiral 
inversion mechanism. Perhaps more worrying than interesting, however, is the 
formulation of these drugs as the racemate, when evidence suggests that the R 
enantiomer (although often partially converted to the S enantiomer in many
11
species) is therapeutically inactive and stereospecifically implicated in possible 
mechanisms of toxicity.
1.4 Application of NMR Spectroscopy to the Analysis of Biological Fluids
The application of high-field FT NMR spectroscopy to the study of 
biological fluids is now relatively common-place. Although rather insensitive in 
comparison with other analytical techniques, its advantages include rapid, noi- 
destructive, qualitative and (with addition of a suitable standard and with care) 
quantitative analysis with minimal sample preparation and, indeed, sample volume 
required. Applications of the method have recently been reviewed [63-70] and may 
be divided into two general categories:
1. the monitoring of endogenous metabolites aimed at the understanding of 
biochemical and toxicological pathways and the diagnosis of various disease 
states, particularly of organic acid metabolic disorders and of cancer,
2. the analysis of both endogenous and exogenous metabolites following drug 
administration in the study of xenobiotic metabolic processes.
Discussion is restricted here predominantly to the second of these two 
categories. Some general considerations in carrying out such studies are given, and 
specific applications to the study of profen metabolism are reviewed;
1.4.1 Considerations of Experimental Protocol in NMR Studies of Xenobiotic 
Metabolism
1. Substrate Suitability for NMR Analysis
As a result of the comparative insensitivity of NMR, for spectra , for 
example, concentrations typically of the order of IOOjiM at 400MHz are required 
for measurement. For this reason, low efficacy drugs (hence given in large doses)
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which are rapidly excreted as a small number of metabolites are particularly 
appropriate for this method of analysis. Samples taken following overdose are also 
readily examined. Thus, changes in endogenous metabolite levels as well as the 
occurrence of drug and exogenous metabolites have been readily observed by 
NMR in various bio-fluids following paracetamol [71], aspirin [72,73] and alcohol
[72] ingestion in overdose. NMR analysis is also recommended where the drug 
metabolites (or in the case of overdose, even the drug itself) are unknown, shce 
unlike a technique such as chromatography, no presumption about the structure of 
metabolites need be made prior to analysis. Thus, on the basis of NMR of uine 
samples from various species, new metabolites have been identified for ampicllin 
sodium in the rat [74], DMF in the mouse [75], NMF in rats and mice [76,77], ind 
by 19F NMR, novel metabolites for 5'-deoxy-5-fluorouridine [78] and 5- 
fluorocytosine [79] in man have also been elucidated. Similarly, Vermeersch etal.
[73] were able to determine by !H NMR analysis of a urine sample that the 
symptoms of a four month old girl arose from aspirin-poisoning rather than an 
organic aciduria as first suspected.
In structural terms, drug structures which give signals with relatively 
simple splitting patterns in regions of the NMR spectrum free of endogenous 
signals are to be preferred.
2. The Choice of Biological Fluid for NMR Analysis
The choice of an appropriate biological fluid for analysis is governed by 
many factors. Obviously it is essential to choose a fluid into which the drug is 
excreted and which gives the necessary biological information. The ease of 
obtaining the sample and its available volume are also considerations. Thus, most 
work in this area makes use of blood and urine samples. Endogenous composition 
of the fluid is also important. Fluids containing a large percentage of endogenous 
bio-macromolecules will give spectra with broad peaks arising from them. In
13
addition, any drug bo>und to such bio-macromolecules will similarly give rise to 
broadened resonances’). Althoiugh such resonances may be eliminated by the use of 
a Hahn [80] or Carr-Purcell-Meiboom- Gill (CPMG) [81,82] spin-echo sequence 
or the use of convolution difference [83], quantitative measurements remain 
inaccurate. Bell et al. [84] have reported the observation of so-called 'NMR 
invisible lactate1 in human plasma. Only after addition of a suitable agent such as 
ammonium chloride, which disrupts binding of lactate to plasma proteins, was it 
possible to make a reliable estimation of total lactate concentration by ]H NMR. 
Similarly, Bock [72] used perchloric acid to precipitate plasma proteins, which 
broadened JH signals from aspirin metabolites as a result of binding, in a sample 
taken from a human overdose subject. Alternatively, it may be necessary to extract 
the plasma-bound species with an organic solvent, as has been reported for the 
determination of esterified and non-esterified cholesterol in serum by ]H NMR 
[64]. The use of sodium 3-(trimethylsilyl)propionate (TSP) as an internal standard 
in quantitation in such samples is also precluded, as macromolecular binding 
broadens its resonance. Alanine is suggested as a suitable alternative for use in 
plasma [64]. In some cases, however, protein binding need not be a problem. Thus, 
Meynial et al. [85] observed two distinct signals in the 19F NMR spectrum of 
human serum following administration of the anti-neoplastic agent 5’-deoxy-5- 
fluorouridine, corresponding to free and plasma-bound drug, allowing 
quantification of the binding process. Human urine and cerebrospinal fluid are 
notable in their low protein content.
Bio-fluids which have been used in NMR analysis include blood, urine, 
cerebrospinal, amniotic and seminal fluids as well as sweat, aqueous humour, milk 
and bile.
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3. Sample Preparation! for NMR Analysis
At its simplest, sample preparation requires only the addition of 10% 
deuterated water, as a field-frequency lock, to the biological fluid (of which there 
may be as little as 0.3ml) prior to analysis. Where the sample is required after use 
or it is undesirable to contaminate the sample with deuterium, a concentric 
capillary tube of deuterated water may be used.
The possible need to precipitate bio-macromolecules has already been 
considered. The predominant component of bio-fluids is, however, water, which 
gives rise to a very large peak in the !H spectra of these samples, which will not 
only obscure part of the spectrum, but will also severely restrict sensitivity as a 
result of the limited dynamic range of the analogue-to-digital converter of the 
spectrometer. Several solutions to these problems are available. A straight-forward 
approach is to freeze-dry the sample and to reconstitute it in deuterated solvent. 
Thus, where necessary, sample concentration may be achieved, but the loss of 
volatile and unstable constituents from the sample and the absence of 
exchangeable protons from the resulting spectrum may, however, be undesirable. 
The extent to which a sample may be concentrated is also limited, because if ionic 
strength becomes too high, salting out of solute may occur and the tuning of the 
radio-frequency circuitry of the spectrometer may be affected [86]. Alternatively, 
spectroscopic techniques, generally referred to as solvent suppression methods, are 
available. These eliminate the water signal from the spectrum either by selective 
excitation of all other resonances or by nullifying the water signal at the point of 
acquisition. Numerous methods are available , but probably the most established 
have been discussed by Freeman [87] and Sanders and Hunter [83]. None of these 
methods is ideal for all situations, and it is important to weigh-up the advantages 
and disadvantages of each for any particular application. Thus, the most straight­
forward method of presaturation of the water resonance prior to acquistion is
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simple and easy to uise, but exchangeable protons and signals close in chemical 
shift to the water signal may be eliminated from the spectrum.
Where complexity of the sample is a problem, the use of solid phase 
extraction cartridges is also advocated. This allows removal of endogenous 
components, simultaneous concentration and, with careful method development, 
may allow separation of a drug and its metabolites. For example, studies relating to 
!H NMR determination in human urine of ibuprofen, paracetamol, aspirin, 
oxpentifylline and naproxen have been reported [86]. Their use, however, does 
detract from the rapidity of NMR bio-fluid analysis.
Where endogenous peak interference alone is the problem, it may be 
possible simply to separate overlapping signals by careful adjustment of the 
sample pH for protons close to an ionisable group [64]. Sample pH must also be 
considered in multi-nuclear studies with 14N or 15N. Protonation of the nitrogen 
nucleus in such cases leads to line-broadening through chemical-exchange. In 
extreme cases such broadening may be sufficient for the signal to be unobservable 
[69].
4. The Observation Nucleus for NMR Analysis
The !H nucleus has high abundance and magnetogyric ratio and is of wide­
spread occurrence, and as such should be a good choice of observation nucleus in 
bio-fluid analysis. The necessity of the elimination of the large water peak from 
such spectra has already been discussed The wide-spread occurrence coupled with 
the narrow chemical shift range of the proton can, however, lead to highly 
complex, overlapping spectra. This may be alleviated to a certain extent by 
working at higher magnetic field, where frequency dispersion (and sensitivity) is 
improved.
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The narrow clhemicall shift range of the proton is almost unique to this 
nucleus. It may, therefore, be possible to circumvent this problem by the use of 
another suitable observation nucleus. 19F and 31P are particularly attractive in this 
regard because of their high magnetogyric ratio and 100% natural abundance, but 
there are comparatively few drug molecules which contain one of these nuclei as 
part of their structure.
19F NMR studies of bio-fluids have included work with flucloxacillin 
[88,89], the anti-cancer fluoropyrimidines [67] and with flurbiprofen [90] in 
various fluids and species. 19F chemical shifts have been reported to be sensitive to 
molecular changes up to 8-10 bonds from the fluorine atom in such experiments 
[88].
Phosphorus occurs endogenously in compounds involved in the body's 
energetic cycles. 31P NMR studies have, therefore, tended to be restricted to the 
examination of such processes in samples of whole cells, tissues, perfused organs 
or in the body itself. Concentrated samples of urine from patients undergoing 
treatment with the cyclophosphamide analogue ifosfamide have been examined by 
31P NMR at 24.3MHz (equivalent to 60MHz for !H), but the peaks for ifosfamide 
and a metabolite resulting from dechloroethylation were not well resolved at this 
low field, and organic extraction of samples was found to be necessary [91].
Although notoriously insensitive, 13C NMR studies of bio-fluids have also 
been reported. Nicholson and Wilson [69] report that they were able to obtain 
reasonable spectra in 20 minutes (125MHz, proton-decoupled, corresponding to 
500MHz for 1H) from rat urine following administration of acetazolamide. Nuclear 
Overhauser enhancements and long relaxation times may preclude quantification. 
Alternatively, the use of 13C-labelled xenobiotic may be appropriate. Dohn et al. 
[92] have, for example, followed the metabolism of 3-13C labelled l,2-dibromo-3- 
chloropropane, previously used as a soil fumigant, in the rat, in order to gain 
greater understanding of its mechanisms of toxicity.
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Other nuclei used im bio-fluid analysis include 14N and 15N. 14N is 
reasonably sensitive, Ibut as at quadrupolar nucleus gives rise to very broad signals, 
so that only those molecules with highly symmetric electronic environments about 
the nitrogen centre are ideally studied by this method. Norman and Sadler [93] 
have examined the reactions of some platinum anti-tumour agents in plasma by 
this method, in an attempt to achieve essentially physiological conditions for their 
experiments.
Whilst 15N is a spin 1/2 nucleus, its natural abundance and magnetogyric 
ratio are low. 15N-labelled drugs are, therefore, to be recommended in metabolic 
studies with this nucleus [94].
A disadvantage of the use of nuclei other than protons, however, is that 
information relating to endogenous metabolites may be lost. Thus, for example, 
there are no fluorine-containing endogenous metabolites.
Alternative methods for over-coming resolution problems in ]H NMR have 
included the use of 2D homonuclear and heteronuclear correlation experiments. 
The homonuclear or COSY experiment was first applied to bio-fluid analysis to 
study the fate of paracetamol in a concentrated urine sample [95]. The overlapping 
resonances of free paracetamol and its cysteinyl conjugate observed in one­
dimensional JH spectroscopy were readily distinguishable in two. The utility of 
such COSY experiments has since been demonstrated by studies of the metabolism 
of N- methylformamide (NMF, [76]) and hydrazine [96] in the rat. Heteronuclear 
2D correlation experiments have been used to give additional structural 
information relating to the metabolites of, for example, flucloxacillin in rat urine 
by correlation [88] and, by 13C-!H correlation, of [3-13C]- l,2-dibromo-3- 
chloropropane also in the rat [92]. These experiments are difficult to quantify and 
are generally time-consuming. Wade et al. [90], for example, were only able to 
distinguish 6 of the 10 metabolites which they had observed in the 19F spectrum in 
a 19F- correlation experiment of human urine following a dose of the NSAID
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flurbiprofen. The sanne authcors have also recommended the use of !H {19F} spin- 
echo difference spectroscopy, which edits out all protons not coupled to 19F, 
leading to considerable spectral simplification, and envisage its application for 
other heteronuclei.
l .4.2 n m r  BiQ-fhiid Studies Qf Profgn Metabolism
1. Naproxen
Wilson and Ismail [97] have examined the urine of a female patient with 
suspected osteoarthritis. Following the administration of a single oral dose of 
500mg of naproxen, Figure 1.3, 2ml aliquots of urine were freeze-dried, 
reconstituted in deuterated water and analysed by NMR at 250MHz, with 
presaturation to suppress the residual HDO signal.
COOH
COOH
Figure 1.3 Structure of (I) naproxen and (II) its O-desmethyl metabolite
Urine collected 0-5.5 hours following dosing showed several drug- related 
resonances associated with the methyl, methoxy and aromatic protons, and 
additionally a signal from the anomeric proton of glucuronic acid, consistent with
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the formation of glu<curonid<e conjugates. Stepwise gradient elution of acidified 
urine from a solid phase extraction cartridge with deuteromethanol and acidified 
deuterated water allowed separation of endogenous metabolites, and the collection 
of exogenous metabolites in two fractions, which by NMR were found to 
contain 1. unchanged naproxen and its O-desmethyl metabolite, Figure 1.3, both 
present as the glucuronide and 2. unchanged naproxen as its glucuronide.
Wilson and Nicholson [86] have since reported the isolation of pure 
naproxen and O-desmethyl naproxen glucuronides, in sufficient yield for 13C 
NMR, by additional concentration and solid phase extraction of such samples.
2. Ibuprofen
!H NMR at 250MHz was used to examine the urine of a healthy male 
following administration of a single therapeutic dose of 400mg ibuprofen, Figure 
1.4, [86,98]. 2ml of urine was freeze- dried and reconstituted with 1ml of 
deuterated water, with the residual HDO peak suppressed in the resulting spectrum 
by presaturation.








The urine sample colllected 2-4 hours after dosing showed several signals 
arising from the drug and its metabolites: in the aromatic region around 7.25ppm, 
from 0.8-1.5ppm and a doublet at 5.4 ppm, indicating the presence of 
glucuronides. A large singlet at 1.18ppm was identified as the metabolite 2-[4-(2- 
hydroxy-2- methylpropyl)phenyl]propionic acid (HMPPP, Figure 1.4). Passage of 
the acidified sample through a solid phase extraction cartridge lead to considerable 
improvement of the spectrum, and by using stepwise gradient elution, it was 
possible to separate the ibuprofen metabolites into two fractions: 1. the 
glucuronides of HMPPP and 2-[4-(2-carboxypropyl)phenyl]propionic acid (CPPP, 
Figure 1.4) and 2. ibuprofen glucuronide. The subsequent separation of the 




Figure 1.5 Structure of (I) flurbiprofen and (II) its metabolite 2-(2-fluoro-4'- 
hydroxy-4-biphenylyl)propionic acid
21
The metabolism of flurbiprofen, Figure 1.5, has been studied following oral 
dosing of 150mg flurbiprcPfen or 800mg of a slow release formulation by a male 
volunteer [90]. *H NMR. analysis of the collected urine showed few clearly 
identifiable signals from the drug or its metabolites, except for a resonance at 
1.5ppm arising from a methyl group. In the 19F{ JH} spectrum, however, 
exogenous signals were very clearly seen. Two major metabolites were identified 
by alkaline hydrolysis as glucuronides, one of unchanged flurbiprofen. In addition, 
eight minor metabolites were detected, and were thought to be sulphates and 
glucuronides of reported metabolites. Solid phase extraction allowed separation of 
the metabolites into two fractions, which on the basis of and 19F NMR and 
FAB-MS were found to contain 1. flurbiprofen and 2-(2-fluoro-4'-hydroxy-4- 
biphenylyl)propionic acid, Figure 1.5, as their glucuronides and 2. flurbiprofen 
glucuronide.
A 19F-]H correlated spectrum and *H{ 19F} spin-echo difference 
spectroscopy of samples gave additional structural information, and were 
consistent with metabolism taking place on the non-fluorinated ring of the drug.
1.5 Determination of Optical Purity bv NMR Spectroscopy
NMR has found wide-spread use in the determination of enantiomeric 
excess [99-102]. Since enantiomeric species are chemically and magnetically 
equivalent in an achiral chemical environment, in order for chiral discrimination to 
be realised in an NMR experiment, inequivalence via a diastereomeric relationship 
must be introduced either through derivatization or intermolecular association with 
an optically active reagent.
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1.5.1 Derivatization with ?an Optically Pure Reagent
Derivatization requires the reaction of the enantiomeric mixture to be 
determined with an opttically pure reagent prior to analysis. It is therefore 
necessary for the molecule under investigation to possess functional groups 
suitable for such reactions as part of its structure. The optical purity of the 
derivatizing reagent is essential for accurate determination by this method, and 
care must also be taken that variable rates and extents of formation of the 
diastereomer from each enantiomer do not occur, and that stereochemical 
configurations are maintained throughout. The derivatizing reagent may be chosen 
so as to contain a resonance signal suitable for NMR analysis, and ideally also 
contains a phenyl ring or other highly magnetically anisotropic groups to increase 
the chemical shift non-equivalence of resonances arising from the different 
enantiomers. Conformational preferences of the reagent which can maximise the 
effects of such groups are also advantageous. Mosher's reagent, (oc-methoxy-a- 
trifluoromethylphenylacetic acid) or MTPA [103], is the most widely used chiral 
derivatizing agent (CDA) for NMR studies, and has been used for the 
determination of the enantiomeric purity of alcohols and amines. Other CDAs 
which have been used to determine enantiomeric excess by NMR have recently 
been discussed by Yamaguchi [99]. Chiral splittings in the 0.01- 0.15ppm range in 
such studies may be anticipated. In cases where chemical shift non-equivalence is 
small, the addition of a lanthanide shift reagent may lead to enhanced separation 
[104]. The formation of a diastereomeric derivative may additionally allow 
deduction of the absolute configuration of the analyte.
The derivatization reaction need not necessarily result from covalent 
linking of analyte and reagent. Thus, Parker and Taylor [105] have recently 
reported the determination of electron- deficient or strained alkenes and allenes by 
reaction with the platinum or palladium complexes (diop)M°-C2H4 (diop=2,2-
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dimethyl- 4,5-bi s(diphenyllphosphiromethyl)-1,3-dioxolane). The facile 
displacement of the ethene ligand gives complexes which may readily be examined 
by 31P NMR, thus exploiting the sensitivity and wide chemical shift range of this 
nucleus. As with other CDAs, care must be taken that there is no enantioselectivity 
in binding. It is envisaged that this may be a problem where the chiral centre of the 
analyte is close to the binding site or a substituent is capable of additionally 
binding to the metal.
1.5.2 Chiral Lanthanide Shift Reagents
Another commonly used method for the determination of optical purity by 
NMR, first reported by Whitesides and Lewis [106], requires the use of a chiral 
lanthanide shift reagent (CLSR) [101,102,107], which gives rise to a differential 
lanthanide hnduced shift for the two enantiomers of a molecule. The CLSR 
generally consists of three molecules of a bidentate P-diketonate derivative of d- 
camphor complexed to a lanthanide ion such as europium or praesodymium in 
non-competitive solvents such as carbon tetrachloride or deuterated benzene. The 
possible expansion of the coordination sphere of the lanthanide ion allows chiral 
discrimination to be achieved by substrate binding. Solutions are thought to 
contain a complex series of equilibria, usually in fast exchange, but are not as yet 
fully understood. It is not clear, for example, whether chiral discrimination results 
predominantly from a difference in stabilities of the diastereomeric complexes 
formed by each enantiomer, or from an intrinsic difference in magnetic 
environment of the complexes themselves. The choice of lanthanide ion and chiral 
ligand in any given application also remains somewhat empirical. It is known, 
however, that complexes of europium and ytterbium give rise to downfield shifts, 
whereas those of praesodymium are upfield, and on the basis of experimental data, 
Fraser [101] has suggested the following protocol: For the determination of the
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optical purity of an unlknown ssample, experiments with at least four CLSRs should 
be attempted. Eu(dcm))3, Pr(hflbc)3, Yb(hfbc)3 and Eu(hfbc)3 (dcm =dicampholyl-d- 
methanato-, hfbc =heptafluoropropylhydroxy- methylene-d-camphorato-) are the 
most likely to give success. Variations in temperature and achiral substrate 
derivatization are a last resort Splittings up to 0.2ppm may be expected.
Since the lanthanide complexes are hard acids, the best results with CLSRs 
are observed for hard bases. For weaker bases, binding may be enhanced by the 
introduction of a fluorine atom in the biketonate ligand of the CLSR, thus 
increasing its acidity (and solubility) [108]. Studies with soft bases such as alkenes 
and aromatics require the additional presence of a silver (I) p-diketonate [109]. 
Evidence suggests that the silver ion is ion- paired with a lanthanide (III) tetrakis 
chelate anion formed in situ, and that binding of the substrate to the reagent is 
through the silver ion.
Although most CLSRs are appropriate for use in apolar solvents, the use of 
some in aqueous systems has also been reported. Na[Eu(IH)(R or S)pdta(H20 )3] 
(pdta=l,2- propanediaminetetraacetate) has been used in deuterated water to 
determine the enantiomeric purities of chelating ligands such as a-amino and a- 
hydroxy acids as well as carboxylic acids [110,111]. Kabuto and Sasaki [111] 
have, for example, reported a 0.03ppm splitting of the methyl resonance of 2- 
phenylpropionic acid in D20  by this method, p-hydroxy acids [112] as well as a- 
[113] may also be studied in aqueous solution by the use of europium chloride and 
an excess of an additional chiral acid also capable of chelation. The stoichiometry 
and structure of the resulting lanthanide complex which allows chiral recognition 
has been studied [114]. Complexes with a  3:1 ligand to metal ratio would appear to 
be of primary importance, presumably as a result of steric crowding around the 
lanthanide ion forcing ligands into a more stereochemically rigid position. The 
method may be extended to the self-resolution of non-racemic mixtures of 
appropriate ligands. A further chiral lanthanide reagent, based on the ligand (S)-
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carboxymethyloxysuc(?inate (CMOS) and suitable for use in D20 , has been 
reported by Peters et al. [115]. Substrates included amino acids and a range of 
polycarboxylates.
Chiral shift reagents based on cobalt have also been reported for use in 
aqueous solution. Cobalt (II) adenosine 5'- triphosphate has been used to 
determine, for example, the enantiomeric excess of norepinephrine [116]. Chiral 
discrimination is thought to occur by substrate binding to adenosine 5'-triphosphate 
stabilised by ring stacking and electrostatic interactions between the ammonium 
and phosphate groups. The optical purity of 2-(5,6-dihydroxy-l,2,3,4- tetrahydro- 
l-naphthyl)imidazoline and 2-(5,6-dimethoxy-l,2,3,4- tetrahydro-1- 
naphthyl)imidazoline have also been determined by this method [117].
1.5.3 Chiral Solvating A gents
Chiral Solvating Agents (CSAs) [100,102] were developed following the 
observation by Pirkle [118] that chiral discrimination of 2,2,2-trifluoro-l- 
phenylethanol was observed in its 19F NMR spectrum in the presence of the 
asymmetric solvent l-(-)-phenethylamine. The compounds which have been used 
as CSAs are structurally diverse, but the most popular are probably the 
aryltrifluoromethylcarbinols and 1-arylethylamines. The CSAs are used in 
optically enriched, and preferably optically pure, form and often in large molar 
excesses. Simplistically, their mechanism of action may be considered to involve 
binary association between molecules of the analyte and the reagent, resulting 
from hydrogen bond interactions between the two, with discrimination of 
enantiomers generally enhanced where the CSA contains a magnetically 
anisotropic aryl group directly attached to its asymmetric centre. Although 
chemical shift differences are generally smaller than for the CLSRs, spectra do not 
suffer from the disadvantage of line-broadening associated with the latter, and are 
more useful in the determination of absolute configuration. Small splittings may,
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however, be enhanced by the additional presence of an achiral lanthanide shift 
reagent where necessary [119].
The CSA category may also be considered to encompass NMR 
enantiomeric excess determination by diastereomeric ion-pair formation. Thus, 
Baxter and Richards [120] have reported the determination of the optical purity of 
the antischistosomal agent 2- N- isopropylaminomethyl-6-methyl-7-nitro -1,2,3,4- 
tetrahydro- quinoline following the formation of a diastereomeric salt with MTPA 
in ethyl acetate. Whilst the method was successful in deuterochloroform, in a polar 
solvent such as deuteromethanol ion-pairing was disrupted. Parker and Taylor 
[121] have recently suggested the use of O-acetyl mandelic acid as an improved 
reagent for the analysis of chiral amines and aminoalcohols, because of the 
improved solubility of ion-pairs of this acid in apolar solvents, and because, with 
the substrates examined, splittings were larger than those observed for MTPA or 
mandelic acid.
Where molecular association occurs between two molecules of the analyte 
itself, self-induced non-equivalence in NMR spectra may additionally be observed. 
Thus, Dobashi et al. [122] have reported the observation of non-equivalence in the 
NMR spectrum of N-acetylvaline rm-butyl ester enantiomers in carbon 
tetrachloride. The authors propose a dimeric structure resulting from 
intermolecular N-H to C=0 hydrogen bonding as being responsible for this 
observation.
An important class of CSAs, because of their effectiveness in water and 
certain other polar solvents, are the cyclodextrins [123]. These are water-soluble 
oligomers containing from 6 to 12 glucose units connected through a(l,4) 
linkages, the most common being those with 6,7 and 8 units, referred to as a-,P- 
and y-cyclodextrin respectively. The toroidal structure of these molecules, shown 
in Figure 1.6, allows inclusion of a range of hosts in the molecular cavity, the 
diameter of which depends on the number of glucose units in the macrocycle. This
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cavity is hydrophobic in natiure as a result of the methylenic and glycosidic 
linkages which forms its walls, and it is therefore generally hydrophobic 
molecules, or parts thereof, which are preferentially included.
In 1977, Ma:Nicol and Rycroft [125] reported the inequivalence in the 19F 
NMR spectra of the trifluoromethyl groups of a,a-bis(trifluoromethyl)- 
benzenemethanol and 1-methyl-4-[2,2,2-trifluoro- l-(trifluoromethyl)ethyl]-
benzene, Figure 1.7, in the presence of p-cyclodextrin. They suggested that 
interactions of the two enantiomers of a compound with the chiral cyclodextrins 
would lead to the formation of diastereomeric complexes which could be 
distinguished by NMR, and demonstrated this by their observation of a 4.3Hz 
chemical shift difference (measured at a frequency of 94.15MHz) in the 19F signal 
for the two enantiomers of 1-phenyl-2,2,2-trifluoroethanol in the presence of a- 
cyclodextrin in deuterated water.
Figure 1.6 Structure of the cyclodextrins, illustrated for a-cyclodextrin [124]
2,3'-hydrogen bond 
between tw o glucose 
units
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Figure 1.7 Structure of (I) a,a-bis(trifluoromethyl)benzenemethanol and (II) 1- 
methyl-4-[2,2,2-trifluoro-l-(trifluoromethyl)ethyl]benzene [125]
Subsequently, chiral discrimination of a range of substrates in the presence 
of cyclodextrins and their derivatives have been reported. The majority of these 
studies have employed deuterated water as solvent [126-140], although deuterated 
dimethylsulphoxide has also been used [140,141]. The applicability of this method 
to a given substrate and the most appropriate choice of cyclodextrin remains 
somewhat empirical. This is perhaps a reflection of the conclusions of some 
workers that the different magnetic environments of the diastereomeric 
cyclodextrin complexes, rather than their formation constants, are primarily 
responsible for the chiral recognition process [128,129]. Experimental variables 
which have been shown to affect the recognition process include pH [128], 
temperature [125,141] and the presence of salts [125]. These factors will be 
considered in greater detail in Chapter 2.
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CHAPTER 2
Studies of the Enantioselective Metabolism of the Profens bv NMR Bio-fluid
Analysis
2.1 Introduction
Chapter 1 referred to the aim of this work, which was to examine the 
enantioselectivity of profen metabolism, particularly with regard to the chiral 
inversion mechanism, by NMR studies of biological fluids. Ibuprofen and 
flurbiprofen were chosen as model compounds, since the metabolites of these 
drugs excreted in urine have already been elucidated by NMR [86,90,98]. On this 
basis, and because of its ready availability, urine was also chosen as the medium of 
study here.
It was our intention that the two stereochemistries of the unchanged drug in 
the biological fluid be distinguished by the addition of an appropriate water- 
soluble chiral NMR reagent. Two possible reagents capable of resolving a mono- 
functionalised carboxylic acid were identified, namely Na[Eu(III)(R or 
S)pdta(H20 )3], which was used by Kabuto and Sasaki [111] with 2- 
phenylpropionic acid, and the cyclodextrins, which have shown chiral recognition 
with ibuprofen [126] and piiprofen [128]. The commercial availability of the 
cyclodextrins, and the many literature reports of interactions of the profens with 
them [142-145], made these the reagents of choice.
Prior to the addition of such a reagent, however, it would first be necessary 
to free that part of the unchanged drug present as its glucuronide conjugate. In the 
body hydrolysis of the conjugate is brought about by the action of the p- 
glucuronidase enzyme [40]. Decomposition under basic conditions, as was used by 
Wade et al. [90] in their study of the metabolism of flurbiprofen by NMR was, 
however, considered a simpler method for use in this work.
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Initial studies were aimed at assessing the viability of the proposed method 
by examining discrimination of the enantiomers of ibuprofen and flurbiprofen by 
NMR in deuterated water in the presence of cyclodextrins, before extending the 
method to biologically relevant conditions.
2 .2 .1H, NM..R Data for ,the Cyclodextrins
The NMR spectra for ibuprofen and flurbiprofen were recorded in a 1:1 
mole ratio in the presence of a range of cyclodextrins in D20 . The cyclodextrins 
which were available to us were the a-, P- and y-cyclodextrin oligomers, and the 
p-cyclodextrin derivative 2,6-di-O-methyl-p-cyclodextrin (DMCD, Figure 2.1). 
The NMR spectra of the a-,P- and y-cyclodextrin were consistent with reported 
data [126] and showed no significant level of impurity. Chemical shifts and 
coupling constants are summarised in Table 2.1.
OM e
Me
Figure 2.1 Structure of DMCD
The !H spectrum of DMCD in D20 , shown in Figure 2.2 with assignments 
from Kobayashi [146], clearly showed significant levels of impurity, however. 
This is most clearly seen for the glycosidic HI resonance around 5.33ppm. The 
high level of impurity was not unexpected. Indeed, Irie et al. [147] have reported 
the analysis of a number of commercial preparations of DMCD by plasma-
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Cyclodextrin H1 H2 H3 H4 H5 H6
a 5.141 3.721 4.068 3.672 overlapping multiplets
(d,3.4) (dd,10.0,3.4) (dd,10.0,8.8) (t.9-2) 4.022-3.907
0 5.158 3.738 4.050 3.670 overlapping multiplets
(d,3.7) (dd,9.8,3.7) (t.9.4) (t.9.0) 4.009-3.930
y 5.196 3.742 4.020 3.674 overlapping multiplets
(d,3.9) (dd,9.9,3.8) (t.95) (t.9.4) 3.988-3.927
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Figure 2.2 400MHz 1H NMR spectrum of a 0.014M solution of DMCD in p p  at 3CPC
desorption MS and have shown them to be markedly impure, with P-cyclodextrin 
molecules carrying 13 and 15 methyl substituents as the primary contaminants. It 
was not possible to accurately assess the purity of the DMCD samples used in this 
work by !H NMR, however, because as a complex mixture of closely related 
components, there are many overlapping and unresolved resonances, at least in 
D20  [148]. No attempt at purification was made, because of the difficulty of 
identifying impurities in such samples and subsequent purification [148-150]. This 
was considered reasonable since most impurities differ in structure from DMCD 
itself only by the presence or absence of one or two methyl groups, and because no 
quantitative measurement was made concerning interaction of the drug molecule 
with DMCD.
2.3 NM.R .Stnd.jg.S-Qf IbuprQfsn and Cyclodextrin Mixtures
The JH NMR data for ibuprofen sodium (Figure 2.3), chosen over the free 
acid because of its higher aqueous solubility, in D20  is summarised in Table 2.2.
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Table 2.2 400MHz iH NMR data for a 0.014M solution of ibuprofen sodium in 
D20  at 30°C
The chemical shifts of the pair of doublets associated with the aromatic 
protons are calculated on the basis of a strongly coupled AB spin system, using 
equations given in most basic NMR texts [151]. These have been used for the 
simple para-disubstituted aromatic ring system throughout this work where the 
frequency difference of the two ]H resonances is less than six times greater than 
the coupling constant between them [152].
The assignment of the ibuprofen sodium spectrum from chemical shifts, 
coupling patterns and integrals is straight- forward, except in the case of the 
aromatic signals. The presence of the inductively electron-withdrawing 
carboxylate functionality on the alkyl chain ortho to H2’ might be expected to lead 
to a down-field shift of this resonance compared to H3'. This was confirmed by 
nOe difference spectroscopy (see Chapter 4).
The duplication and the magnitude of splitting of these signals observed in 
the presence of a mole equivalent of a-, p- and y- cyclodextrin and DMCD are 
indicated in Table 2.3. The H2 resonance is, however, masked by the cyclodextrin 
signals, so that information regarding its duplication is not available. The largest 
duplications are seen for P-cyclodextrin, the results for which reproduce those of 
Casy and Mercer [126], who reported splittings of 3Hz and 5Hz at 400MHz for the
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H3 and low field arotmatic siignals respectively. Whilst no chiral recognition is 
apparent in the presentee of y-cyclodextrin, splitting of the H3" signal is observed 
for a-cyclodextrin and DMCD, although the former is very small.
Ibuprofen sodium 
resonance
Chiral splitting in presence of cyclodextrin/ppm 
a  (3 y DMCD
H2' 0 0.009 0 0
H3' 0 0 0 0
H2 obscured obscured obscured obscured
HI" 0 0 0 0
H2" 0 0 0 0
H3 0 0.006 0 0
H3" 0.001 0 0 0.006
Table 2.3 Chiral duplication of 400MHz !H resonances of a 0.014M solution of 
ibuprofen sodium in the presence of a mole equivalent of cyclodextrin in D20  at 
30°C
The cyclodextrin chiral recognition process necessarily requires some form 
of interaction between cyclodextrin and drug. Inclusion of a substrate in the 
cyclodextrin cavity is the most commonly observed complexation process [146]. 
The formation of such an inclusion complex may be apparent from changes in 
chemical shift of both drug and cyclodextrin NMR resonances on mixing of the 
two. That each species only gives rise to a single set of resonances in such a 
mixture of ibuprofen sodium and cyclodextrin (except where duplication of drug 
signals is apparent), indicates that complexation is a fast exchange process, and as 
a result, resonances will be a population weighted average of those for the free and 
complexed species. Table 2.4 summarises the shifts of the ibuprofen sodium 






H2’ +0.022 -0.016,-0.007 -0.003 -0.015
H3’ +0.026 -0.160 -0.086 -0.263
H2 obscured obscured obscured obscured
H1" +0.058 -0.014 -0.031 -0.062
H2” +0.070 -0.011 -0.049 -0.029
H3 +0.005 +0.015,+0.009 +0.011 +0.062
H3” +0.066,+0.065 +0.029 -0.023 +0.055,+0.050
Table 2.4 Changes in 400MHz 1H NMR chemical shifts of resonances of a 0.014M solution of ibuprofen sodium in the presence of 
a mole equivalent of cyclodextrin in [^O at 30°C
in the cyclodextrin signals. The residual HDO resonance was used as an internal 
reference standard for comparison of these spectra.
Resonance a-cyclodextrin p-cyclodextrin y-cyclodextriri DMCD
HI 0 -0.029 -0.020
H2 0 -0.033 -0.021
H3 +0.010 -0.111 -0.041 -0 .0 8 0
H4 +0.002 -0.009 -0.014
H5 * >-0.179 >-0.066 — 0.175
H6 ♦ ♦ *
Table 2.5 Changes in 400MHz NMR chemical shifts of resonances of 
cyclodextrin at a concentration of 0.014M in the presence of a mole equivalent of 
ibuprofen sodium in D20  at 30°C
Common referencing methods have been discussed by Brevard and 
Granger [153]. The use here of an external reference contained in a capillary or of 
a reference sample contained in a separate tube was considered inappropriate for 
the accurate measurement of chemical shift. The use of an internal standard was 
also ruled out, since it was thought that this might interfere with the complexation 
process. Thus, Brereton et al. [154] reported that they were unable to use 
trifluoroacetate as an internal reference for their 19F NMR studies of the inclusion 
of fluoro- and difluoro- trans- cinnamates by a-cyclodextrin, as the reference was 
itself found to include within the cyclodextrin. The use of the HDO resonance as 
reference here was considered a reasonable alternative in view of the low 
concentration of the solutions used, such that necessarily most HDO molecules are 
associated with bulk solvent, and because all spectra were acquired at a fixed 
temperature of 30°C.
The shifts of the aromatic system in Table 2.4 are calculated on the basis 
that no cross-over of these signals occurs on formation of the cyclodextrin 
complex. This has been confirmed at least in the case of P-cyclodextrin (see
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Chapter 4). Determination of smaill changes in chemical shift of the cyclodextrin 
H5 and H6 resonances in the presence of ibuprofen sodium was not possible as a 
result of the overlapping nature of these resonances. Where larger changes were, 
however, observed, these are given approximately in Table 2.5.
The large shifts of the cyclodexrin H3 and H5 signals which point into the 
molecular cavity indicate the occurrence of inclusion for p- and y-cyclodextrin. 
Approximate calculations for the H3 and H5 resonances of DMCD show similar 
evidence for the inclusion process. Such upfield shifts are consistent with the 
inclusion of an aromatic ring as was shown by Demarco and Thakkar [155], who 
applied the theory of Johnson and Bovey [156,157] to inclusion complex 
formation. The shielding component of the secondary magnetic field arising from 
the aromatic ring current normal to the plane of the benzene ring is greater than the 
deshielding component in its plane at any distance from its centre, so that unless 
the guest molecule assumes some preferred fixed orientation in the cyclodextrin 
cavity, an up-field shift of the inwardly pointing cyclodextrin signals is observed. 
In contrast, the a-cyclodextrin molecule shows a down-field shift of the H3 proton 
in the presence of ibuprofen sodium, which implies that inclusion of the aromatic 
ring does not occur for this host.
Analysis of the shifts in drug signals is less straight forward, since both 
insertion into the cyclodextrin cavity and interaction near its rim have been 
suggested as causes of the larger shifts on complexation. Thus, Djedaini et al. 
[158] and Backensfeld et al. [159] both observed large down-field shifts of the ]H 
NMR signals of the indole unit compared with those of the p-chlorobenzoyl unit 
upon inclusion of indomethacin (Figure 2.4) in P-cyclodextrin and hydroxypropyl- 
p- and y-cyclodextrin respectively. Backensfeld and co-workers [159] argued that 
the indole ring was too large for insertion in the cyclodextrin cavity and that the 
large shifts in its signals arose from the butting of the indole moiety on the margin 
of the cyclodextrin ring on inclusion of the p-chlorobenzoyl ring. Djedaini et al.
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[158], however, interpreted their results as occurring as a consequence of the 
inclusion of part of the indole ring in the cyclodextrin cavity. It would therefore 
appear difficult to unequivocally correlate such shifts with complex structure. 
Additionally, in relation to the ibuprofen sodium structure, precedents for the 
insertion of both aromatic rings and aliphatic chains are also known. Kotake and 
Janzen [160], for example, were able to observe inclusion of both the r-butyl 
substituent and the phenyl ring of some nitroxide radicals with p-cyclodextrin by 
ESR. The same authors have also used ESR to demonstrate the relative preferences 
of y-cyclodextrin for various structural units [161].
Figure 2.4 Structure of indomethacin
Two classes of complex may be distinguished from the changes in 
chemical shift of the ibuprofen sodium signals, given in Table 2.4. Firstly, in the 
presence of P- and y-cyclodextrin and DMCD a large upfield shift of one of the 
aromatic signals (regardless of whether signal cross-over occurs or not), which is 
bigger than any other shift, is observed. For the a-cyclodextrin solution the shift o f 
the H2" resonance of the ibuprofen sodium isobutyl chain is larger than that for 
any other cyclodextrin. In addition, this resonance and that for the isobutyl H I" 
show a down-field shift in contrast to that of the other hosts. These observations
CHo-C00H
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suggest that in the case of a-cyclodixtrin, inclusion of the isobutyl chain is 
favoured over that of the aromatic ring, whereas for the other cyclodextrins 
examined here, aromatic inclusion is preferred. This is presumably a result of the 
greater compatibility of inclusion of the isobutyl chain either partially or fully into 
the smaller cavity of the a-cyclodextrin macrocycle. Since the isobutyl chain lies 
far from the chiral centre of the drug molecule, this perhaps contributes to the 
minimal chiral duplication of the ibuprofen sodium signals in the presence of a- 
cyclodextrin . For the larger y-cyclodextrin oligomer, it is reasonable to assume 
that binding of the aromatic ring is not sufficiently tight for chiral recognition 
between guest and host to occur. Requirements for chiral discrimination are 
considered further in Chapters 3 and 4.
The differences in magnitude of shifts in both drug and cyclodextrin signals 
for this series of complexes may be associated with differences in formation 
constant or the intrinsic magnetic environment of the complex. Chiral 
discrimination may similarly be ascribed to small differences in the formation 
constant of the complexes of each enantiomer or to structural differences of the 
two diastereomeric complexes. The ibuprofen sodium/DMCD complex is 
particularly interesting in this regard. Figure 2.5 (i) and (ii) shows the H3" 
resonance of ibuprofen sodium and its duplication in the presence of DMCD. The 
unequal peak sizes observed for the complex are consistent with resonances arising 
from the two methyl groups of the isobutyl substituent remaining equivalent in the 
diastereomeric complex of one enantiomer, but becoming inequivalent in the 
complex of the other with partial peak overlap. This was confirmed by analysis of 
the sodium salts of the two pure ibuprofen enantiomers in the presence of DMCD, 
Figure 2.5 (iii) and (iv). The complex of the S enantiomer is that which shows an 
inequivalence of the two methyl groups. This distinction of the two methyl groups 
highlights the importance of the differential magnetic environment in such 
complexes. Other authors have similarly attributed chiral discrimination in NMR
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Figure 2.5 400MHz H3" resonance of a 0.014M solution of (i) ibuprofen sodium, 
(ii) ibuprofen sodium in the presence of a mole equivalent of DMCD, (iii) S(+)- 
ibuprofen sodium in the presence of a mole equivalent of DMCD and (iv) R(-)- 
ibuprofen sodium in the presence of a mole equivalent of DMCD in DzO at 30°C
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spectra by cyclodextrins primarily to magnetic rather than thermodynamic 
differences of the diastereomers [128,129].
The inequivalence of the two isobutyl methyl resonances observed for the 
ibuprofen sodium/DMCD complex must also raise the question as to whether the 
pair of doublets forming the H3" signal for the ibuprofen sodium/a-cyclodextrin 
complex is indeed the result of a chiral discrimination process or of the 
inequivalence of the two methyl resonances in both of the ibuprofen sodium/a- 
cyclodextrin diastereomeric complexes. This could ideally be elucidated by 
examination of the !H NMR spectra for the individual ibuprofen sodium 
enantiomers in the presence of a-cyclodextrin, as in the case of DMCD, but the 
splitting of the resonances with a-cyclodextrin was considered too small for this 
distinction to be made.
With use of an appropriate resolution enhancement function, it was 
possible to obtain baseline separation of the chiral splitting of the ibuprofen 
sodium H3" resonance in the presence of DMCD , and of the low field aromatic 
and H3 signals in the presence of p-cyclodextrin. Under such conditions, 
additional duplications of some ibuprofen sodium resonances were identified, but 
since these were not observable under routine processing conditions were 
considered insignificant.
Resolution enhancement may lead to distortion of peak integrals and a loss 
of accurate quantitative information. To ensure that quantitation was not precluded 
by the use of such a function here, a series of solutions prepared from different 
ratios of the pure ibuprofen enantiomers to fixed total concentration in the 
presence of a mole equivalent of P- cyclodextrin were examined and their 
enantiomeric purity determined. Ibuprofen sodium salts were formed in situ by use 
of alkaline D20  as solvent The !H H3 resonance of these solutions was chosen for 
quantitation since the low field aromatic resonance showed some fine structure 
associated with deviation from first order coupling behaviour. For simplicity, a
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comparison of peak heights of the H3 signal of each of the two enantiomers was 
made, and the enantiomeric purity compared with the known value. Table 2.6 
shows the results of this study.






Table 2.6 Determination of the enantiomeric purity of ibuprofen sodium at a 
concentration of 0.040M in the presence of a mole equivalent of p-cyclodextrin in 
0.07M NaOD in D20  by 400MHz 'H NMR at 25°C
In general, the ratio of (S)- to (R)-ibuprofen found by NMR is in close 
agreement with the expected value. Only one solution showed any significant 
deviation between the two, which suggests that it may be the consequence of an 
inaccuracy in the weighing of a small quantity of enantiomer. Examination of 
solutions of the supposedly pure enantiomers confirmed that each contained less 
than 5% of the other.
For the ibuprofen sodium/DMCD mixture, peak heights were found to be 
inadequate for the determination of the enantiomeric purity from the H3" 
resonance, since the overlapping peaks which give rise to the low field doublet 
lead to broadening of this signal in comparison to that at higher field (Figure 2.5). 
The measurement of peak integrals is therefore required.
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2.4 Extension of NMR Studies of Ibuprofen Sodium and Cyclodextrin Mixtures to 
Biological Fluids
The NMR spectrum of a freeze-dried human urine sample reconstituted 
in D20 , with some concentration, is shown in Figure 2.6. Many of the resonances 
from endogenous metabolites have previously been identified, and the most 
prominent are labelled here [65,86,98]. It can be seen from this spectrum that there 
are several areas free of these endogenous metabolites, and therefore suitable for 
study of xenobiotic metabolism.
Figure 2.6 also shows an identical sample spiked with 0.65mg of ibuprofen 
sodium, which is of the order of the concentration to be expected in vivo. The drug 
resonances, which are all within O.Olppm of their shifts in D20 , are indicated 
where they are clearly identifiable, and it is readily apparent that the H3" signal 
would be most suited to any attempt at chiral discrimination because of its large 
height and separation from endogenous peaks. The comparative prominence of the 
H3" signal of ibuprofen and its metabolites in urine samples can similarly be seen 
in Figure 2.7, which shows the NMR spectrum of a human urine sample 
following ingestion of 400mg ibuprofen, and confirms the work of Wilson and 
Nicholson [86,98]. Reconstitution of an equivalent sample in alkaline D20  allows 
glucuronide hydrolysis to be achieved as expected. This is most readily apparent 
from the disappearance of the H3 resonance of ibuprofen glucuronide from the 
spectrum under such conditions. The H3 resonance of the resulting free ibuprofen 
is obscured beneath that of the other metabolites, and is thus ruled out for use in 
determinations of enantiomeric purity (Figure 2.7).
The only cyclodextrin which allowed reasonable chiral discrimination of 
the isobutyl methyl resonance was the ibuprofen sodium/DMCD system, and the 
reproduction of this recognition was therefore attempted in urine.
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a = histidine 
b = hippuratc 
c = urea 
d = creatine 
e = glycine
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Figure 2.6 400MHz 1H NMR spectrum of (i) freeze-dried human urine reconstituted in 1^0 and (ii) as (i) with added ibuprofen sodium at 30AC
1. aromatic resonances of ibuprofen and metabolites
2. glucuronide resonance
3.113 resonance of ibuprofen glucuronide
4-6. methyl resonances of metabolites IIMPPP and CPPP
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Figure 2.8 400MHz JH H3" resonance of a 0.0044M solution of ibuprofen sodium 
in the presence of varying equivalents of DMCD (A) in D20  and (B) in freeze- 
dried human urine in D20  at 30°C
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Figure 2.8 shows the chiral splitting of the H3" resonance of ibuprofen 
sodium in D20  with increasing equivalents of DMCD added. Above a 1:17 ratio of 
drug to cyclodextrin the splitting is lost. That shifts in !H resonances of the drug 
observed in the presence of a mole equivalent of DMCD are not enhanced at high 
mole ratio of cyclodextrin suggests that this is the result of some disruption of the 
inclusion process, possibly as a result of associative complexation of the 
cyclodextrin molecules at high concentration. The viscosity of such a concentrated 
solution may also lead to enhanced rates of relaxation and consequent line- 
broadening and loss of resolution.
Figure 2.8 also shows the isobutyl methyl resonance for equivalent 
solutions used to reconstitute samples of the same freeze-dried urine specimen as 
that used in Figure 2.6. A greater than 1:1 ratio of ibuprofen sodium to DMCD was 
chosen to allow for competitive inclusion by the many endogenous urinary 
components. Even at a mole ratio of 1:5, for which a 0.006ppm splitting was 
observed in D20 , no chiral recognition of the H3" resonance is apparent in the 
urine sample. Several possible explanations for this observation may be 
considered.
i  - i  t ~ i  i i |  i r  i  t  j
2. 3 2.7 2. 6
Figure 2.9 Part of the 400MHz spectrum of a freeze-dried human urine sample 
reconstituted in D20  at 30°C, showing overlap of the sarcosine N-methyl and 
citrate resonances
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1. The increased viscosity and particulate nature of the urine sample compared to 
that of D20  may lead to an increase in relaxation rate and loss of homogeneity 
respectively, which results in peak broadening and a loss of resolution.
Some measure of the effective resolution of the spectra can, however, be 
achieved by observation of the sarcosine N-methyl signal which overlaps with that 
arising from one of the citrate doublets (Figure 2.9). Their separation is 0.005ppm 
in blank urine, which suggests that the 0.006ppm splitting of the ibuprofen 
sodium/DMCD system in such a medium should be readily apparent if achieved. 
In fact, the resolution of the sarcosine and citrate resonances is still apparent in the 
presence of the 1:5 ibuprofen sodium/DMCD solution, but is lost for the 1:17 mole 
ratio solution, most probably as a result of line-broadening in such a highly 
concentrated and viscous sample.
2. The level of DMCD may not be sufficient to eliminate disruption of the 
ibuprofen complexation process by competing endogenous metabolites. Inspection 
of the aromatic resonances of ibuprofen in urine samples spiked with the drug 
shows, however, their chiral duplication in the presence of 5 and/or 17 mole 
equivalents of DMCD and indicates that significant levels of complexation of the 
drug with the cyclodextrin remain, Figure 2.10.
3. Chiral discrimination of these aromatic resonances was not observed in 
equivalent samples prepared in D20 , which suggests that rather than preventing 
inclusion of the ibuprofen molecule in the DMCD cavity, some endogenous 
urinary component gives rise to a change in structure, and hence nuclear magnetic 
properties, of the resulting complex.
The protonation of the ibuprofen salt might, for example, give rise to some 
such alteration of complex structure. The pH of a human urine sample is, however, 
typically in the range 4.8-7.8 [162], and since the pKa of ibuprofen is 4.63 [142],
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Figure 2.10 Part of the 400MHz NMR spectrum of freeze-dried human urine 
spiked with 0.65mg of ibuprofen sodium and reconstituted in DzO in the presence 
of (A) 5 equivalents and (B) 17 equivalents o f DMCD at 30°C
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the carboxylate group of the ibuprofen molecule should remain at least 
approximately 50% ionised. It must be noted, however, that deviation from this 
pKa value may occur as a result o f the deuterated solvent environment [163] and 
upon inclusion of the drug in the cyclodextrin macrocycle [123].
Since the desired duplication of the ibuprofen H3" resonance in the 
presence of DMCD is not achieved and the aromatic resonances of the drug, which 
do show duplication, are not resolved from those of its metabolites in vivo, Figure
2.7 and the work of Wilson and Nicholson [86,98], it is concluded that the nature 
of the biological medium precludes the use of DMCD as a chiral reagent for the 
determination of the enantiomeric purity of ibuprofen in such studies.
The significance of the effects of medium would presumably have been 
less had the initial chiral splitting in D20  been larger and thus more robust. 
Methods of enhancing the enantioselectivity of the ibuprofen sodium/cyclodextrin 
system are considered further in Section 2.7 below.
2.5 NMR Studies of Flurbiprofen and Cyclodextrin Mixtures
C H  o — \ n £ 0 0 ~ N aH
4”
Figure 2.11 Structure of flurbiprofen sodium
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The !H NMR spectrum of flurbiprofen sodium (Figure 2.11) in DzO is 
considerably more complex than that of ibuprofen sodium, because of the biaryl 
ring system and the additional complication of coupling to the 19F nucleus. Table
2.7 summarises the data. Assignments are based on coupling patterns and peak 
integrals, and since there is some discrepancy between our interpretation and that 
of Wade et al. [90], they were confirmed by a COSY-45 experiment (Chapter 4).
In the presence of a mole equivalent of a-cyclodextrin, the chemical shifts 
of the drug signals show a small down-field shift, whereas those of the 
cyclodextrin move slightly up-field (Tables 2.8 and 2.9 respectively). Again, 
chemical shifts for the cyclodextrin H5 and H6 protons could not be accurately 
determined because of their overlapping nature, but changes upon addition of 
flurbiprofen sodium were clearly small. Such data are not consistent with any 
significant level of inclusion complex formation, so that as for ibuprofen sodium, 
the cavity of the a- cyclodextrin macrocycle would appear to be too small for 









7.283 (dd, 12.2,1.7) H2'
3.773 (q,7.2) H2
1.522 (d,7.3) H3
Table 2.7 400MHz JH NMR data for a 0.014M solution of flurbiprofen sodium in 
D20  at 30°C
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Table 2.8 Change in 400MHz !H chemical shift of resonances of a 0.014M 
solution of flurbiprofen sodium in the presence of a mole equivalent of a- 
cyclodextrin in D20  at 30°C
In the case of P- and y-cyclodextrin and DMCD, however, large up-field 
shifts of the H3 and H5 cyclodextrin proton signals are observed in accordance 
with the inclusion of an aromatic substrate (Table 2.9). Shifts in the drug signals 
are also apparent but, as a result of extensive overlap of the aromatic resonances, 
are not readily assigned in most cases. Some broadening of the aromatic signals, 
resulting in a loss of small couplings and fine structure, is also seen. This may be 
accounted for by the reduced rate of tumbling of the aromatic ring system of the 
flurbiprofen molecule on complexation with the cyclodextrin , leading to enhanced 
rates of relaxation. The rate of exchange of the drug between free and complexed 
states could also have some effect on the linewidths of drug resonances if it were 
to be intermediate between the two extremes of slow and fast exchange. Since 
other resonances do not appear to be affected, however, it is believed that the 
complexation process remains in the fast exchange lim it
As a result of the complexity of the aromatic resonance coupling pattern, 
chiral recognition of the flurbiprofen molecule leading to duplication of the 
NMR signals is most readily observed for the H3 and H2 (where visible) protons. 
Even so, in the latter case chiral splitting was difficult to determine with accuracy 




Change in chemical shift/ppm 
H3 H4 H5 H6
a -0.012 -0.014 -0.030 -0.014 * ★
0 -0.075 -0.102 -0.177 -0.041 >-0.246 *
y -0.055 -0.050 -0.109 -0.043 >-0.118 *
DMCD --0.157 -  -0.223
Table 2.9 Change in 400MHz ’H chemical shift of a 0.014M solution of cyclodextrin in the presence of a mole equivalent of 
flurbiprofen sodium in D^O at 30°C







DMCD partially obscured 0.002
Table 2.10 Chiral splitting of 400MHz *H H2 and H3 resonances of a 0.014M 
solution of flurbiprofen sodium in the presence of a mole equivalent of 
cyclodextrin in D20  at 30°C
Splittings are observed for the p- and y-cyclodextrin and DMCD solutions, 
which are those shown to favour inclusion of the aromatic ring system of 
flurbiprofen. As for ibuprofen sodium, chiral recognition of flurbiprofen sodium is 
greatest with P-cyclodextrin again because of the compatibility of the sizes of the 
flurbiprofen molecule and the p-cyclodextrin cavity (Chapter 3). That methylation 
of the P-cyclodextrin molecule appears to hinder this discrimination process, and 
also alters the nature of that with ibuprofen sodium may be associated with the 
marked difference in conformational properties of p-cyclodextrin and DMCD 
[164-166], The structure of the flurbiprofen sodium complex with cyclodextrins 
will be considered in more detail in Chapters 3 and 4.
The 19F NMR spectra of flurbiprofen in the presence of a-,P- and y- 
cyclodextrin and DMCD were also examined for evidence of inclusion and chiral 
discrimination of the flurbiprofen molecule. Table 2.11 shows the shifts and 
splittings of the 19F{]H} singlet resonance. Note that these samples were prepared 
by dissolution of the free acid flurbiprofen (and cyclodextrin) in approximately







Table 2.11 Chiral splitting of the 254MHz 19F{ 1H} resonance of a solution of 
0.011M flurbiprofen in the presence of a mole equivalent of cyclodextrin in 0.07M 
NaOD in D20
The largest splitting was observed for DMCD, and was sufficiently large 
that use of a sine-bell window function, in place of the exponential function 
routinely used, allowed baseline resolution of the resonance from each enantiomer 
and the possibility of quantitation.
2.6 Extension of NMR Studies of Flurbiprofen and Cyclodextrin Mixtures to 
BiplQgiqal Flpids
Since the splitting of the 19F{ !H} resonance in the flurbiprofen/DMCD 
system was the greatest of those observed, and because of the ease of analysis of 
bio-fluids by 19F NMR, as a result of the lack of interfering endogenous 
metabolites, we chose to examine flurbiprofen metabolism by 19F{ NMR, 
using DMCD as chiral solvating agent. The rat was chosen as the species for study 
in the first instance.
Figure 2.12 shows the 19F{!H} NMR spectrum of a urine sample collected 
0-7.5 hours following oral administration of a lOmg/kg dose of a suspension of 
flurbiprofen in 1% aqueous tween 80. The signal-to-noise ratio of this spectrum 
remains low despite the accumulation of 9000 scans, corresponding to an 
experiment time of 5 hours. The improvement in sensitivity as a result of sample
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Figure 2.12 aySMHz^FlVf} spectrum of rat urine following oral administration of flurbiprofen. The sample has been freeze-dried and reconstituted 
in 0.07M NaOD in D p
concentration is limited by the srmall volume of urine a rat typically produces. In 
this study, for example;, 2-4ml was collected in the first 7.5 (day-time) hours with 
an increased production of 6-8ml (Overnight.
The sample has been fireeze-dried and reconstituted in approximately
0.07M NaOD in D20 , to allow hydrolysis of any glucuronides present. Significant 
levels of a number of metabolites are clearly present. Spiking of an equivalent 
blank urine sample with flurbiprofen suggested that the resonance of the drug 
should appear in the region of metabolite (iv), but since it was expected to be 
present at considerably lower levels in comparison to other metabolites [34], and 
therefore in this case was probably not detected, we identify (iv) as more likely 
arising from the metabolite 2-(2-fluoro-4'-hydroxy-4-biphenylyl)propionic acid, 
Figure 2.13, which is known to lie very close in chemical shift to the free drug 
[90]. Resonances (ii) and (iii) lie within 0.3ppm down-field of metabolite (iv) and 
probably arise from other known metabolites, Figure 2.13. The remaining 
prominent signal at -116.62ppm shows an unexpectedly large down-field shift in 
relation to other resonances (approximately 3ppm) which suggests that it is most 
likely the product of metabolic transformation of the fluorophenyl as opposed to 
phenyl aromatic ring. This proposal is supported by the effect on 19F chemical shift 
of the introduction of a hydroxyl substituent to the fluorobenzene ring, Table 2.12. 
Data in this table suggest that metabolite (i) may then be the result of oxidative 
metabolism at the 5' position of flurbiprofen. Such a metabolite has not previously 
been identified in metabolic studies of flurbiprofen, however.
The experiment was repeated with an increased dosage of 75mg/kg (oral 
LD50=88mg/kg, [168]) for improved sensitivity. Dissolution of the dose was 
achieved in an equivalent of aqueous sodium hydroxide to avoid the inaccuracies 
of the administration of a suspension. The higher dose was, however, found to 
induce diarrhoea in the rat which received it, and was therefore considered 























Table 2.12 19F chemical shift data (relative to CFC13) for fluorobenzene and the 
fluorophenols. Ranges represent the results of a number of studies in a range of 
solvents [167]
Attempts to reproduce the duplication of the flurbiprofen 19F resonance 
observed in D20  in the presence of DMCD were unsuccessful in the biological 
fluid as in the case of ibuprofen. Thus, a ffeeze-dried rat urine sample reconstituted 
in alkaline D20  and with 0.35mg of a flurbiprofen spike added failed to show 
duplication of the 19F{JH} resonance in the presence of DMCD, added in excess 
(approximately 16.4 equivalents), to avoid competitive binding of other urinary 
constituents. A down field shift of the 19F resonance suggested that some 
interaction of the flurbiprofen and cyclodextrin was present, and that 
discrimination of the flurbiprofen enantiomers was not achieved for reasons 
similar to those outlined for ibuprofen sodium (Section 2.4).
2.7 Factors Affecting Chiral Recognition of Ibuprofen and Flurbiprofen . by 
Cyclodextrin.s in, NMR. Spectroscopy
Since the action of cyclodextrins as chiral solvating agents appeared to be 
diminished in urine samples, methods were investigated to enhance the chiral 
recognition process in an attempt to minimise the effect of changing from an 
aqueous to biological medium. Such experiments also allow some insight into the 
importance of various aspects of the recognition process. The P-cyclodextrin 
complexes of ibuprofen sodium and flurbiprofen sodium were chosen for these
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studies, as a result of the considerably lower cost of p-cyclodextrin compared to 
that of the other cyclodextrins used in this work.
2.7.1 Effect Qf Variations in Mofe RflpQ and CQPCentratiQn
Complexation of a chiral drug with a cyclodextrin molecule can be 
represented as a pair of rapidly-exchanging, competing equilibrium processes of 
the form:
R-drug + cyclodextrin (R-drug.cyclodextrin)
S-drug + cyclodextrin ^  (S-drug.cyclodextrin)
for which the equilibrium constants KR and Ks may be given by:
Kr = [(R-drug.cvclodextrin)] (2.1)
[R-drug] x [cyclodextrin]
Ks = [(S-drug.cyclodextrin)] (2.2)
[S-drug] x [cyclodextrin]
These expressions presuppose that the stoichiometry of the complex is 1:1 
drug:cyclodextrin, as is most commonly the case [123]. If it is further assumed that 
Kr=Ks, the system may be simplified to:
drug + cyclodextrin ^  drug.cyclodextrin
with an equilibrium constant K such that:
K = [ (drug.cyclodextrin)] (2.3)
[drug] x [cyclodextrin]
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Perturbation of the equilibrium by addition of further cyclodextrin will lead 
to increased formation of complex, such that the ratio of free to complexed drug 
will be reduced, and where chiral discrimination is present in the NMR spectrum 
as a result of the differential magnetic environment experienced by each 
enantiomer within the cyclodextrin cavity, this will be enhanced. Table 2.13 shows 
the effect on !H drug resonances of increasing the drug: p-cyclodextrin mole ratio 
from 1:1 to 1:3 for flurbiprofen sodium and ibuprofen sodium. Whilst the expected 
increase in splitting of stereochemically-recognised signals is observed, its size is 
in all cases small. Similarly, the splitting of the H3" resonance of ibuprofen 
sodium in the presence of DMCD was not found to improve at a 1:5 mole ratio of 
drug to cyclodextrin, whereas much higher levels of cyclodextrin were found to 




Ibuprofen sodium Flurbiprofen sodium
H2' H3 H3 H2
1:1 0.009 0.005 0.008 0.012
1:3 0.011 0.007 0.009 -0.016
Table 2.13 The effect of mole ratio on the chiral discrimination of 400MHz 
resonances of 0.0056M solutions of ibuprofen sodium and flurbiprofen sodium in 
the presence of varying mole ratios of p-cyclodextrin in D20  at 30°C
It was thought that the limited effect of the changes in drug to cyclodextrin 
mole ratio might be a consequence of extensive binding of the drug to the 
cyclodextrin, such that increased concentrations of p-cyclodextrin would then not 
significantly alter the ratio of bound to free drug. In order to further investigate this 
proposal, changes in !H NMR chemical shift of the drug resonances in each
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solution from those in the absence of cyclodextrin were calculated. Table 2.14 
shows the results for ibuprofen sodium. The increase in change of chemical shift in 
the presence of 3 mole equivalents of cyclodextrin over that in the presence of 1 is 
small, and thus supports the argument above.
Ibuprofen sodium 
resonance
Change in chemical shift/ppm 
Mole ratio ibuprofen sodium: p-cyclodextrin 
1:1 1:3





H3 +0.010 & +0.005 +0.012 & +0.005
H3" +0.023 +0.028
Table 2.14 Changes in 400MHz chemical shift of resonances of a 0.0055M 
solution of ibuprofen sodium in the presence of varying mole ratios of p- 
cyclodextrin in D20  at 30°C
If it is again assumed that the formation constants for each diastereomeric 
complex are equal, then the observed drug chemical shift 5d0 in each solution will 
be given by:
8d0 = (l-f)5df + f5dc (2.4)
where 5df and 8dc are the drug chemical shift in the free and complexed state 
respectively, and f is the mole fraction of the drug in the complex.
Thus,
5d0 - 5df = f(5dc -8df) (2.5)
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so that since (8dc-8df) is a constant, the change in drug chemical shift on addition 
of the cyclodextrin is directly proportional to the mole fraction f of complex. For 




where fj and f2 are the mole fractions of complex for each solution.
Analysis of the data in Table 2.14 reveals the following linear relationship 
between the two data sets,
The constant term in this expression is sufficiently small that it may be neglected, 
which gives:
with correlation coefficient 0.99995, where 6dj and 8d2 refer to the 1:1 and 1:3 
drugxyclodextrin solutions respectively.
Comparison of equation (2.7) with equation (2.6) suggests that the 
assumption required for the derivation of the former is valid for the ibuprofen 
sodium/p-cyclodextrin system, that is, that chiral recognition occurs as a result of 
differences in magnetic shielding in each diastereomeric complex, and not from 
differences in the formation constant for each complex.
Then, for the two ibuprofen sodium/p-cyclodextrin solutions examined
here,





which allows calculation of the equilibrium constant for complex formation K, 
assuming a 1:1 stoichiometry of the ibuprofen sodium: p-cyclodextrin complex 
(which is later demonstrated, Section 4.5) such that:
K = 4080 M 1
A similar analysis of the flurbiprofen sodium/p-cyclodextrin system is 
precluded by the complexity of the aromatic region of the !H NMR spectrum of 
flurbiprofen sodium in the presence of the cyclodextrin. Changes in chemical shift 
of the H3 resonance with different mole ratios of p-cyclodextrin do, however, 
suggest levels of complexation comparable with those of ibuprofen sodium.
Equilibrium constants for the P-cyclodextrin complexes of ibuprofen and 
flurbiprofen in aqueous solution have previously been calculated to be 10800 M 1 
and 4340M*1 (at 25°C) respectively. These values, although of a similar order of 
magnitude to the equilibrium calculated here, are not, however, strictly comparable 
with measurements of the salts of the drug.
Increased concentrations of host and guest at fixed mole ratio may also be 
expected to lead to raised levels of complexed to free drug and enhanced chiral 
splittings. Table 2.15 shows the effect on the resonances of ibuprofen sodium 
and flurbiprofen sodium of increasing concentrations in the range 5.5-56mM in the 
presence of a mole equivalent of P-cyclodextrin. The splittings of the H3 and H2' 
signal of ibuprofen sodium are essentially independent of concentration over the 
range studied.
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Concentration/mM Chiral splitting/ppm 
ibuprofen sodium flurbiprofen sodium
H2' H3 H3 H2
-5.5 0.009 0.005 0.008 0.012
-14 0.009 0.006 0.010 -0.016
-55 0.010 0.006 0.016 0.018
Table 2.15 Effect of concentration on the chiral splitting of 400 MHz JH 
resonances of ibuprofen sodium and flurbiprofen sodium in the presence of a mole 
equivalent of P-cyclodextrin in D20  at 30°C
Our results have already suggested that the mole fraction f of the p- 
cyclodextrin complex for ibuprofen sodium will be the same for each enantiomer 
of the racemate drug. Then the observed chemical shift of the R and S
enantiomers, in the presence of cyclodextrin, 8R0 and 8S0, will be given by:
5R0 = (l-f)8Rf + f5Rc (2.8)
8S0 = (l-f)5Sf + f8Sc (2.9)
where subscripts f and c denote the free and complexed states respectively.
Thus, from equations (2.8) and (2.9), since 8Rf=8Sf
chiral splitting= 8R0 -8S0 = f(8Rc - 8Sc) (2.10)
and since (8RC - 8Sc) is a constant,
chiral splitting a  f  (2.11)
In order therefore to achieve a significant increase in the chiral splitting of 
a resonance, it is necessary to bring about a corresponding increase in the mole
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fraction of the complex. From our calculations above, we determine that 
approximately 81% of the ibuprofen sodium is complexed in the solution of the 
lowest concentration examined here. It is therefore not surprising that increased 
concentrations of solution did not bring about a marked improvement in chiral 
discrimination, since even in weak solutions recognition is already close to its 
maximum value.
For the H3 resonance of flurbiprofen sodium a doubling of the chiral 
splitting following a ten-fold increase in concentration was observed in addition to 
a large increase of that of the H2 resonance. On the basis of preceding discussions, 
this increase was unexpectedly large, and was therefore suspected of being a 
consequence of some change in the complexation process at high concentrations, 
presumably as a result of molecular association. Interpretation of such differences 
in behaviour are difficult, however, because of the complexity of the equilibrium 
process.
2.7.2 Effect of Variations in Temperature
Solution temperature can significantly alter the position of the equilibrium 
processes described above. At temperatures which favour complexation, improved 
performance of the cyclodextrin as a chiral solvating agent may be anticipated. 
Thus, MacNicol and Rycroft [125] reported increased prochiral recognition of an 
aromatic substrate by P-cyclodextrin as the temperature was decreased.
The effect of both high and low temperatures on the duplication of the H3 
and H2' resonances of ibuprofen sodium in the presence of a mole equivalent of P- 
cyclodextrin are shown in Table 2.16. Enhanced chiral splitting at lower 
temperatures (although necessarily limited by the freezing point of the aqueous 
solvent) is clearly observed, and is indicative of increased levels of complexation 
and therefore the exothermicity of the complexation process. Cyclodextrin
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complexation is indeed commonly associated with a negative change in enthalpy. 
The thermodynamics of complexation will be considered in greater detail in 
Chapters 3 and 4.






Table 2.16 Effect of temperature on the chiral splitting of 400MHz ]H resonances 
of a 0.014M solution of ibuprofen sodium in the presence of a mole equivalent of 
p-cyclodextrin in D20
An enhancement of the splitting of the H2 and H3 resonances of a 1:1 mole 
ratio of flurbiprofen sodium and p- cyclodextrin at reduced temperature is also 





Table 2.17 Effect of temperature on the chiral splitting of the 400MHz 
resonances of a 0.014M solution of flurbiprofen sodium in the presence of a mole 
equivalent of P-cyclodextrin in D2Q
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2.7.3 Effect of Added Salts on Complexation
During the course of their work, MacNicol and Rycroft [125] also observed 
that chiral discrimination by cyclodextrins may be improved by the presence of 
inorganic salts such as the chlorides of sodium and lithium. The authors suggest 
that the salt leads to a type of 'salting out' of the guest into the cyclodextrin cavity 
and possibly a change in structure of the complex itself. Other studies have also 
related the importance of ionic species in the complexation process [123].
We investigated the effect of 5M sodium chloride on the splittings of the 
ibuprofen sodium and flurbiprofen sodium p- cyclodextrin systems.
The ibuprofen sodium spectrum shows a very slight reduction of the 
splitting of the low-field aromatic doublet (0.008ppm), whilst that of the H3 
resonance is lost completely, with some asymmetry of the H3" resonance 
becoming apparent. This differential effect upon the chiral splittings of the low- 
field aromatic and H3 resonances suggests that the salt leads to some structural 
change within the complex.
The H3 resonance of 1:1 flurbiprofen sodium: p- cyclodextrin in 5M 
sodium chloride, in contrast, shows a slight increase in splitting to 0.01 lppm 
compared to that in D20  solution, although its cause remains unclear. The H2 
resonance is insufficiently resolved from neighbouring cyclodextrin resonances to 
determine either the presence or extent of chiral duplication under such conditions.
That the presence of salts may give rise to structural changes in the 
cyclodextrin complex, at least in the case of ibuprofen sodium, renders their use as 
additives to enhance chiral duplication unpredictable. Their sometimes detrimental 
effect, observed here for ibuprofen sodium must have important implications 
regarding the use of cyclodextrins in biological media which contain large amounts 
of inorganic salts. Thus, such salts must be considered a possible source of the 
alteration of chiral recognition effects in the urine samples examined previously.
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2.7.4 Effect of Variations in Solution pH
pH has been shown to have a significant effect on the formation of 
inclusion complexes by cyclodextrins. Thus, Uekama et al. [128] observed that 
chiral recognition of the NSAID pirprofen , Figure 2.14, by P-cyclodextrin was 
increased in acidic as opposed to alkaline solution. The authors suggested that this 
was a consequence of differential binding modes. In alkaline solution, the 
carboxylic acid group is deprotonated, and inclusion occurs preferentially at the 
more hydrophobic pyrroline site. In acidic solution, however, protonation of this 
pyrroline ring favours inclusion of the phenylpropionic functionality, which, lying 
closer to the chiral centre, leads to improved chiral discrimination.
Figure 2.14 Structure of pirprofen [128]
The effect of pH on the chiral recognition by cyclodextrins in the !H NMR 
spectra of ibuprofen and flurbiprofen were investigated here. We attempted to 
examine each of the three possible ionisation states of the inclusion complexes, by 
dissolution of:
1. the free acid NSAID and p-cyclodextrin in D20 ;
2. the salt of the NSAID and p-cyclodextrin in D20;
3. the salt of the NSAID and p-cyclodextrin in approximately 1M NaOD in D20 , 






Observations for mixtures of salt and cyclodextrin in D20  have already 
been described above. Dissolution of mixtures of the free acid and p-cyclodextrin 
in D20  were not achieved despite agitation for two hours in an ultrasonic bath. 
This may be a consequence of either a thermodynamic or kinetic phenomenon 
[123]. Certainly, in the case of flurbiprofen dissolution is limited by the low 
solubility of the p-cyclodextrin complex [143].
Dissolution of a mole equivalent of ibuprofen sodium and p- cyclodextrin 
in NaOD/D20  leads to a substantial change in the NMR spectrum of the drug to 
that observed in D20 . Table 2.18 summarises the duplication of drug resonances in 
both cases.
A reduction in splitting of the H3 and low-field aromatic resonance is 
accompanied by an increase in that of the H3" doublet (although this may be a 
distinction of a prochiral rather than chiral nature, Section 2.3). Additionally, the 
H2 resonance is now visible and is seen to show chiral duplication. This 
simultaneous observation of both increases and decreases in signal splitting within 
the spectrum suggests that the result of raised solution pH is to bring about a 
change in complex structure.
Ibuprofen sodium resonance Chiral splitting/ppm 





Table 2.18 Chiral splitting of 400MHz resonances of a 0.014M solution of 
ibuprofen sodium in the presence of a mole equivalent of p-cyclodextrin in 
approximately 1M NaOD in D20  at 30°C
A mixture of flurbiprofen sodium and P-cyclodextrin failed to dissolve 
completely in alkaline D20  following shaking in an ultrasonic bath for two hours.
2.7.5 Effect of Variations in Solvent
The thermodynamic stability and structure of a cyclodextrin complex will 
depend greatly on the solvent in which it is dissolved. The formation of complexes 
is best achieved in aqueous solvents, DMSO or DMF [123]. Since deuterated DMF 
is very expensive, and because the non-deuterated molecule gives rise to three 
resonances in its ]H NMR spectrum which would be difficult to suppress 
simultaneously to obtain an adequate dynamic range, ibuprofen sodium and 
flurbiprofen sodium complexes have been investigated only in dg-DMSO. The 
comparison of spectra in deuterated and non-deuterated water has also been made.
1. Deuterated versus Non-deuterated Water
The hydroxylic protons of cyclodextrins are in fast exchange in aqueous 
solution. In deuterated water, this will mean their replacement by deuterons, which 
w ill, for example, lead to differing thermodynamic stability of the complex should 
the exchangeable hydroxyl groups be involved in the donation of a hydrogen bond 
to an included drug. Additionally, changes in solvation of the complex may be 
anticipated.
Table 2.19 summarises the chiral splittings of those resonances in the 
NMR spectra of ibuprofen and flurbiprofen sodium which are readily observed to 
undergo recognition in the presence of a mole equivalent of p-cyclodextrin when 
dissolved in D20  and 60%H20/40%D20 . Suppression of the intense solvent 
resonance in the latter case was achieved by presaturation. Discrimination in these 




ibuprofen sodium flurbiprofen sodium
H2' H3 H3 H2
60%H20/40%D20 0.010 0.006 0.010 0.014
d 2o 0.009 0.006 0.010 -0.016
Table 2.19 Chiral splittings of 400MHz *H resonances of 0.014M solutions of 
ibuprofen sodium and flurbiprofen sodium in the presence of a mole equivalent of 
P-cyclodextrin in D20  and 60%H20/40% D20  at 30°C
2. Studies in c^-DMSO
p-cyclodextrin dissolves more readily in d6-DMSO than in D20 , although 
resonances in its NMR spectrum are more difficult to distinguish, particularly 
where the solvent has absorbed atmospheric water which obscures the H2 and H4 
resonances. The spectrum is shown in Figure 2.15, with assignments taken from 
Yamamoto et al. [170] The hydroxyl proton resonances, which were absent from 
the D20  spectrum as a result of their facile exchange, are now clearly visible.
Although duplication of the flurbiprofen sodium H3 resonance in the 
presence of a mole equivalent of P-cyclodextrin is lost in d6-DMSO, significant 
splittings of the low field aromatic and isobutyl H2" and H3" groups of ibuprofen 
sodium are observed, Table 2.20. The H3" resonance must be a consequence of 
both enantiomer recognition and of prochiral discrimination of the individual 
methyl groups within each enantiomer, since the signal has a five line structure. As 
a result, the chiral splitting could not be determined without further peak 
assignment. The H2 resonance was obscured by cyclodextrin signals in the case 
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Figure 2.15 400MHz 1H spectrum of a 0.014M solution of 0-cydodextrin in dc-DMSO at 30^0
Ibuprofen sodium resonance Chiral splitting/ppm
H 2’ 0.005
H2" 0.006
H3" undetermined (see text)
Table 2.20 Chiral splitting of 400MHz !H resonances of a 0 .014M solution of 
ibuprofen sodium in the presence of a mole equivalent of p-cyclodextrin in dg- 
DMSO at 30°C
The differences in splitting patterns observed between mixtures of 
ibuprofen sodium and p-cyclodextrin in DzO and d6-DMSO suggest that a change 
of solvent can bring about a significant structural change in the complex formed 
between the two. For flurbiprofen sodium it is not clear whether loss of chiral 
duplication is a consequence of such a structural change of the corresponding p- 
cyclodextrin complex or of its reduced thermodynamic stability. Certainly, shifts 
in both the resonances of drug and cyclodextrin indicate that some interaction 
between drug and cyclodextrin remains in DMSO. Further consideration of the 
structures of the complexes with P-cyclodextrin in DMSO will be given in Chapter
4.
2.8 Conclusion
The NMR spectra of the NSAIDs ibuprofen sodium and flurbiprofen 
sodium were examined in the presence of a range of cyclodextrins in D 2O. The 
desired chiral recognition was observed for certain combinations of drug and 
cyclodextrin, but attempts to reproduce these results in biological media were 
unsuccessful, and studies relating to the enantioselective metabolism of the profens 
could not, therefore, be pursued.
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The effects of* experimental variables such as pH, temperature and solvent 
were examined with a  view to enhancing the cyclodextrin discrimination process, 
but whilst many had ;a marked effect, none brought about the significant increase 
desired. Alteration of many of these variables was thought to bring about a 
structural change of the complex which results from interaction between the drug 
and cyclodextrin, but the nature of this change was unclear. Further studies were 
therefore aimed at the gaining of a greater understanding of the structure of the 
cyclodextrin complex and its response to changes in its environment. It was hoped 
that these would reduce the degree of empiricism associated with the use of 
cyclodextrins as agents for chiral recognition, not only in NMR, but in the many 
other areas in which the chirality of the cyclodextrin is exploited. Chapter 3 
discusses properties of the cyclodextrin molecule and its complexes which provide 
a useful basis for this work.
77
CHAPTER 3
Introduction to Aspects of Cyclodextrin Complexation and NMR Methods for their
Examination
3.1 Introduction
In order to gain a greater understanding of the cyclodextrin chiral 
recognition process, it is appropriate to consider initially in more detail the 
structural aspects of these compounds. Since P-cyclodextrin is that host used in 
these studies, this discussion will be restricted to its conformational properties both 
in the solid state and in solution. The structural forms of the complexes this 
macrocycle is able to form with other guest molecules will then be considered 
together with the energetic processes which favour the formation of such 
complexes. The results of previous structural studies of the complexes of P- 
cyclodextrin with 2-arylpropionic acids are then discussed in view of their 
relevance to this work. Factors thought to be of importance in the cyclodextrin 
chiral recognition process are also reviewed.
The work reported in Chapter 4 has been aimed at further elucidation of the 
solution structure of the cyclodextrin complexes of the 2-arylpropionic acids, and 
the possible concomitant chiral recognition, using NMR spectroscopy. A large part 
of this work centres on the interpretation of chemical shift and changes in its value 
on complexation. Use has also been made, however, of measurements of the 
nuclear Overhauser effect, in both the laboratory and rotating frame, and of the 
longitudinal relaxation time. Aspects of their measurement are therefore reviewed 
here to clarify the discussions which follow. By way of introduction, however, the 
practical applications of the cyclodextrin complex, many of which make use of the 
chirality of the carbohydrate, are first considered to give some perspective to the
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importance of the complexation and chiral recognition properties of the 
cyclodextrins.
3.2 Applications of Cyclodextrin Complexation
The ability of cyclodextrins to complex with a wide range of substrates 
[123], both organic and inorganic, has been exploited in many areas, which may be 
broadly divided into three categories. These categories may be subdivided into 
those which make use only of the ability of the cyclodextrin to form complexes, 
and those which additionally exploit the chirality of the cyclodextrin molecule. 
Thus, the interaction of the two enantiomers of a compound with the cyclodextrin 
leads to the formation of two physically and chemically distinct diastereomeric 
complexes.
3.2.1 Analytical Chemistry
The use of cyclodextrins as chiral solvating agents in the determination of 
enantiomeric excess by NMR spectroscopy has already been referred to in 
Chapters 1 and 2. The chiral discriminatory properties of cyclodextrins have also 
been exploited in the field of chromatography, where they are being increasingly 
used both as chiral mobile phase additives in HPLC [171] and TLC [172], and as 
chiral stationary phases in HPLC [173], SFC [174] and GC [175] in the resolution 
of a range of enantiomeric molecules. The selectivity of binding of cyclodextrins 
also extends to other isomeric forms, and has, for example, been of use in the 
HPLC separation of a series of structural isomers [176], which were otherwise 
difficult to separate on conventional columns because of their similarity.
3.2.2 Preparative Chemistry
Cyclodextrin-based chromatographic methods have allowed not only the 
determination of the enantiomeric purity of many chiral molecules, but in some
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cases have also allowed small scale preparative separation of the two enantiomers 
to be achieved [177,178]. For preparation of enantiomerically enriched compounds 
on a larger scale, fractional crystallisation of the two diastereomeric complexes 
formed between the two optical isomers of a molecule and a cyclodextrin have 
been used. The method was first introduced by Cramer and Dietsche [179], and is 
of particular use for those compounds which do not contain a functional group 
appropriate for the more commonly used method of derivatization to the 
diastereomeric salt.
Cyclodextrins have also been used in an alternative approach to the 
preparation of enantiomerically pure species, that is as chiral catalysts in the field 
of asymmetric synthesis [180,181].
The organic asymmetric catalytic properties of cyclodextrins have also 
promoted their use as models of biological systems, for example in studies of the 
action of enzymes. Such applications have recently been reviewed by Dugas [124]. 
a-cyclodextrin has been proposed as being particularly appropriate for such 
studies, since it is believed to undergo conformational changes on complexation 
which parallel those observed on interaction of a substrate molecule with a 
biological receptor [182]. The validity of this induced fit mechanism of 
cyclodextrin complexation will be considered in more detail in Section 3.4.4.
3.2.3 Pharmaceuticals
The physical and chemical properties of the cyclodextrin complex of a 
molecule may be markedly different from those of the uncomplexed species. Thus, 
modification of many undesirable qualities of a drug may be achieved by its 
formulation as the cyclodextrin complex. Such properties include its solubility, 
taste, smell and stablility. The use of cyclodextrins in the pharmaceutical industry 
has recently been reviewed by Duchene and Wouessidjewe [183]. Such technology
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is equally applicable in related industries including those of cosmetics and food 
[184,185].
3.3 The Structure of The Cyclodextrins
The structure of the cyclodextrins has already been referred to in Chapter 1 
(Section 1.5.3). They are generally formed from the degradation of starch by the 
cyclodextrin glycosyltransferase enzyme isolated from Bacillus macerans [186]. 
The a , P and y  oligomers containing 6, 7 and 8 glucose units respectively are 
formed in greatest yield, although evidence also exists supporting the formation of 
small amounts of higher oligomers [187]. Indeed, the crystalline structure of the 
comparatively rare 8-cyclodextrin, composed of 9 glucose units, has recently been 
described [188]. Cyclic structures of smaller size have not been isolated and indeed 
are thought to be unlikely on steric grounds [189,190]. Many chemical derivatives 
of these native cyclodextrins have been prepared since their original isolation, in 
attempts to enhance certain of their properties. Thus, the 2,6-di-O-methyl-p- 
cyclodextrin derivative used in Chapter 2 has a considerably higher aqueous 
solubility than the underivatized p- cyclodextrin as a result of a reduction of 
intermolecular interactions and increased amorphicity associated with the 
impurities in the crude form [183]. The work which follows in Chapter 4, however, 
concentrates on the complexing properties of P-cyclodextrin, which although 
considerably less soluble in water than the a  and y oligomers and the most 
commonly available derivatives, is also considerably less expensive, and therefore 
more widely used. Its structure and conformation are now considered.
3.3.1 Solid State Studies of the Structure of p-cvclodextrin
P-cyclodextrin has been shown to crystallise in two forms from aqueous 
solution, which may be distinguished by the number of water molecules in the 
structure, or more easily by comparison of the unit cell parameters of the crystal,
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since the former would! o>ften seem to be difficult to determine with sufficient 
accuracy as a result probably of partial occupancies of many of the water sites 
[191]. The crystal form depends largely on the history of the crystals. Thus, 
transition of one form (form II) to the other (form I) has been observed to occur 
over a period of four weeks. Most studies have used the form I crystal [191-196] 
and it is therefore that which is considered here. The form II crystal differs mainly 
in the distribution of the disordered water molecules in the p-cyclodextrin cavity
1. The Structure of the Glucopyranose Unit
The X-ray diffraction study of the p-cyclodextrin form I crystal 
[192,193,196] showed that the glucopyranose units were all in the 4Cj chair 
conformation with essentially similar dimensions. The distance of the C4 and Cl 
atoms from the C2-C3-C5-05 plane, Figure 3.1, are however increased and 
reduced respectively compared to those found for a-cyclodextrin as a result of the 
greater radius of the P-cyclodextrin macrocycle.
Figure 3.1 The structure of the glucopyranose unit in the p-cyclodextrin crystal: 
the distances of Cl and C4 from the C2-C3-C5-05 plane
[196].
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The greatest differences between the glucopyranose units are observed for 
the 05-C5-C6-06 torsion angle. Three staggered conformations about the C5-C6 
bond may be envisaged: the trans, the (+)gauche and the (-)gauche. These are 














Figure 3.2 Staggered conformations about the C5-C6 bond in cyclodextrins
Of these, the trans conformation has never been observed in the crystal 
structures of the cyclodextrins and their complexes. It has been suggested that this 
is a consequence of the resulting unfavourable steric interaction between the 0H 6 
group and the adjacent glucopyranose ring and/or of the gauche effect [197]. Of 
the two gauche conformations, the (-)gauche form which directs the OH6 group 
away from the cyclodextrin cavity is generally preferred, although the formation of 
a hydrogen bond between this group and some molecule within the cyclodextrin 
cavity may lead to orientation in the (+)gauche conformation [197].
In agreement with these observations, in the hydrated (3- cyclodextrin 
crystal four of the seven OH6 groups take up the (-)gauche conformation, two the 
(+)gauche and one is disordered over the two. In the (+)gauche conformation, the 
OH6 groups are observed to hydrogen bond with water molecules in the p-
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cyclodextrin cavity. TThe hydrogen bonding pathways will be considered in greater 
detail below.
2. Structure of the Cyclodextrin Macrocycle
The 04 atoms of each glucopyranose unit lie in a regular heptagonal 
arrangement with the angle between the plane of the 04-C6-04' atoms and that of 
the 04 heptagon lying in the range 82.9°-120.6°. As a result, the structure of the 
macrocycle may be described as open, circular but slightly conicular, with the 
secondary hydroxyls lining the slightly wider rim of the cyclodextrin cavity. 
Lindner and Saenger [193] give the width of the annular aperture of this cavity as 
6 .2A.
The conformation of the macrocycle is stabilised by a ring of hydrogen 
bonds between the 02  and 03  atoms of neighbouring glucopyranose units, 
although it was not possible from the X-ray study to assign the directional sense of 
these, since the position of the hydrogen atoms could not be located. Similarly, 6.5 
water molecules were found to be highly disordered over 8 sites within the 
cyclodextrin cavity, but the hydrogen atoms associated with these again could not 
be found.
3. Structure of the Hydrogen Bonding Network
Most of the information regarding the hydrogen bonding network within 
the p-cyclodextrin crystal has been gained by neutron diffraction studies at both 
room [191] and reduced [194] temperature of a sample exchanged with, and 
crystallised from, D20 . These studies show the hydrogen bonding scheme to be 
highly complex with circular arrangements and extended hydrogen bond chains 
being observed. Of most interest, however, are the interglucose hydrogen bonds 
which have already been suggested as a source of stablisation for the cyclodextrin
84
structure. DSC and low temperature (120K) neutron diffraction studies [194] show 
these to be dynamically (as opposed to statistically) disordered flip-flop bonds 
which concertedly interchange at room temperature as shown in Figure 3.3.
0 - - - - H  O  v O ------ H - - O
H V—S  \ H
Figure 3.3 The concerted interchange of hydrogen bonding networks within the 
P-cyclodextrin crystal
At low temperature, the flip- flop nature of these bonds disappears, 
although bonding between the 0 2  atom on glucopyranose ring 4 and 0 3  on ring 5 
remains disordered. Additionally, these bonds have been shown to be bifurcated 
with a weak binding to the inter-residue glycosyl 0 4  atom, which represents a rare 
example of the acceptance of a hydrogen bond by a glycosidic oxygen.
3.3.2 The Structure of p-Cvclodextrin in Solution
Amongst many other techniques, NMR spectroscopy has been used to 
study the structure of p-cyclodextrin in solution and its relationship to that in the 
solid state.
1. Structure of the Glucopyranose Ring
The NMR spectrum of p-cyclodextrin in D20  shows a single set of 
signals for all seven glucopyranose units of the structure, which indicates that on 
the NMR time-scale each of these units is equivalent. Thus, the three-bond !H 
coupling constants Jj 2, J2.3, J3,4 and J4^  for p-cyclodextrin have been determined,
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and have been found to be' consistent with a chair conformation of each of the 
glucopyranose rings [19:8]. Additionally, measurement of 13C longitudinal 
relaxation times; for the p-cyclodextrin molecule, and interpretation of these in 
terms of its motion indicate rapid internal rotation about the C5-C6 bond in 
solution, so that, in contrast to the solid state structure, no marked conformational 
preference is exhibited [199].
2. Structure of the Macrocycle
Lipkind et al. [200] used nOe measurements following pre-irradiation of 
the glycosidic protons and three-bond carbon-proton coupling constants near the 
glycosidic linkage, in conjunction with theoretical calculations to determine 
torsional angles for p-cyclodextrin in D20  which describe the relative orientation 
of glucopyranose rings within the macrocycle. These compare favourably with 
equivalent angles found in the solid state [193], and indicate that on average the 
conformation of the p-cyclodextrin macrocycle in solution is comparable with that 
in the crystal. Measurements of 3Jch for p-cyclodextrin have also been made by 
Mulloy et al. [201] in their work relating such coupling constants to the dihedral 
angle between two sugar units.
3. Structure of the Hydrogen Bonding Network
Onda et al. [202] have studied the intramolecular hydrogen bonding 
interactions of cyclodextrins in dg-DMSO by !H NMR. They observed that the 
resonances of the secondary hydroxyl groups of P-cyclodextrin were down-field 
of that of the primary hydroxyls and of all OH resonances of methyl a-D- 
glucoside, Figure 3.4, and concluded that this must be a consequence of formation 
of intramolecular hydrogen bonds in the macrocycle. This conclusion was 
supported by the temperature dependence of these resonances, which further
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indicated that the bondls were predominantly a consequence of donation from the 
OH3 proton to the OH2 group of the neighbouring residue.
Determination of orientation of the secondary hydroxyl groups from a 
Karplus type relationship equating 3Jho(2,3)CH to dihedral angle across the HO- 
CH bond were in agreement with this proposal. The results of this study, which are 
considered in miore detail in Chapter 4, Section 4.6.3, support earlier work on the 
analysis of 3JHoch [203] and the effect of 2H substitution on and 13C chemical 





Figure 3.4 Structure of methyl a-D-glucoside
It is therefore concluded that whilst the main structural form of the p- 
cyclodextrin macrocycle remains relatively unperturbed on dissolution, the 
introduction of free rotation about the C5-C6 bond and the change in directional 
preferences of the hydrogen bonding network of the secondary hydroxyl functions 
indicate significant differences between the solid and solution state.
3.4 Thermodynamics of Cyclodextrin Complexation
3.4.1 The Structural Typespf .Cyglodexttm Complexes
Cyclodextrin complexes may be broadly divided into three structural types, 
illustrated in Figure 3.5, and termed axial, equatorial or lid-type complexes
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depending on the oriemtation of the longer molecular axis of the guest to that o f the 
cyclodextrin cavity [2(05]. In some cases it has been shown that complex type 
depends on the choice of solvent [206-209]. The axial complex is that most 
commonly observed, particularly for para-substituted benzenes, whilst the lid-type 
complex has been observed only for a limited number of substrates [205-211], and 
rarely in aqueous solution.
Figure 3.5 Structural types of cyclodextrin complexes, illustrated schematically 
for a p-substituted aromatic substrate
Most studies which have addressed the solution thermodynamics of 
cyclodextrin complexation have been concerned with complexes of the axial and 
equatorial types, which may be collectively termed inclusion complexes, as a result 
of the penetration of the cyclodextrin cavity by the substrate. The results of such 
studies are briefly reviewed here because of their importance in understanding the 
complexation process.
The solution thermodynamics of cyclodextrin complexation, generally 
studied in aqueous solution, have recently been reviewed by Clarke et al. [186].
LidEquatorial
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The process is usually associated with a favourable negative enthalpy (0 to -10 
kcal/mol) and a negative entropy (0 to -20 cal/(mol.deg)), although positive 
entropies of complexation are also known. Several physical processes have been 
proposed as contributing to these observations, although the relative importance of 
each of these necessarily depends on the nature of the particular substrate and the 
choice of cyclodextrin.
3.4.2 The Contribution of Hydrophobic Interactions to the Cyclodextrin 
Complexation Process
The hydrophobic effect [212], which has been shown to have important 
consequences regarding the structure of biological macromolecules, describes the 
tendency to association of apolar species dissolved in an aqueous solution. 
Dissolution of an apolar molecule in water leads to a highly ordered solvent 
envelope with increased hydrogen bonding around the solute molecule. This 
process is characterised by a negative enthalpy and a very large negative change in 
entropy, and is thus energetically disfavoured. This unfavourably may be 
reduced by association of the apolar molecules which reduces contact between 
solute and solvent.
The hydrophobicity of the cyclodextrin cavity is comparable with that of 
the octanol molecule [213]. Thus, interaction of the cyclodextrin with an apolar 
substrate might reasonably be expected to be influenced by the hydrophobic effect, 
and indeed many complexes are found to be weaker in non-aqueous solvents where 
the degree of such hydrophobic interactions will be less [186]. Hydrophobicity 
alone cannot, however, be the driving force of the cyclodextrin complexation 
process, since such interactions are generally associated with a very favourable 
change of entropy [214], in contrast to that usually observed for cyclodextrin 
complexation [186].
89
3.4.3 The Contribution of Van der Waals Interactions to the Cyclodextrin
Complexation Process
Van Etten et al. [215] have reported an approximately linear relationship 
between the logarithm of the dissociation constants for a series of cyclodextrin 
complexes and the molar refraction of the substrate, a measure of its polarisabiiity. 
This observation indicates the importance of permanent dipole-induced dipole 
interactions and London dispersion forces in determining complex stability. 
Additionally, X-ray crystallographic studies have revealed interatomic distances 
between guest and cyclodextrin which are consistent with the occurrence of Van 
der Waals interactions [186].
Recently, the dipole moments of a range of cyclodextrins have been 
calculated and been found to be of a significant size [216,217]. They are the result 
of contributions from the individual glucopyranose residues, and are generally 
directed from the secondary to the primary hydroxyl end of the cyclodextrin 
molecule, although asymmetry of the structure may cause some deviation from the 
cavity axis. Whilst the contribution of these dipole moments to stabilisation of a 
cyclodextrin complex will depend largely on the polarity and polarisabiiity of the 
guest substrate, it has also been suggested that for substrates with significant 
polarity the dipole moment of the cyclodextrin dictates the orientation of the guest 
within the cavity. Thus, guests with large dipoles align preferentially with their 
dipole moment anti-parallel to that of the cyclodextrin.
3.4.4 The Contribution of Conformational Changes to the Cyclodextrin 
Complexation Process
Saenger and co-workers [182,218-222] have examined each of the three 
crystalline forms of a-cyclodextrin obtained from aqueous solution by X-ray 
crystallography, and have found that both forms I [218-220] and II [221,222]
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display significant assymmetry of the macrocycle with one of the glucopyranos;e 
rings rotated to lie miore nearly normal to the axis of the cyclodextrin, which thus 
disrupts inter-residue hydrogen bonding between the OH2 and OH3 hydroxyls. 
This strained conformation is not found in the crystalline inclusion complexes of 
a-cyclodextrin, and it has therefore been proposed that this apparent relaxation of 
conformation on complexation (so-called induced fit) might provide an important 
favourable contribution to the stabilisation of the cyclodextrin complex. The form 
in a-cyclodextrin structure, which is more symmetrical and can only be formed in 
the presence of barium chloride, is considered as representative of the transition 
state of this change [ 182].
Whilst other experimental techniques, reviewed by Clarke et al. [186], have 
similarly suggested changes in conformation of the a-cyclodextrin molecule on 
formation of an inclusion complex, 13C CPMAS NMR studies of Gidley and 
Bociek [223,224] in this area are particularly elegant. These authors were able to 
identify resonances associated with the Cl and C4 atoms of the rotated 
glucopyranose ring of the a-cyclodextrin molecule in the solid state [223]. They 
found that these resonances were, however, absent from a frozen aqueous solution 
of a-cyclodextrin [224], which suggests that the strained conformation of the a- 
cyclodextrin macrocycle observed in crystalline samples does not contribute 
significantly to that present in solution. Additionally, the theoretical calculations of 
Tabushi et al. [225] indicate that rather than promoting complex stability, the 
conformational change of a-cyclodextrin on complexation is associated with a 
slight increase in energy of approximately 4 kcal/mol. Thus, the existence and 
significance of changes in conformation of the a-cyclodextrin macrocycle upon 
substrate inclusion remain unclear.
In contrast, X-ray crystallographic studies of hydrated p- and y  
cyclodextrin show structures which are more symmetrical than that of a-
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cyclodextrin forms I and n, such that conformational changes on complexation for 
these oligomers are minimal [226].
3.4.5 The Contribution of Activated Cavity Water to the Cyclodextrin 
Complexation Process
The enthalpy and entropy changes associated with the formation of 
cyclodextrin complexes with a wide range of cyclodextrin hosts have been shown 
to be linearly related by a compensation temperature Tc [186]. This relationship 
implies a common mechanism of formation, which some have suggested is a 
consequence of solvent effects [186]. Others have, however, proposed that this 
observation may be a result of the predominance of dipolar interaction between 
host and guest [227] or of changes in the structure of the cyclodextrin [228]. 
Certainly changes of solvation of both guest and host must be anticipated since the 
generally tight fit of the substrate in the cyclodextrin, as judged from crystal 
structure determinations and molecular models, necessarily restricts the number of 
molecules of water of solvation surrounding the substrate in the complex [186].
It has been suggested by Griffiths and Bender [229] that those water 
molecules which solvate the hydrophobic cyclodextrin cavity are unable to realise 
their full hydrogen bonding potential, and as such may be regarded as enthalpy 
rich. The expulsion of such high energy water on complexation of the cyclodextrin 
cavity may thus contribute to the favourable enthalpic process associated with 
inclusion. This proposal has been supported by the calculations of Tabushi et al. 
[225].
3.4.6 The Contribution of Hydrogen Bonds to the Cyclodextrin Complexation 
Process
The hydroxyl groups of the cyclodextrin molecule provide an ideal site for 
hydrogen bonding interactions with a suitable substrate, and indeed the formation
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of such bonds have been observed in the X-ray crystallographic studies of 
crystalline complexes (see for example Section 3.5) and have been proposed to 
exist in solution [230]. That many stable complexes are formed with substrates 
incapable of either donating or accepting such a hydrogen bond suggests, however, 
that hydrogen bonding does not provide an important contribution to complex 
stability. A recent study by Buvdri and Barcza [230] with p-cyclodextrin and a 
wide range of substrates in aqueous solution similarly concluded that although 
hydrogen bonding interactions between host and guest certainly enhance the 
stability of the complex, their role is not dominant.
3.5 X-rav Crystallographic Studies of the Structures of Complexes of some 2- 
Arylpropionic Acids with P-cyclodextrin
The Cambridge Crystallographic Database [231] currently lists five X-ray 
crystallographic studies of the inclusion complexes formed between p-cyclodextrin 
and 2-arylpropionic acids. These complexes are of the individual enantiomers and 
the racemate of the NSAIDs flurbiprofen [232-234] and fenoprofen [235,236], 
whose structures are represented in Figure 3.6.
The results of these studies are briefly reviewed here for the insight they 
allow us to the possible solution state structures of these complexes, and indeed for 
some sense of relative steric proportions of the guest and host molecules used in 
this work.
3.5.1 The P-cvclodextrin Complexes of Fenoprofen
Crystals prepared from an aqueous mixture of racemic fenoprofen and p -  
cyclodextrin show a 3:1 occupancy ratio of (S)- to (R)-fenoprofen. Hamilton and 
Chen [236] suggest that this chiral recognition is a reflection of the preferential 
binding of the S enantiomer by the macrocycle. Structurally, the (S)- and (R)- 
fenoprofen complexes in the racemate crystal are the same as those observed in
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crystalline complexes of the individual enantiomers [235], except for small 
differences in the (R)- fenoprofen complex, which may be attributed to additional 




Figure 3.6 Structures of flurbiprofen and fenoprofen
The S and R enantiomers in the racemate complex crystallise in separate 
dimeric units. Both consist of two p-cyclodextrin units with their secondary 
hydroxyl faces joined by extensive intermolecular hydrogen bonding between the 
OH3 groups. A single fenoprofen molecule is included by each of the cyclodextrin 
macrocycles in the manner shown in Figure 3.7.
There is a fundamental difference between the two complex structures: the 
(R)-fenoprofen complex is described as head-to- head, with the phenoxy 
substituents of each molecule lying adjacent, whereas that of the S enantiomer is 
head-to-tail, with the phenoxy group of one molecule close to the propionic 
substituent o f the other. This difference is attributed by Hamilton and Chen [235] 
to three basic interactions
1. the fit of the guest in the cyclodextrin cavity;
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2. the relative strengths of phenyl/phenyl and phenyl/methyl hydrophobic forces in 
the centre of the p-cyclodextrin dimer,
3. the hydratiom requirements of the carboxylic acid group.
s
ce»
Fi|ure 3.7 Dimeric structure of the (S)-fenoprofen and (R)-fenoprofen complexes 
of p-cyclodextrin in a crystal prepared from the racemate [235]
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As a result cof the different stereochemical orientations of the carboxylic 
acid group in each fenoprofen enantiomer, and steric restrictions imposed by the 
bulky aromatic ring system, it is not possible for each optical isomer to achieve the 
same hydrogen bonding interactions in the complex. Thus, the carboxylic acid 
groupings of the R enantiomers are restricted to hydrogen bonding with waters of 
crystallisation, whereas one of the S enantiomers hydrogen bonds to the primary 
hydroxyl group of a neighbouring p-cyclodextrin molecule, whilst the other 
hydrogen bonds to secondary hydroxyl groups at the p-cyclodextrin dimer 
interface. In this way, Armstrong’s criteria for chiral recognition [236] (which were 
formulated for use in chromatographic analysis with cyclodextrins, Section 3.6.1) 
are satisfied.
3.5.2 The p-cyclodextrin Complexes of Flurbiprofen
X-ray crystallographic studies of hydrated flurbiprofen p -  cyclodextrin 
complexes have been reported for both the (S)- flurbiprofen enantiomer [233,234] 
and the racemate [232,234]. Crystals precipitated from an aqueous solution of p- 
cyclodextrin saturated with racemic flurbiprofen show no preference for inclusion 
of either flurbiprofen enantiomer. As for the fenoprofen p- cyclodextrin crystal, the 
structure of the complex is dimeric with extensive intermolecular hydrogen 
bonding joining the secondary hydroxyl faces of two cyclodextrin molecules in 
each unit. Again, the glucopyranose rings maintain a *0} chair conformation and 
inter-residue hydrogen bonding gives a round regular structure to each macrocycle. 
One p-cyclodextrin molecule includes a flurbiprofen molecule of S 
stereochemistry and the other one of R. The orientation of these flurbiprofen 
molecules within these macrocycles is such that the fluorobenzene ring lies at the 
centre of the cyclodextrin cavity so that the two phenyl rings are directed toward 
the dimer interface, are partially inserted in the adjacent cyclodextrin molecule, 
and possibly interact via a hydrophobic interaction. The steric restrictions of the
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cyclodextrin cavity are thought to be responsible for the reduction in the angle 
between the planes of the two aromatic rings from that of 54.4° in the 
uncomplexed state to 34.8° and 37.4° for the S and R enantiomers in the 
complexed state respectively. Close contact between the fluoro- substituent and the 
glycosidic oxygen also suggest that van der Waals interactions may contribute to 
complex stability.
Hydrogen bonding interactions in the complex are such that the carboxylic 
acid group of the R enantiomer hydrogen bonds with a primary hydroxyl group of 
an adjacent cyclodextrin molecule, whereas the S enantiomer forms two such 
bonds to cyclodextrin primary hydroxyl groups and additionally bonds to a water 
molecule. The absence of hydrogen bonds between the carboxylic acid group and 
the cyclodextrin secondary hydroxyl has been suggested as the reason for the 
failure to observe chiral separation of the two enantiomers in the formation of the 
crystal. In comparison with the fenoprofen P-cyclodextrin complex, Hamilton and 
Chen [236] believe that the reduced flexibility of the flurbiprofen biphenyl system 
compared to that of the meta phenoxyphenyl of fenoprofen gives rise to this 
difference in behaviour. Despite this lack of chiral separation of the flurbiprofen 
optical isomers, some element of chiral discrimination must be present, however, 
to ensure that the dimeric structure includes a single molecule of each enantiomer.
The geometry of the racemate complex is generally similar to that observed 
for the (S)-flurbiprofen complex, except for slight differences in orientation of the 
cyclodextrin primary hydroxyl groups and the distribution of waters of 
crystallisation. Differences in hydrogen bonding interactions of the carboxylic acid 
group shown in Figure 3.8 may be understood in terms of the change in orientation 
of the functionality on replacement of the R enantiomer in the racemate by the S, 
which disfavours the formation of the hydrogen bond to the cyclodextrin primary 
hydroxyl.
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Figure 3.8 Schematic representation of the differences in hydrogen bonding of the 
carboxylic acid group of flurbiprofen in the P-cyclodextrin complexes of the 
racemate and the S enantiomer [234]
3.6 Chiral P iscriminatiQn by Cyclpdextring
The ability of a cyclodextrin molecule to recognise the two enantiomers of 
a chiral substrate in any given process depends upon some difference in structural 
or physical properties of the two diastereomeric complexes thus formed. Since 
many processes which make use of the chirality of cyclodextrins often exploit 
differences in different physical properties, it is difficult to generalise about which 
substrates and cyclodextrins are best suited to these methods.
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3.6.1 Chiral Discrimination In Chromatographic Analysis
The extensive studies by Armstrong and co-workers [173,237] directed 
towards the use of cyclodextrins as chiral stationary phases in HPLC have allowed 
the deduction of the following empirical rules for those chiral substrates which are 
most likely to be resolved:-
1. The substrate should include into the cyclodextrin macrocycle;
2. The complex so-formed should be tight, promoting increased binding and 
restricted rotation of the guest;
3. The chiral centre of the guest, or substituents off it, should lie near to the mouth 
of the cyclodextrin and interact with it, either sterically or through hydrogen bond 
formation. Interactions with the uni-directional secondary hydroxyl group 
hydrogen bonding network of the cyclodextrin are thought to be particularly 
important;
4. Guests generally have a rigid n system a  or p to the chiral centre, groups off of 
the chiral centre which are capable of hydrogen bonding, and a second n system or 
amino group, which perhaps restricts the possible conformations of the guest.
These rules relate to use of the column in the reverse phase mode, and will 
be a reflection of the difference in distribution of the two enantiomers between the 
stationary and mobile phase. Stationary phases which have been derived for use in 
normal phase HPLC have been prepared by derivatization of the cyclodextrin 
chiral stationary phase with aromatic isocyanates or acid chlorides to give the 
carbamate and ester derivatives respectively [237]. As such, interaction with chiral 
analytes is thought to occur predominantly at the 7t bonding sites of these 
derivatives, as in a Pirkle-type stationary phase [238], and are therefore not 
considered further here.
Derivatized cyclodextrins are also used as chiral GC stationaiy phases, and 
are preferred to the crystalline native forms as a result of their higher
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chromatographic efficiency [237]. This is a consequence of their composition; the 
complex mixture of isomers and varying degrees of substitution gives rise to 
highly viscous liquids which are more amenable to use as GC stationary phase 
coatings. The work of Armstrong et al. [239] has suggested that the penetration of 
the guest into the cyclodextrin cavity is not as deep as that in solution. Resolution 
is, however achieved because of a lack of competing solvent effects. Konig et al. 
[240] have also observed that whilst inclusion may have a similar importance to 
that proposed in liquid chromatography, some of the chiral compounds which these 
authors were able to resolve appeared to be too large for inclusion to occur. They 
also noted that whilst hydrogen bonding interactions may be present for some GC 
chiral stationary phases, enantioselectivity is also possible for analytes which do 
not contain functional groups capable of hydrogen bonding. Cyclodextrin chiral 
stationary phases in GC, including their possible mechanism of resolution, have 
recently been reviewed by Schurig and Nowotny [175].
Enantiomeric resolution in reversed phase liquid chromatography using 
cyclodextrins as a mobile phase additive has recently been discussed by Sibilska 
and Zukowski [171]. They identify three interactions which may contribute to the 
method
1. differences in stability of the cyclodextrin/analyte complex
2. differences in adsorption of these diastereomeric complexes on the achiral 
stationary phase;
3. differences in adsorption of the analyte on a dynamically generated cyclodextrin 
stationary phase.
These authors conclude that whilst practical applications of the method are 
being increasingly reported, understanding of the relative importance of each of 
these mechanisms, together with suitable properties of the analyte, have yet to be 
determined.
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3.6.2 Cyclodextrins as Chiral Solvating agents in NMR
The cyclodextrins are being increasingly used as CSAs for the 
determination of enantiomeric excess by NMR spectroscopy. Most studies have, 
however, been concerned only with practical applications of the method, with little 
consideration given to understanding of the cyclodextrin chiral recognition 
process. It is possible, however, to deduce several empirical rules, some of which 
have already been exploited in Chapter 2.
1. Many reports of the use of cyclodextrins as CSAs have also noted significant 
shifts of the cyclodextrin H3 and H5 resonances which line the macromolecular 
cavity [126,127,130,137,138], indicative of the occurrence of inclusion 
complexation. This is perhaps a somewhat unsurprising observation since chiral 
recognition necessarily requires some interaction between the analyte and the 
cyclodextrin, and that cyclodextrin complexation usually involves the formation of 
an inclusion complex has already been referred to above (Section 3.4.1). It would, 
however, seem reasonable to assume that any factors which favour the inclusion 
process, such as the use of aqueous as opposed to organic solvent [186] and the 
manipulation of parameters such as those investigated in Chapter 2, would 
promote chiral recognition.
2. Several authors have reported that chiral recognition of the substrate by the 
cyclodextrin is the consequence of a difference in structure and not stability of the 
resulting diastereomeric complexes [128,129]. There is as yet, however, 
insufficient data in the literature to confirm this as a general rule.
3. Murakami et al. [130] were able to observe enhanced chiral recognition in the 
!H NMR spectra of mandelic acid, methyl mandelate and N-acetyl-a- 
phenylglycine in the presence of 3- acetylamino-3-deoxy-p-cyclodextrin in 
comparison to that in the presence of the primary substituted derivative and native
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p- cyclodextrin. This observation was attributed to an inversion of configuration of 
C2 and C3 of one of the sugar residues. Although the use of derivatized 
cyclodextrins as CSAs has been limited, probably because of difficulties associated 
with their preparation, we believe that they will find increasing use in this field. 
Thus, studies have also suggested that derivatized cyclodextrins tend to enhance 
structural differences of diastereomeric inclusion complexes as a result of their 
increased asymmetry [165,166].
Determination of specific interactions such as hydrogen bonding within the 
substrate/cyclodextrin complex and their significance in the NMR chiral 
discrimination process in the solution state remains relatively unexplored.
3.6.3 Chiral Discrimination in Fractional Crystallisation
Factors governing the resolution of a chiral substrate by cyclodextrins 
depend largely on experimental method. Thus, Drabowicz et al. [241] reported 
resolution of sulphurous acid derivatives prepared by grinding the cyclodextrin and 
analyte in the solid state, followed by washing with ether and decomposition in a 
mixture of methylene chloride and water. The success of such a process must be a 
consequence of the differential formation of each of the diastereomeric 
analyte/cyclodextrin complexes.
More commonly a classical fractional crystallisation method is used, 
whereby complexation is achieved in solution and the inclusion complex 
subsequently allowed to crystallise. Thus, this method may additionally 
incorporate differences in solubility of the two cyclodextrin complexes. Despite 
this, Michon and Rassat [242] were able to associate the preferential precipitation 
of (+)-fenchone/p-cyclodextrin from a mixed aqueous/DMSO solvent system with 
the greater formation constant of the (+)- versus (-)-fenchone P-cyclodextrin 
complex. Mikolajczyk and Drabowicz [243] were further able to interpret their 
data relating to the resolution of chiral benzyl-, phenyl- or p-tolyl-alkyl
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sulphoxides using p- cyclodextrin in terms of a model involving inclusion of the 
aromatic ring in the cyclodextrin cavity, a hydrogen bond interaction between a 
cyclodextrin hydroxyl functionality and the sulphoxide oxygen and a steric 
interaction between the alkyl substituent and the rim of the cyclodextrin molecule.
3.7 NMR Methods
That the use of cyclodextrins as CSAs in NMR spectroscopy remains 
largely empirical prompted us to further examine the chiral recognition properties 
of the cyclodextrins in solution using NMR spectroscopy (Chapter 4). We describe 
here some of the less commonly used NMR methods which form part of this work.
3.7.1 Measurement of Longitudinal Relaxation Times
Studies of the rates of relaxation of a nuclear spin system can yield useful 
information regarding the dynamics of a molecule in the solution state. 
Measurement of the transverse relaxation time T2 requires use of a spin-echo 
sequence such as that of Carr, Purcell, Meiboom and Gill (CPMG) [81,82] in order 
to eliminate the adverse effects of magnetic field inhomogeneities, diffusion and 
inaccuracies in pulse widths. Even so, measurements of T2 remain difficult, 
particularly in samples where homonuclear J coupling provides an additional 
complication [244]. We concentrate here, therefore, on the more routine 
determination of longitudinal relaxation time Recent methods designed to 
reduce the time required to measure NMR relaxation parameters are described.
It is generally assumed that longitudinal relaxation is a first-order process, 
characterised by a longitudinal relaxation time T j such that:-
dMz = Mo^ l Mz (3.1)
dt Tj
where Mo is the equilibrium longitudinal magnetisation and Mz is the longitudinal 
magnetisation at some time t following application of a radio-ffequency pulse to
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the nuclear spin system. This expression forms the basis of experimental methods 
for the determination of Tj.
3.7.1.1 The Inversion-Recoverv Experiment
The inversion-recovery experiment [245] is the classical sequence for the 
measurement of longitudinal relaxation time. It requires the use of the sequence 




Figure 3.9 The inversion-recovery sequence for the measurement of longitudinal 
relaxation times
A number of data sets with differing t are acquired. The initial 180° pulse 
inverts the equilibrium magnetisation M0/ which from equation 3.1 relaxes back to 
a value Mz in time t such that:-
ln(M0 -M z) = ln2M0 - I (3.2)
T,
Mz is then read by the application of a 90° pulse and subsequently allowed 
to relax to equilibrium during the pulse delay which must therefore be of the order 
of 5 ^ .  M0 corresponds to Mz for t > 5T2, and its measurement allows a semi- 
logarithmic plot of ln(M0-Mz), or in practice, lnflo-IJ, where I0 and Iz are the 
measured peak intensities corresponding to M0 and Mz, against t to be made, from
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which Tj may be found. Alternatively, an approximation to its value can be readily 
determined from the time t at the null point at which Mz=0, which from equation
3.2 occurs for a value t^u such that:-
T j  =  In u ll ( 3 . 3 )
ln2
Imperfections in the inversion pulse in the standard inversion recovery 
experiment can be avoided by the use of a composite pulse or the residual 
transverse magnetisation removed by use of a homospoil pulse or suitable phase 
cycling [87,246]. Phase cycling may also be used to eliminate the effects of 
multiple quantum coherences which may be generated [246].
The inversion recovery experiment is generally regarded as the most 
accurate method for the measurement of longitudinal relaxation times [244], but 
suffers from the disadvantage of the necessity of acquiring a number of data sets 
with long pulse delays, which for insensitive nuclei, where extensive signal 
averaging is required, leads to unacceptably long experiment run times. Several 
faster methods have been introduced to circumvent this difficulty, most notably 
those of progressive saturation [247] and saturation recovery [248]. These methods 
and many others have been discussed by Martin et al. [244]. Two of the most 
recent methods, DESPOT and SUFIR, were considered for use in the measurement 
of 13C longitudinal relaxation times of the low concentration cyclodextrin complex 
solutions examined in this work.
3 . 7 . 1 . 2  D E S P O T
The DESPOT (Driven Equilibrium Single Pulse Observation of Tj) method 
was originally introduced by Christensen et al. [249], but has more recently been 
re-evaluated by Homer and co- workers [250,251]. The sequence has the form
(0-FS-t)m-(0-A-FS-t*)n
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where an initial series of m pulses is used to set up a steady state prior to  s-ome 
number n of the acquisition (A) sequence. FS represents application o f  a 
homospoil pulse for the elimination of residual transverse magnetisation, and the 
pulse delays t and t* are such that the total inter-pulse delay tj is constant 
throughout so that the steady state is maintained, that is,
tj = FS + 1 = A + FS + 1* (3.4)
Consider the longitudinal magnetisation once the steady state has been 
achieved, Ms. Following application of the pulse of angle 0, the longitudinal (M J  
and transverse (MT) components are such that:-
Mt = Mssin0 , Ml = Mscos0 (3.5)
Following the homospoil pulse, only the longitudinal component remains. 
This will begin to relax to its equilibrium value M0 and at the end of the period tj 
will have reached a value given by:-
Mu = M0 - (Mo - Mscos0)e-t^ T1 (3.6)
Since the system is in a steady state,
MS = MU (3.7)
Thus, at constant tj and over a range of 0, a plot of Ms against Mscos0 
gives Tj. In practice, since the NMR signal is detected in the transverse plane, the 
measured intensity Is of signals will be related to Ms through
Is a  Mssin0
so that the regression will, in fact, be of Is/sin0 versus Iscos0/sin0.
Reasonable results with this method have been obtained with as little as 
two data points, in which case,
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In  I1sin9? - Usinp!  = - U (3.8)
I1sin02cos01 - I2sin0!cos92 Ti
where Ij and I2 are the intensities corresponding to flip angles 0 t and 02 
respectively.
Homer and co-workers [250,251] have described the protocol for the 
successful use of the DESPOT method, and have highlighted the need to 
implement a sufficient number of dummy pulses to establish the stationary state, to 
use a tj value such that t/T j is approximately 0.2 and to systematically increase 0 
between data sets. Additionally, the sample must be restricted to the effective 
volume of the excitation coils and a pulse offset value determined to ensure 
proportionality between the pulse width and its flip angle.
3.7.1.3 SUFIR
The SUFIR (SUper Fast Inversion Recovery) method has been described 
by Canet et al. [252]. The sequence has the form shown in Figure 3.10. and 
requires acquisition into separate memory blocks at two stages in the cycle.




t t t t t t
preparation sequence acquisition sequence
Figure 3.10 The SUFIR sequence for the measurement of longitudinal relaxation 
times
If it is assumed that immediately prior to each pulse no transverse 
magnetisation remains, the effect of the sequence may be determined from
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equation 3.1. Figure 3.11 shows the orientation and magnitude of magnetisation at 
each stage of the sequence.
The initial preparation sequence gives rise to ths steady state of the 
acquisition sequence for which the two signals Si and S2 arc given by:-
51 = Mo(l-y) (3.9)
52 = Mo(l-y)2 (3.10)
where y = e^t/T^, which eliminating Mq from equations 3.9 and 3.10 gives:-
Tj = - t (3.11)
lntf-Sa/Sj)
Thus, Tj may be calculated from a single experiment. For optimum accuracy, the 
authors recommend a t value such that t=0.5-3Tj and that sufficient transients be 
accumulated to ensure good signal to noise in the resulting spectra. Additionally, 
composite 180° pulses are recommended to avoid errors during inversion. The 
eight step phase cycle proposed by the authors eliminates the effects of 
misadjustment of the 90° pulse width and residual transverse magnetisation.
3.7.2 Measurement of the Nuclear Overhauser Effect
The nuclear Overhauser effect (nOe) [253] describes the change in intensity 
of the resonance of one nucleus as a result of a perturbation of the population of 
the nuclear energy levels at some other, which need not necessarily be found 
within the same molecule. It is a consequence of the dipolar cross-relaxation which 
may occur between two such spin systems, and where additional pathways of 
relaxation are operative, may be related to intemuclear distance. Consequently it is 
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Figure 3.11 A vector model representation of the SUFIR sequence
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3.7.2.1 The nOe Difference Experiment
In order to observe an nOe, it is necessary to compare resonance intensities 
in a control spectrum acquired in the absence of perturbation, with the nOe 
spectrum in which one resonance has been selectively perturbed prior to 
acquisition. Since the nOe resulting from the perturbation may be small, it is then 
most readily visible if these two spectra, or the FIDs from which they are derived, 
are subtracted. This is the nOe difference experiment [254]. Selective saturation 
with a weak radio-frequency field is the most common method of generating the 
nOe. In practice, for convenience and improved spectral subtraction, this field is 
not absent from the control spectrum, but is positioned in an area of the spectrum 
free from resonances. Thus, the nOe difference sequence may be represented as 
shown in Figure 3.12.
Presaturation of the selected resonance is continued for several TjS to 
ensure that the nOe has adequate time to be established. Several other precautions 
are also generally taken to improve spectral subtraction and thus allow small nOes 
to be observed [83,253,255]. The effect of fluctuations of temperature during 
acquisition are generally avoided by use of the spectrometer variable temperature 
unit to control sample temperature. The deuterium lock unit reduces drifting of the 
magnetic field, and it is therefore desirable to study samples in a solvent which 
gives rise to a strong and shaip deuterium resonance which facilitates its operation, 
although the choice of solvent may also be influenced by its effect on molecular 
correlation time. Non-viscous solvents are more likely to give solutions in the 
extreme narrowing limit Finally, the nOe and control spectra are not acquired 
consecutively, but cycle between nOe and control acquisitions in blocks of a small 
number of scans. In terms of sample preparation, it is desirable to reduce 
competing relaxation pathways, which if highly efficient may significantly reduce 
the size of an nOe or eliminate it completely. Steps should therefore be taken to
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remove paramagnetic ions and possibly oxygen dissolved in the solvent. Dilute 
solutions also restrict the contribution of intermolecular relaxation mechanisms.
control spectrum irradiation in area of spectrum free 
of resonances -  pulse -  acquire
nOe spectrum irradiation of resonance of interest
-  pulse -  acquire
difference spectrum = nOe spectrum - control spectrum
Figure 3.12 The nOe difference experiment
3.7.2.2 The Transient nQg and.NOESYExpsrimsnis
The transient nOe experiment [256] provides an alternative method for the 
measurment of nOes in one dimensional NMR spectroscopy. A selective 180° 
pulse, generated by use of a soft pulse or the DANTE sequence [257], is used in 
place of saturation to perturb the population difference of the nuclear energy levels 
of a single resonance. A series of spectra acquired with increasing t allows the 
build-up rate of the nOe, which may be related to intemuclear distance, to be 
measured. The method has, however, been largely superseded by its two 
dimensional equivalent, the NOESY (Nuclear Overhauser Effect SpectroscopY) 
experiment.
I l l
The NOJESY experiment [258] has the form shown in Figure 3.13:- where 
tj is the two dimensional incremental time delay and tm the constant period called 
the mixing time during which the transient nOe develops. A basic understanding of 
the experiment imay be achieved with the vector model [246], Figure 3.14.
90° CD O O 9 0 °
t t1 m
Acquire
Figure 3.13 The NOESY experiment
The initial 90° pulse rotates the bulk magnetisation M0 into the xy plane. 
Evolution during q then follows. At the end of this period, the magnetisation 
vector will lie at some angle 0, to the y axis. This vector may be resolved into two 
perpendicular components, lying along the x and y axes, the size of which depend 
on 0, which in turn is a function of the precessional frequency of the nucleus and 
the value of t!. In this way, amplitude modulation of the components at the end of 
the tj period leads to frequency labelling of the vector. The second 90° pulse then 
flips the magnetisation component lying along the y axis down onto the -z axis, 
whilst the remaining transverse magnetisation is removed by phase cycling or the 
use of a homospoil pulse. Cross relaxation of the z component of magnetisation of 
this nucleus and that of some other during the mixing time t^ that follows then 
leads to a transfer of magnetisation which may be read by the final 90° pulse and 

















read pulse ■ y
Figure 3.14
A vector model representation of the NOESY experiment
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For qualitative studies the mixing time ^  is generally of the order of Tj 
which allows sufficient time for the transient nOe to develop. Quantitative work 
generally requires NOESY data acquired over a series of ^  [259], although a 
single spectrum acquired with short ^  and following the so-called initial rate 
approximation may yield distance information directly [246].
Methods suitable for the elimination of cross-peaks arising from coherence 
transfer pathways which may confuse spectral interpretation have recently been 
discussed [253].
3.1.23 The ROESY or CAMELSPIN Experiment
The CAMELSPIN (Cross relaxation Appropriate for Mini- molecules 
EmuLated by SPIN-locking) experiments [260] in one or two dimensions are 
analogous to the transient nOe and NOESY methods described above, but are a 
consequence of cross- relaxation in the transverse plane rather than along the 
longitudinal axis.
The one dimensional experiment requires the collection of two data sets as 
in the case of nOe difference spectroscopy: one in which the transverse or rotating 
frame nOe (iOe) is generated, and the other used as a control, Figure 3.15.
The spin-lock field is typically of the order of l-10kHz [253] and is either 
applied continuously [260] or intermittently at high power [261]. Its importance in 
the generation of the rOe can be understood from Figure 3.16.
The 180° pulse of the iOe sequence selectively inverts one of the 
resonances so that it lies along the z axis. The 90° pulse then flips magnetisation 
along the longitudinal axis to the transverse plane. Application of the spin-lock 
field in a direction perpendicular to this pulse then serves two purposes [253]:-
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Control spectrum 180° 90° spin-lock
tm
 Acquire
selective pulse in area 
of spectrum free of 
resonances
CAMELSPIN spectrum 180 90





difference spectrum = CAMELSPIN spectrum - control spectrum
Figure 3.15 The one dimensional CAMELSPIN experiment
selective 180° pulse 





■> cross-relaxation between A and neighbouring nuclei
Figure 3.16 A vector model representation of the one dimensional CAMELSPIN 
experiment
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1. It generates a magnetic field along the y axis which functions in a manner 
analogous to the static field along the z axis. Pseudo longitudinal relaxation 
relative to this Bj field gives rise to the rOe in the event of cross-relaxation.
2. It serves to prevent relative precession of vectors in the transverse plane which 
would otherwise lead to overall cancellation of the rOe.
More commonly the rOe is observed in a two dimensional experiment, 
often referred to as ROESY [262] (Rotating frame Overhauser Effect 




Figure 3.17 The two dimensional CAMELSPIN or ROESY experiment
There are several advantages associated with measurement of the rOe as 
opposed to the nOe. Thus, chemical exchange may be readily distinguished from 
the rOe by its difference in phase, and spin diffusion, which can hamper the 
acquisition of nOe data for large macromolecules, is limited in the rOe experiment 
[263]. Its greatest use, however, is in the examination of medium sized molecules 
in the molecular weight range 800-2000 [253,260]. Such molecules are typically 
characterised by a correlation time tc such that co0tc ~ 1 and lie on or near the cross­
over point between the positive nOe of the small molecule in the extreme 
narrowing condition and the negative nOe associated with larger molecules. Thus,
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the nOe observed for such molecules is generally zero or very small. In contrast, 
the iOe is positive and of a reasonable magnitude irrespective of molecular 
correlation time amd therefore size. This may be understood qualitatively in terms 
of ©o [253]. For the nOe, ©o characterises the precessional frequency about the 
longitudinal axis and thus is of the order of hundreds of MHz for the !H nucleus. In 
the rOe experiment, precession is about the weak Bj field, giving frequencies of 
the order of kHz. As a result all molecules necessarily satisfy the extreme 
narrowing condition co0tc« l  and give rise to a positive rOe.
Disadvantages of observation of the rOe arise primarily from interactions 
which either obscure the iOe or confuse its interpretation. Most may be 
distinguished by their phase properties, so that it is essential to acquire two 
dimensional spectra in the phase sensitive mode. The cross-peaks most commonly 
observed for medium sized molecules relative to a diagonal of positive double 
absorption phase are then summarised in Table 3.1.
Elimination of the TOCSY interaction is particularly desirable, since such 
correlations are often large and may obscure underlying ROESY cross-peaks, and 
additionally give false ROESY cross-peaks through the TOCSY-ROESY or 
ROESY-TOCSY pathways [264]. Methods proposed for their reduction have 
included the use of a low power spin-lock field [262] and of an intermittent spin- 
lock field composed of a train of small flip angle pulses [261] (although Bax [265] 
has questioned this proposal). In practice it is difficult to remove such interactions 
completely, however, and more commonly they are identified by their dependence 
on carrier frequency. Thus, the ROESY cross-peak is generally little affected by 
small changes in the carrier frequency, in contrast to the TOCSY (and 
consequently ROESY-TOCSY and TOCSY-ROESY) cross-peak [264].
The other main disadvantage of the ROESY method is concerned with 
practical difficulties in the generation of a uniform excitation pulse and spin-lock 
field. Deviations from uniformity reduce the efficiency of the experiment and
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Cross-peak Cause Phase Properties *
ROESY transverse cross-relaxation between 
nuclei close in space
negative, in-phase, double absorption
COSY coherence transfer between 
J coupled nuclei
doubly antiphase, double dispersion
TOCSY magnetisation transfer between 
J coupled nuclei
positive, in-phase, double absorption
ROESY-TOCSY 
or TOCSY-ROESY
consecutive operation of the ROESY 
and TOCSY mechanisms
negative, in-phase, double absorption
★
Relative to a diagonal of positive, double absorption phase
Table 3.1 Cross-peaks commonly observed in the ROESY experiment: their phase properties and cause
fadditionally complicate quantitative interpretation of spectra [253]. Practical 
aspects of the ROESY experiment will be considered in greater detail in Chapter 4.
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CHAPTER 4
NMR Studies of the Complexation of ft-Cvclodextrin With Some 2-
Arvlpropionates
4.1 Introduction
Chapter 2 referred to the use of cyclodextrins as chiral solvating agents 
(CSAs) in NMR spectroscopy. Our results showed that the sodium salts of the 
NSAIDs ibuprofen and flurbiprofen chosen for study exhibited chiral recognition 
in the form of peak duplication in their NMR spectra in the presence of various 
cyclodextrins and under a range of experimental conditions. In all cases, however, 
the splitting was* small (<0.02ppm) and less than ideal for use as a method of 
measurement of enantiomeric excess. The use of cyclodextrins as CSAs remains 
largely empirical, and in an attempt to gain greater understanding of their 
applicability, a study of the interaction of a range of 2-arylpropionic acids with P- 
cyclodextrin by NMR spectroscopy has been undertaken, the results for which are 
reported here. NMR was chosen as the technique for studies of this system, 
because of its unique ability to probe molecular structure in solution. Yamamoto 
and Inoue have recently reviewed the application of NMR spectroscopy to the 
cyclodextrin inclusion process [266]. Interactions of molecules with cyclodextrins 
in the solution state, aside from their relevance to the use of cyclodextrins as 
CSAs, are additionally of interest in regard to their action, for example, as 
catalysts, enzyme mimics and formulation agents for pharmaceuticals, as was 
discussed in Chapter 3.
The structures of the compounds used in this study are shown in Figure 4.1. 
Flurbiprofen, ibuprofen and naproxen are used as NSAIDs [2], whilst 2- 
phenylpropionic acid, 2-(4-chlorophenyl)- and 2-(4-nitrophenyl)-propionic acid 





























arylpropionic acid series of drugs. Throughout this work, these compounds were 
used as the racemate, excepting naproxen, which is available commercially only as 
the therapeutically active S enantiomer. Additionally, all compounds were used in 
the form of their sodium salts as a result of the improved aqueous solubility over 
the free acid.
4.2 NMR Studies of the Cbmplexation of B-Cvclodextrin with some 2- 
Arvlpropionates in D?Q
Several common features of the interaction of ibuprofen sodium and 
flurbiprofen sodiuim with various cyclodextrins in D20  were discussed in Chapter 
2. Thus,
1. Changes in !H NMR chemical shift of both drug and cyclodextrin resonances 
were indicative of the formation of an inclusion complex.
2. The presence of a single set of resonances for the cyclodextrin and the drug (in 
the absence of its chiral recognition) demonstrated that the equilibrium between 
the free and complexed species was in the fast exchange limit.
3. The observation of chiral recognition of the drug molecule by the cyclodextrin 
was dependent on the choice of cyclodextrin.
For the four additional substrates examined here, namely, the sodium salts 
of naproxen, 2-phenylpropionic acid and 2-(4-chlorophenyl)- and 2-(4- 
nitrophenyl)-propionic acid, in all cases an inclusion complexation interaction in 
the fast exchange limit was again observed in the ]H NMR spectra recorded in the 
presence of a mole equivalent of P-cyclodextrin in D20 , although broadening of 
some guest resonances may represent approach towards a more intermediate rate 
of exchange. Table 4.1 summarises changes in chemical shift of the !H NMR 





Change in chemical shift/ppm of 0-cydodextrin resonance 
H2 H3 H4 H5 H6
ibuprofen sodium -0.029 -0.033 -0.111 -0.009 > -0.179 ★
flurbiprofen sodium -0.075 -0.102 -0.177 -0.041 > -0.246 *
naproxen sodium -0.058 -0.065 -0.154 -0.050 > -0.240 *
sodium 2 -phenylpropionate -0.017 -0.022 -0.039 -0.021 > -0.050 ★
sodium 2-(4-chlorophenyl)propionate -0.033 -0.050 -0.099 -0.032 > -0.096 ★
sodium 2-(4-nitrophenyl)propionate -0.031 -0.047 -0.106 -0.027 > -0.103 ★
Table 4.1 Changes in 400MHz 1H chemical shift of the resonances of a 0.014M solution of 0-cyclodextrin in the presence of a mole equivalent of sodium 
2-aryl propionate in D^O at 3(fc
sodium 2-arylpropionate substrates examined. Data relating to the sodium salts of 
ibuprofen and flurbiprofen, already reported in Chapter 2, are reproduced here for 
comparison. All spectra are again referenced to the residual HDO resonance of the 
solvent
In addition to providing evidence for the formation of an inclusion 
complex, we suggest that the large up-field shifts in the H3 and H5 resonances of 
the cyclodextrin may also give some indication of the structure of this complex. 
Thus, by comparison of the magnitude of these resonances in the presence of each 
substrate, three categories of guest molecule may be identified:
1. Sodium 2-phenylpropionate:
The up-field shifts of the cyclodextrin H3 and H5 resonances are both 
small. We attribute this to the low formation constant of the inclusion complex of 
this substrate.
2. Ibuprofen sodium, sodium 2-(4-chlorophenyl)propionate, sodium 2-(4- 
nitrophenyl)propionate:
The up-field shift of the cyclodextrin H3 resonance is comparable in the 
presence of each of these substrates and considerably larger than that observed in 
the presence of sodium 2-phenylpropionate. We suggest that this is a consequence 
of a similarity of structure of the inclusion complex for each of these substrates 
and of a comparable formation constant, considerably greater than that of the (3- 
cyclodextrin complex formed with sodium 2-phenylpropionate. This greater 
stability may be associated with a number of factors, including increased van der 
Waals interactions in the complex as a result of the bulk of the para substituent, 
and in the case of sodium 2-(4-nitrophenyl)propionate, the possibility of hydrogen 
bonding between the nitro group and the hydroxylic groups of the cyclodextrin 
[267].
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?This argument neglects the widely differing electronic effect of each of the 
para substituenits of these substrates on the aromatic ring current, which in view of 
the work of Demarco and Thakkar [155], described in Chapter 2, might be 
considered an important influence on the cyclodextrin H3 resonance. It is noted, 
however, that Yamamoto et al. [268] similarly neglected the electronic properties 
of aromatic substituents in their calculations, based on the theory of Johnson and 
Bovey [156,157], relating to the structure of cyclodextrin inclusion complexes. 
Certainly, it is clear that ring current effects alone cannot account for variations in 
shifts of the cyclodextrin resonances observed here, since changes in chemical 
shift in the presence of sodium 2-(4-chlorophenyl)propionate are markedly 
different from those of sodium 2-phenylpropionate, despite the minimal electronic 
influence of an aromatic chloro substituent.
Despite the similarity of the cyclodextrin H3 resonance in the presence of 
each of the substrates in this category, a large difference of chemical shift of the 
cyclodextrin H5 resonance is observed in the presence of ibuprofen sodium in 
comparison with sodium 2-(4-chlorophenyl)- and 2-(4-nitrophenyl)-propionate. 
This may be attributed to the differential effect of the para substituent on the 
cyclodextrin H5 resonance, either through a direct interaction, or indirectly 
through its influence on the level of penetration of the substrate in the cyclodextrin 
cavity, and is therefore suggestive of their proximity. This observation allows us to 
propose a structure of the inclusion complex with these para substituted substrates 
shown schematically in Figure 4.2.
3. Flurbiprofen sodium and naproxen sodium:
These substrates induce a very large up-field shift in both the cyclodextrin 
H3 and H5 resonances, which may be interpreted, at least in part, as a consequence 
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Figure 4.2 Proposed structure of the P-cyclodextrin inclusion complex of some 2- 
arylpropionates in D20
Shifts in JH resonances of the cyclodextrin, other than those of the H3 and 
H5 protons, may be attributed to conformational changes on formation of the 
inclusion complex.
Changes in chemical shift of the JH sodium 2-arylpropionate resonances in 
the presence of a mole equivalent of P-cyclodextrin are shown in Figure 4.3. They 
are given as ranges where exact determination of chemical shift in the presence of 
P-cyclodextrin was not achieved. JH NMR data for these salts are given in 
Appendix 4.1 at the end of this chapter. NOe difference, COSY-45, ROESY and 
homonuclear decoupling experiments, in addition to the Job plots discussed in 
Section 4.5, were used to confirm assignments where they were thought to be 
ambiguous.
Inspection of Figure 4.3 reveals that trends in the changes of chemical 
shifts of the salt resonances are less apparent than were those of the cyclodextrin. It 
is suggested that this is a consequence of the greater sensitivity of guest resonances 
to variations in depth of penetration of the cyclodextrin cavity [269].
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Figure 4.3 Changes in 400MHz chemical shift of the resonances of a 0.014M 
solution of some 2-arylpropionates in the presence of a mole equivalent of p- 
cyclodextrin in D2Q at 30°C
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Although determination of the H2' and H3' resonances of sodium 2- 
phenylpropionate in the presence of p-cyclodextrin was not possible because of 
strong coupling between these two nuclei, it remains clear that changes in chemical 
shift of resonances of this substrate are in most cases small. This is consistent with 
the low formation constant previously proposed for its inclusion complex.
A common structure for the p-cyclodextrin inclusion complexes of 
ibuprofen sodium, sodium 2-(4-chlorophenyl)- and 2-(4-nitrophenyl)-propionate 
was also suggested above. For these substrates, we note a common up-field shift of 
the H3' resonance, which is larger than that for any other resonance in the 
molecule. In terms of the structure of Figure 4.2, this suggests that such an up-field 
shift may be associated with aromatic protons deep in the cyclodextrin cavity. On 
this basis it is proposed that it is the central portion of the naproxen sodium 
molecule which lies within the cyclodextrin cavity.
Changes in chemical shift of the resonances of the fluorophenyl 
aromatic ring and H3 group of flurbiprofen sodium in the presence of a mole 
equivalent of p-cyclodextrin are comparable with those of ibuprofen sodium and 
sodium 2-(4-chlorophenyl)- and 2-(4-nitrophenyl)-propionate. This suggests a 
structure for the p-cyclodextrin inclusion complex of flurbiprofen sodium similar 
to that of these substrates and shown schematically in Figure 4.2.
*H resonances of the non-fluorinated phenyl ring also show a large up-field 
shift in the presence of cyclodextrin, however. Since the biphenyl ring system is 
too large to be wholly accommodated within a single cyclodextrin molecule, this 
suggests that the flurbiprofen sodium molecule interacts simultaneously with more 
than one cyclodextrin macrocycle, either through the formation of a complex of 
1:2 guestrhost stoichiometry, or through dimerisation of the 1:1 complex in a 
manner analogous to that observed in its crystal structure.
It has also been suggested by Imai et al. [270], who used 13C NMR to 
examine the interaction between P-cyclodextrin and flurbiprofen in 0.05M NaOD,
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that changes in chemical shift may also be attributed in part to ring current effects 
associated with the constraints of the inclusion process on the torsional angle 
between the two phenyl rings. We do not believe, however, that this effect is a 
primary cause of the observed changes in chemical shift of the resonances of 
flurbiprofen sodium in the presence of p-cyclodextrin, since the phenyl rings do 
not appear equally affected.
The chiral duplication of drug resonances in the presence of p-cyclodextrin 
has already been described in Chapter 2 for ibuprofen sodium and flurbiprofen 
sodium. For the additional racemic substrates examined here, only the sodium 2- 
phenylpropionate molecule shows duplications. Splittings of 0.001 ppm and 
O.OlOppm are observed for the H3 and H4' resonances respectively.
4.3 ]H NMR Studies of the Complexation of B-cvclodextrin with some 2- 
Arvlpropionates in d^-DMSO
During the course of this work, interaction between the 2- arylpropionates 
and p-cyclodextrin was also examined in d6-DMSO. Sodium 2-(4- 
nitrophenyl)propionate was, however, found to be unsuitable for study in this 
solvent, as a result of its rapid decomposition (in both the presence and absence of 
P-cyclodextrin). Two decomposition products were formed in significant amounts, 
and were identified as 4-ethylnitrobenzene and 4'-nitroacetophenone, on the basis 
of ]H NMR data. These products are a consequence of decarboxylation and 
subsequent autoxidation of the salt, and are favoured for this substrate as a result of 
stabilisation of the intermediate carbanionic and radical species by the electron- 
withdrawing nitro group. Presumably this decomposition pathway is not observed 
in aqueous solvents because of improved solvation and stabilisation of the 
carboxylate functionality.
NMR data for all other substrates, referenced to the residual solvent 
resonance at 2.5ppm, are given in Appendix 4.2 at the end of this chapter.
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Assignment off the aromatic resonances of naproxen sodium and flurbiprofen 
sodium was achieved by comparison with the corresponding data for solutions in 
D20 . The electtronic influence of the isobutyl and chloro substituents of ibuprofen 
sodium and sodium 2-(4-chlorophenyl)propionate on the resonances of sodium 2- 
phenylpropionate determined in D20  were used to assign the aromatic resonances 
of ibuprofen sodium and sodium 2-(4-chlorophenyl)propionate from those of 
sodium 2-phenylpropionate in d^-DMSO.
Changes in chemical shift of the *H 2-arylpropionate resonances in the 
presence of a mole equivalent of p-cyclodextrin arc given in Figure 4.4. These 
changes are calculated assuming where necessary that no change of relative 
position of aromatic resonances occurs on addition of cyclodextrin. We believe 
that this isa  reasonable assumption, since spectra appear little changed from that 
of the free salt.
The small shifts of resonances given in the figure arc suggestive of low 
levels of complexation between substrate and cyclodextrin. Changes in chemical 
shift of the cyclodextrin H5 resonance in the presence of a mole equivalent of the 
salts, shown in Table 4.2, further support this conclusion. Although these are 
difficult to measure with great accuracy as a result of the broad nature of the 
doublet resonance, they are clearly reduced from the large values observed in DJ3. 
The cyclodextrin H3 resonance which also showed large changes in chemical shift 
in D20  in the presence of a guest substrate is obscured by the over-lying signal of 
the H6 resonance ind6-DMSO, Figure 2.15.
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Figure 4.4 Changes in 400MHz *H chemical shift of the resonances of a 0.014M 
solution of some 2-arylpropionates in the presence of a mole equivalent of (3- 
cyclodextrin in c^-DMSO at 30°C
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Table 4.2 Changes in 400MHz *H chemical shift of resonances of a 0.014M 
solution of p-cyclodextrin in the presence of a mole equivalent of some 2- 
arylpropionates in d^-DMSO at 30°C
Although the reduced stability of cyclodextrin inclusion complexes in 
DMSO has been described [186], we do not believe that this is the sole cause of 
these small changes in chemical shift Thus, the change in chemical shift of the 
cyclodextrin HI resonance in the presence of a mole equivalent of 2- 
arylpropionate in d6-DMSO, also shown in Table 4.2, although reduced from its 
value in D20, remains significant, and may again be associated with 
conformational changes of the cyclodextrin on formation of the inclusion complex. 
Additionally, chiral splittings in the presence of p-cyclodextrin of the H2' and H4' 
resonances of sodium 2-phenylpropionate, both of magnitude 0.006ppm, and of 
resonances of ibuprofen sodium, described in Chapter 2, further indicate extensive 
interaction between the two species, almost certainly through the formation of an 
inclusion complex. Certainly, the formation of a lid-type complex seems unlikely, 
since such interactions have been observed only rarely, and generally for substrates 
which disfavour inclusion on steric grounds, or contain more than one hydrogen 
bonding functionality capable of interacting with the cyclodextrin hydroxyl groups 
[205-211].
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The presence of large amounts of the inclusion complex coupled with a 
minimal shift of tthe cyclodextrin H5 resonance is, however, inconsistent with the 
aromatic ring cunrent arguments of Demarco and Thakkar [155]. We believe this is 
a consequence olf the failure of these authors to take account of the effect on 
chemical shift of the elimination of the solvation envelopes of the host cavity and 
guest which necessarily accompanies the formation of the inclusion complex (see 
Chapter 3). The significance of such solvent effects in cyclodextrin inclusion 
complexation has also been described by Sunamoto et ah [271], but remains 
largely overlooked.
The complexity of changes in chemical shift observed for the 
resonances of the 2-arylpropionates in the presence of p-cyclodextrin in D20  has 
already been referred to. In d6-DMSO, such changes in shift appear more straight­
forward. Thus, for sodium 2-phenylpropionate, sodium 2-(4- 
chlorophenyl)propionate and ibuprofen sodium changes in chemical shift of the H3 
and aromatic H2' and H3’ resonances are of a similar magnitude, which suggest a 
common structure and comparable formation constant for the p-cyclodextrin 
inclusion complex for each of these substrates. The minimal changes of chemical 
shift of the cyclodextrin H5 resonance and the obscured nature of the H3 resonance 
restricts information regarding the nature of this structure . The greater size of the 
shift in the H3’ aromatic resonance of the substrate would, however, suggest that it 
is this end of the aromatic molecule which penetrates the cyclodextrin cavity most 
deeply. Certainly, there would appear to be some fundamental difference in the 
structure of the inclusion complex between the aqueous and organic solvent, 
however, since at least in the case of ibuprofen sodium it is different resonances 
which undergo duplication in the presence of the cyclodextrin.
That the stability of the sodium 2-phenylpropionate complex is not 
substantially weaker than the complexes of other guests as was thought to be the 
case in D2Q suggests that the additional stability associated with the presence of
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substituents in this molecule was most likely a consequence of hydrophobic 
interactions which are less significant in the organic solvent.
Changes in chemical shift of the H3 and H51 and H6’ aromatic resonances 
of flurbiprofen sodium in the presence of P-cyclodextrin in dg-DMSO are 
comparable with the corresponding resonances for these 2-phenylpropionates, and 
suggest a similarity of structure of the inclusion complex. Changes in chemical 
shift of the H3" and H4" resonances are negligible in comparison to the large 
values observed in D20  and indicate that this phenyl ring no-longer interacts 
significantly with the cyclodextrin. This suggests that an important contribution to 
the driving force for its inclusion in aqueous solvent is the dimerisation of the 
cyclodextrin host through the formation of intermolecular hydrogen bonding 
interactions, which are less favoured in the strongly hydrogen bonding DMSO. 
Shifts of the resonances of naproxen sodium in the presence of a mole 
equivalent of p-cyclodextrin in d^-DMSO also suggest a stability of the order of 
that of the other substrates studied, although structural comparisons are difficult.
4.4 m  NMR Studies of Conformational Changes of B-cvclodextrin upon 
Complexation with some 2-Arvlpropionates in D?Q
Conformational changes of the cyclodextrin molecule upon inclusion of a 
guest substrate have been suggested as a contributory factor to the energetic 
favourability of the complexation process, particularly for a-cyclodextrin, as was 
discussed in Chapter 3. Thus, changes in chemical shift of the ]H resonances of 
those protons on the external surface of the P-cyclodextrin molecule in the 
presence of a mole equivalent of sodium 2-arylpropionate in D20  have already 
been suggested as indicative of conformational changes of the cyclodextrin. 
Further analysis of NMR data allows additional insight into these changes.
Conformational changes of the cyclodextrin may be broadly divided into 
two classes:
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!1. Intra-residue conformational changes of the glucopyranose ring,
2. Inter-residue conformational changes as a result of reorientation of these 
glucopyranose rings about the glycosidic linkage.
Inter-residue conformational changes of oligosaccharides are generally 
determined by measurement of inter-residue nOes and long-range carbon-proton 
coupling constants [200,201]. Since measurement of long-range heteronuclear 
coupling constants is generally an insensitive technique, and was not therefore 
considered appropriate for the low concentrations of solutions used in this work, 
changes in inter-residue conformation of P-cyclodextrin on complexation with the 
2-arylpropionates were not examined. Recent methods describing the inverse 
detection of long-range heteronuclear coupling constants provide a suitable 
solution to this difficulty, however [272,273].
Information regarding changes in the conformation of the glucopyranose 
ring itself upon guest inclusion may be gained from the measurement of !H 
coupling constants. A sine bell window function was used in place of the standard 
exponential window to reprocess the data of Section 4.2 with enhanced resolution, 
which allowed for the determination of some coupling constants which were not 
previously accessible because of extensive peak overlap. Such constants represent 
a population-average of those of the cyclodextrin in the free and complexed states, 
and are summarised in Table 4.3, together with those for methyl a-D-glucoside, 
taken from the work of Wood et al. [274], and the predicted values for a 4C1 
glucose ring, taken from the work of Herv6 du Penhoat et al. [275], and calculated 
on the basis of the empirical equations of Altona and Haasnoot [276].
Comparison of the theoretical coupling constants and those of p- 
cyclodextrin in both the free and complexed state confirms that the glucose 














none 3.7 9.8 9.0 9.3 * *
sodium 2-phenylpropionate 3.8 9.9 9.0 9.7 4.4,22 12.4
sodium 2-(4-chlorophenyl)propionate 3.7 9.7 9.5 9.6 4.3,2.2 12.5
sodium 2-(4-nitrophenyl)propionate 3.7 9.7 9.5 9.6 4.3,2.6 12.6
ibuprofen sodium 3.7 9.8 8.8 9.8 3.4,2.3 ★
naproxen sodium 3.8 10.0 8.6 * 3.2,1.9 12.4
flurbiprofen sodium 3.7 9.9 8.3 ★ ★ ★
Substrate H H H H H H
1.2 2.3 3.4 4.5 5.6 6.6
calculated 3.6 9.9 9.4 9.8
methyl a-D-glucoside 3.7 9.8 8.8 10.0 5.7,23 12.3
Table 4.3 Magnitude of 400MHz1H NMR coupling constants of a 0.014M solution of 0-cyclodextrin in the presence of some 2-arylpropionates 
in D>0 at 3oPc
Variations in J5 6 may be interpreted in terms of preferential population of the 
rotameric forms described in Chapter 3. Thus, Wood et al. [274] observed a 
reduction in the coupling constants J5 6t and J5 6b for a-cyclodextrin in comparison 
to those of methyl a-D-glucoside, and interpreted this in terms of the increased 
proportion of the (-)gauche conformer in the cyclodextrin.
We were unable to measure J5>6 for p-cyclodextrin itself since resonances 
of the cyclodextrin H5 and H6 protons were not sufficiently well resolved even 
with the use of a resolution enhancement function. Our results have suggested, 
however, that the cyclodextrin complexes only weakly with sodium 2- 
phenylpropionate and that therefore J5 6 values observed in the presence of this 
substrate may be taken as a measure of J5 6 for the cyclodextrin in its free state. It 
can be seen from Table 4.3 that for ibuprofen sodium and naproxen sodium a 
reduction in magnitude of 5^,6 for p-cyclodextrin in the presence of a mole 
equivalent of sodium 2-arylpropionate is apparent in comparison to coupling 
constants of p-cyclodextrin in the presence of sodium 2-phenylpropionate and of 
methyl a-D-glucoside and again indicates an increased preference for the 
(-)gauche rotamer. Since this rotamer is associated with the OH6 group being 
directed away from the cyclodextrin cavity, this observation rules out interaction 
between the cyclodextrin primary hydroxyl group and the included guest, and may 
be a consequence of the steric requirements of the guest substrate or of the 
expulsion of water molecules from the macrocyclic cavity upon formation of the 
inclusion complex.
In the presence of sodium 2-(4-chlorophenyl)- and 2-(4-nitrophenyl)- 
propionate, however, it can be seen from Table 4.3 that J5 6 for p-cyclodextrin 
show little change from their values in the presence of sodium 2-phenylpropionate. 
Earlier analysis of chemical shift data has indicated that significant levels of 
complexation of these substrates occurs in aqueous solution. Interpretation of this 
contrasting behaviour of J5 6 then lends support to the common structure for the p-
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cyclodextrin complex proposed in Section 4.2. Approach from the secondary 
hydroxyl face of the cyclodextrin by the guest substrates sodium 2-(4- 
chlorophenyl)- and 2-(4-nitrophenyl)propionate leaves the primary hydroxyl face, 
and therefore J56, relatively unperturbed. For ibuprofen sodium, however, an 
equivalent structure of the inclusion complex leads to disturbance of the primary 
hydroxyl face as a Tesult of proximity of the comparatively bulky pjra-isobutyl 
substituent.
4.5 *H NMR Studies of the Stoichiometry of the Inclusion Complexes of ft- 
Cvclodextrin with some 2-Arvlpropionates in P 70
The preceding discussions have required many important assumptions. 
Thus, for example, in the interpretation of chemical shift data and in the 
calculations of Chapter 2, it has generally been assumed that the inclusion process 
involves interaction of a single substrate molecule with one of cyclodextrin. Since 
a 1:1 host:guest stoichiometry is indeed that most commonly observed for the 
inclusion complexes of the cyclodextrins [123], this is perhaps reasonable. Our 
results have suggested, however, that at least in the case of flurbiprofen sodium in 
aqueous solution, other complex stoichiometries may also be of some importance.
Investigation of the stoichiometry of the complexes examined in this work 
was therefore undertaken, using the Job or continuous variation method [277,278]. 
This procedure has been used by several authors in the determination of the 
stoichiometry of the inclusion complexes formed between cyclodextrins and a 
number of guest substrates by NMR [126,127,158].
The Job method requires that two species A and B interact to give a single 
complex of fixed stoichiometry. It can be shown that for a series of solutions of 
fixed total concentration, but varying mole ratio of A and B, that the maximum 
concentration of the complex occurs for that solution which contains the two 
components at a mole ratio corresponding to the stoichiometry of the complex.
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Measurement of some parameter proportional to the amount of complex formed 
for such a series of solutions then readily yields its stoichiometry.
Classically, spectrophotometry has been widely used to monitor the 
concentration of complex in such studies, but NMR may be used equally well. 
Thus, consider the general complexation equilibrium of substrate S with 
cyclodextrin CD,
S + a CD ^  S.CD,
If it is assumed that no discrimination of the two enantiomers of a chiral
substrate by the cyclodextrin is present, then from equation 2.5 (Section 2.7.1) the
mole fraction of S in the complexed state is given by:
f = 8S_ - 8Sf (4.1)
5SC - SSf
where 5Sf and 5SC denote the chemical shift of some resonance of the substrate in 
the free and complexed states respectively and 5S0 is its value observed in solution. 
The concentration of complex in solution is then given by,
[S.CDJ « f[S]t (4.2)
where [S]t denotes the total concentration of the substrate, both free and
complexed, which from equation 4.1 gives,
[S.CDJ = [S]t x5Soi£Sf (4.3)
8SC - 5Sf
and since (5SC - 5Sf) is a constant,
[S.CDJ a  (8S0 - 8Sf)[S]t (4.4)
For the Job method, all solutions are of fixed total concentration, so that, 
[S.CDJ a  F(8S„ - 8Sf) (4.5)
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where F represents the mole fraction of this concentration of substrate added to the 
solution. F(8S0 - 8Sf) is then used as a measure of the concentration of complex in 
solution. A corresponding argument may be applied to the resonances of the 
cyclodextrin macrocycle.
Figures 4.5-4.10 show the results of Job plot studies of the complexation of 
p-cyclodextrin with the sodium 2-aiylpropionates in D p  for various substrate and 
cyclodextrin !H NMR resonances. Those resonances which showed the largest 
shifts and no duplication and were well separated from other signals were found to 
be most suitable for this study. Samples were prepared by quantitative mixing of 
solutions of equal concentration of the sodium 2-arylpropionate and p-cyclodextrin 
in D20. In order to facilitate the dissolution of P-cyclodextrin, the concentration of 
each of these solutions was reduced from that of preceding experiments, and as a 
result, analysis of cyclodextrin resonances was therefore also generally to be 
preferred because of the greater signal-to-noise ratio associated with these signals. 
This difference in solution concentration, combined with acquisition of NMR data 
at ambient temperature as opposed to 30°C, was thought to be responsible for the 
observation that changes in chemical shift of both cyclodextrin and substrate !H 
resonances in the Job solution corresponding to a 1:1 mole ratio of the two 
components showed some deviation from those values given in Table 4.1 and 
Figure 4.3.
Although the Job experiment often required the analysis of undesirably 
small changes in chemical shift of both substrate and cyclodextrin resonances, it 
was possible to assign a 1:1 stoichiometry to all of the P-cyclodextrin inclusion 
complexes of the sodium 2-arylpropionates studied, excepting that formed with 
sodium 2-phenylpropionate. Changes in chemical shift of those resonances of host 
and guest which could be readily determined in this case were too small to allow 
distinction between different complex stoichiometries, again presumably a 
consequence of the weak interaction between the two. It seems unlikely, however,
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Figure 4.5 Selected resonances from a 270MHz Vl Job plot study of the complexation of ibuprofen sodium with ^-cyclodextrin in CfeO
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Figure 4.6 Selected resonances from a 270MHz 1H Job plot study of the complexation of sodium 2-phenylpropionate with 0-cydodextrin in D20










Figure 4.7 Selected resonances from a 270MHz 1H Job plot study of the complexation of sodium 2-(4-nitrophenyl)propionate with /^-cyclodextrin in D^O
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Figure 4.8 Selected resonances from a 270MHz \ \  Job plot study of the complexation of sodium 2-(4-chlorophenyl) propionate with 0 -cyclodextrin in D^O
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Figure 4.9 Selected resonances from a 270MHz 1H Job plot study of the complexation of flurbiprofen sodium with 0 -cyclodextrin In D fi











Figure 4.10 Selected resonances from a 270MHz 1H Job plot study of the complexation of.naproxen sodium with ^-cyclodextrin in
that the stoichiometry of this complex should differ from that of the other 
substrates examined, particularly in view of the structural similarity of the sodium 
2-phenylpropionate molecule to that of, for example, sodium 2-(4- 
chlorophenyl)propionate. Solutions were, however, further examined by 13C NMR 
to support this argument, on the basis that this nucleus, with its wider chemical 
shift range, might be more sensitive to the formation of the inclusion complex
[279]. It was possible to detect only the ,3C resonances of the cyclodextrin 
macrocycle in a reasonable experiment time of approximately one hour per 
sample. These resonances were referenced to a solution of DSS in D20  (the use of 
a reference sample contained in a separate NMR tube being more acceptable for 
the wider chemical shift ranges associated with heteronuclei, see Chapter 2), but 
were found to show no significant variation in chemical shift between solutions.
The determination of a 1:1 stoichiometry for the inclusion complexes 
studied here does not allow distinction between interaction of individual molecules 
and the formation of dimeric structures such as those observed in the crystalline 
complexes of flurbiprofen and fenoprofen with P-cyclodextrin (Section 3.5). 
Further examination of the Job plot for points of inflection, which are not generally 
visible to the eye, may effect such a distinction [278], but since changes in 
chemical shift were generally small, such detailed analysis was not considered 
appropriate.
Our results have already suggested that the complexation of flurbiprofen 
sodium with p-cyclodextrin involves interaction of the guest with more than one 
cyclodextrin molecule. On the basis of the 1:1 stoichiometry found here, a dimeric 
structure for this complex, similar to that observed in the crystal, is therefore 
suggested. A study of the !H NMR spectrum of p-cyclodextrin in D20  over a range 
of concentrations incorporating those of the Job plot showed that resonances were 
essentially independent of concentration which suggests that, at least in the 
absence of guest substrate, there is little tendency to dimerisation of the
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macrocycle [280,281]. We propose on steric grounds that in such a structure it is 
the non-fluorinated phenyl rings of the substrate which would most likely lie 
adjacent at the cyclodextrin interface. This suggestion is supported by the unusual 
observation of large up-field shifts in *H resonance of all protons of this aromatic 
ring. The promotion of dimerisation in the presence of flurbiprofen sodium is then 
a consequence of a favourable hydrophobic interaction between the two phenyl 
rings at the interface or of the partial inclusion of each of these phenyl rings into 
the cavity of the neighbouring cyclodextrin molecule. For the salts of the other 2- 
phenylpropionates it is difficult to envisage a comparable structure with such 
stabilising features, and it is therefore assumed for these complexes that the 1:1 
stoichiometry given by the appropriate Job plot is indicative of a monomeric 
structure of the cyclodextrin inclusion complex. The interaction of naproxen 
sodium is less clear-cut. Thus, for example, Samai has reported the association of 
the 1:1 inclusion complexes of the structurally related compounds naphthalene
[280], 2- methoxynaphthalene [280] and 1-cyanonapthalene [269] with p- 
cyclodextrin in aqueous solutions at concentrations comparable with those used in 
this work.
During the course of this work, an important premise of the use of the Job 
method in NMR. spectroscopy was also examined, that is, that resonances of 
species in the uncomplexed (and complexed) state are independent of 
concentration (equation 4.4). The concentration independence of the chemical 
shifts of the ]H resonances of P-cyclodextrin has already been described. Ibupxofen 
sodium and naproxen sodium were chosen as representative of the 2- 
arylpropionate substrates. It was found that whilst ibuprofen sodium similarly 
showed a concentration independence in its *H NMR spectrum, significant changes 
in the chemical shift of the resonances of naproxen sodium were observed (Table 
4.4). Such dependence is presumably a consequence of molecular association 







H2’ 7.352 7.351 7.352
H3’ 7.297 7.296 7.295
H2 3.693 3.692 3.694
H1” 2.563 2.562 2.561
H2” 1.924 1.922 1.922
H3 1.471 1.470 1.472






H8’ 7.940 7.929 7.881
H4’ 7.912 7.901 7.854
H1’ 7.848 7.839 7.809
H3’ 7.575 7.570 7.549
H5' 7.453 7.438 7.366
H7 7.308 7.296 7.244
OMe 4.034 4.024 3.977
H2 3.867 3.864 3.851
H3 1.572 1.570 1.565
Table 4.4 400MHz ]H NMR data for ibuprofen sodium and naproxen sodium at 
varying concentrations in D20  at 30°C
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complexity of interaction between the 2-arylpropionates and P-cyclodextrin in 
aqueous solution.
4.6 NMR Studies of Hydrogen Bonding Interactions between P-Cvclodextrin and 
some 2-Arvlpropionates
Factors contributing to the thermodynamic stability of cyclodextrin 
inclusion complexes in aqueous solution have been discussed in Chapter 3. It is 
generally considered that hydrogen bonding between host and guest does not 
provide a major contribution to complex stability. In contrast, differential 
hydrogen bonding between the host and the two enantiomers of a guest substrate is 
thought to be an important process in the chiral recognition of the guest by the 
cyclodextrin. It was our aim therefore to attempt to determine the presence or 
absence of such interactions in the P-cyclodextrin inclusion complexes of the 2- 
arylpropionates.
A common potential site of hydrogen bonding of each of the substrates is 
the carboxylate group. We also identify the nitro group of sodium 2-(4- 
nitrophenyl)propionate and the methoxy group of naproxen sodium as additional 
sources of interaction.
Direct observation of the !H resonances of the hydroxyl groups of p- 
cyclodextrin, for further investigations of the presence of hydrogen bonding 
interactions with an included guest, was not possible since these signals are absent 
from spectra recorded in D20 , as a result of the fast exchange which they undergo 
with the solvent. Whilst it has been shown that they may be detected in non- 
deuterated water, Symons et al. [282] report that careful control of both pH and 
temperature is required to slow the exchange process sufficiently for resonances of 
a reasonable sharpness to be obtained. The acidic pH recommended by these 
authors was not considered compatible with the 2-arylpropionate substrates used in 
this study. Other experimental methods were therefore examined.
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4.6.1 ]H NMR Studies of the Complexation of P-Cvclodextrin with Structural
Analogues of the 2-Arvlpropionates in P 20
Structural analogues of 2-phenylpropionic acid were selected to investigate 
the importance of the carboxylic group in the p-cyclodextrin inclusion process. 




2-phenylpropionic acid 0-methylphenethylamine cumene
Figure 4.11 2-phenylpropionic acid and some structural analogues
Mixtures of a 1:1 mole ratio of cumene or p-methylphenethylamine and p- 
cyclodextrin in D20  at concentrations of approximately 0.014M failed to dissolve 
readily, however, and were therefore transferred to an ultra-sonic bath for 1 1/2 
hours. At the end of this period, dissolution of only the mixture of P- 
methylphenethylamine and P-cyclodextrin was achieved, but precipitation 
followed on subsequent cooling to room temperature. Investigations of the 
inclusion properties of the structural analogues of 2-phenylpropionic acid were not 
therefore pursued.
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4.6.2 170  NMR Studies of the Complexation of Cyclodextrins with the 2- 
Arvlpropionates in D?Q
The recent studies of Uedairi et al. [283,284] have highlighted the 
relationship between the 170  longitudinal relaxation time, Tj, of the water 
resonance in aqueous solutions of carbohydrates and the mean number of 
equatorial OH groups of these substrates. Thus, these authors have shown that for 
a -  and y-cyclodextrin the Tj of pure water and of a solution of the carbohydrate of 
concentration m, represented by T0 and T respectively, are related by the 
expression,
Tc = 1 + JidhnJLm (4.6)
T x 55.5
where n ^  is the dynamic hydration number of the oligosaccharide, n ^  has, in 
turn, been shown to be linearly dependent on the number of equatorial hydroxyl 
groups in the carbohydrate.
We postulated that a hydrogen bonding interaction between the 
cyclodextrin host and an included guest might bring about changes in the hydration 
sphere of the macrocycle, and consequently the ,70  Tj of the solvent To test this 
hypothesis we chose to examine the interaction of naproxen sodium with y- 
cyclodextrin, since this cyclodextrin is considerably more soluble than its P 
oligomer and therefore allowed the use of the more highly concentrated solutions 
in which the anticipated effect would be most prominent ]H NMR studies 
confirmed inclusion of the naproxen sodium molecule in this macrocycle.
170  Tt measurements of deuterated water and of solutions of naproxen 
sodium, y-cyclodextrin and a 1:1 mole ratio mixture of the two in D20  were made 
using the standard inversion-recovery sequence described in Chapter 3. Its use was 
possible despite the low natural abundance and magnetogyric ratio of the 170  
nucleus, since rapid quadrupolar relaxation allowed fast pulsing of the sample, and
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because the solvent analyte was present in high concentrations. The results of these 
measurements are shown in Table 4.5.




1:1 naproxen sodiumry-cyclodextrin 5.9
Table 4.5 54MHz 170  Tj of D20  in the presence of 0.078M naproxen sodium 
and/or y-cyclodextrin at 30°C
The observed reduction in Tj in the presence of y-cyclodextrin gives from 
equation 4.6 a dynamic hydration number of 79.9, which is reasonably consistent 
with the value of 77.3 found by Uedairi and co-workers [284], considering that our 
value was calculated from a single data point. This indicates that hydration of the 
sugar is little different in deuterated versus non-deuterated solvent.
We had anticipated that the reduction of nO Tj from that of pure solvent in 
the presence of naproxen sodium would be negligible in comparison to that in the 
presence of y-cyclodextrin as a result of the considerably smaller molecular size of 
the former. In this way, it was our intention to interpret relaxation parameters 
determined in the presence of a 1:1 mole ratio mixture of salt and cyclodextrin 
solely in terms of the hydration properties of the carbohydrate. In practice, it can 
be seen from Table 4.5 that a reduction in Tj in the solution of naproxen sodium 
comparable with that in the presence of y-cyclodextrin is observed. The magnitude 
of this reduction then obviated any attempt to interpret the Tj measured for a 1:1 
mole ratio mixture of naproxen sodium and y-cyclodextrin in terms of the 
hydration properties of the.macrocycle. It is therefore concluded that measurement 
of solvent nO Tj is an inappropriate parameter for the determination of hydrogen 
bonding interactions in the cyclodextrin inclusion complex. That the individual
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effects of naproxen sodium and y-cyclodextriin on D20  170  T! values is not, 
however, additive in a mixture of the two is suggestive of the formation of 
significant amounts of the inclusion complex.
4.6.3 *H NMR Studies of the Complexation of P-Cvclodextrin with some 2- 
Arvlpropionates in d6-DMSO
An alternative approach was to examine the p-cyclodextrin inclusion 
complex interaction in a non-exchanging solvent. NMR studies in dg-DMSO 
have already been described in Chapter 2 and Section 4.3. Little attention has been 
given, however, to the effect of added substrate on the hydroxyl resonances of the 
cyclodextrin. Changes in chemical shift of these resonances in the presence of a 
mole equivalent of 2-arylpropionate are shown in Table 4.6.












Table 4.6 Change in 400MHz chemical shift of hydroxyl resonances in a 
0.014M solution of P-cyclodextrin in the presence of a mole equivalent of some 2- 
arylpropionates in d^DMSO at 30°C
Although OH2 and OH3 resonances of the cyclodextrin are 
indistinguishable in the presence of added substrate, a significant down-field shift 
of these signals remains readily apparent. Such shifts are consistent with the 
formation of a hydrogen bond between the secondary hydroxyl groups of the 
cyclodextrin and an included guest and suggest a common orientation of the two in 
the inclusion complex in which the hydrogen bond accepting carboxylate 
functionality lies at the secondary hydroxyl face of the cyclodextrin (although in
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the case of naproxen sodium a hydrogen bonding interaction with the methoxy 
substituent cannot be ruled out). Such a structure is in agreement with that 
proposed to exist in aqueous solution in Section 4.2. Indeed, the presence of host- 
guest hydrogen bonding in DMSO is suggestive of an equivalent interaction in 
aqueous solvent as a result of the lesser tendency of the latter to disrupt solute 
hydrogen bonding. The magnitude of down-field shifts of cyclodextrin hydroxyl 
resonances are additionally indicative of a comparable stability of the inclusion 
complex for each substrate.
Alternatively, shifts in the hydroxyl resonances may be interpreted in terms 
of an exchange mechanism in the presence of the 2-arylpropionate salt. Marked 
broadening of hydroxyl resonances suggests that such a process is certainly 
contributory to observed changes in chemical shift of the cyclodextrin hydroxyl 
groups.
The temperature dependence of chemical shift of hydroxyl resonances of 
the cyclodextrin in the presence of selected substrates was also examined in this 
work. Linear regression analysis of chemical shift data with temperature gives the 
d5/dT values summarised in Table 4.7.
Substrate 103 x d8/dT in ppm/°C 
OH2 OH3 OH6
none -5.3 -4.1 -5.6
sodium 2-phenylpropionate -5.3 -5.6
ibuprofen sodium -5.4 -5.7
naproxen sodium -5.2 -5.6
Table 4.7 Temperature dependence of 400MHz resonances of a 0.014M 
solution of p-cyclodextrin in the presence of a mole equivalent of some 2- 
arylpropionates in d^DMSO
Temperature dependence of the hydroxyl resonances of p-cyclodextrin is in 
agreement with the results of Onda and co-workers [202], who interpreted the
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lesser sensitivity of chemical shifts of the secondary hydroxyl resonance to 
changes in temperature to the preferential formation of intramolecular hydrogen 
bonds by these groups. In addition, relative magnitudes of the OH2 and OH3 
d5/dT values may be associated with proton donation within this hydrogen 
bonding network arising from the OH3 group.
In the presence of a mole equivalent of guest substrate broadening and 
overlap of the OH2 and OH3 resonances prevents distinction between these two 
group, so that a single d8/dT value may be calculated. This value remains less than 
that of the primary hydroxyl groups in all cases and is indicative of the continued 
presence of intramolecular hydrogen bonding of the secondary hydroxyl groups in 
the presence of guest substrate. Indistinction of the OH2 and OH3 groups prevents 
the determination of the directional sense of this bonding, however.
4.7 Application of the Nuclear Overhauser Effect to Studies of the Complexation 
of P-Cvclodextrin with some 2- Arvlpropionates
The preceding discussions of structural properties of the p-cyclodextrin 
inclusion complexes of the sodium 2-arylpropionates have relied on a somewhat 
subjective interpretation of the results of various NMR experiments. A more direct 
approach to structural information in NMR spectroscopy is, however, achieved by 
the measurement of the nuclear Overhauser effect (nOe), methods for which have 
been described in Chapter 3. Indeed, several authors have reported use of both one- 
and two- dimensional nOe experiments in the elucidation of the structure of 
cyclodextrin inclusion complexes with various substrates [127,267,285,286].
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4.7.1 Studies with the nOe Difference Experime nt
Initial nOe studies of the P-cyclodextrin inclusion complexes of the 2- 
arylpropionates were carried out using the nOe difference method and with 
ibuprofen sodium as the chosen substrate, since earlier experiments had suggested 
extensive formation of a simple monomeric complex with 1:1 guest:host 
stoichiometry in aqueous solution. Additionally, resonances of the ibuprofen 
sodium salt in the presence of a mole equivalent of p-cyclodextrin in D20  are well 
resolved and thus facilitate the acquisition and interpretation of the nOe difference 
spectrum.
Several practical difficulties were encountered in the implementation of the 
nOe difference experiment Thus, for example, the presence of any nOe within the 
cyclodextrin resonances upon irradiation of drug signals was difficult to observe as 
a result of the former's overlapping nature.
Figure 4.12 shows the nOe difference spectrum resulting from the converse 
process, that is irradiation of the cyclodextrin H3, H5 and H6 !H resonances. 
Although small positive enhancements of the ibuprofen sodium H3' resonance are 
apparent following saturation of these cyclodextrin signals, in general other 
resonances of the drug do not exhibit such intermolecular nOes. Inoue et al. [285] 
have pointed out that the molecular size of the cyclodextrin molecule and its 
inclusion complexes is such that nOes lie close to the cross-over point between the 
positive and negative nOe regimes and that therefore nOes for such species are 
often small or even zero. It would therefore seem that this absence of any 
additional nOes for the P-cyclodextrin complex of ibuprofen sodium is most likely 
a consequence of their inherently small size.
We attempted to circumvent this problem by increasing the temperature at 
which the nOe difference spectrum was acquired to 75°C as opposed to 30°C, thus 
decreasing the molecular correlation time and pushing the system into the extreme 
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An additional consequence of this change in temperature was to decrease the 
amount of complex present in solution, but since chiral duplication of the 
ibuprofen anion H2' and H3 resonances was apparent even at this raised 
temperature, clearly significant levels of the inclusion complex remain. Indeed, 
this small reduction in complexation was in practice advantageous. Thus, at 30°C, 
a COSY-45 experiment of a 1:1 mole ratio solution of ibuprofen sodium and P- 
cyclodextrin in D20  showed that the H2 of the ibuprofen anion lies obscured in the 
region of the cyclodextrin H5 resonance, itself only partially resolved from other 
cyclodextrin resonances, so that selective irradiation of the H5 resonance in an nOe 
experiment, without accompanying perturbation of the ibuprofen anion H2 
resonance, may be difficult to achieve. In contrast, at 75°C, a COSY-45 
experiment showed that the down-field shift of the cyclodextrin H5 resonance, 
which may be associated with the reduced levels of complexation, allowed these 
resonances to be readily distinguished (although the H2 resonance of the ibuprofen 
anion remained obscured below the cyclodextrin H2 signal), Figure 4.13.
Irradiation of the cyclodextrin H3 and H5 resonances in an nOe difference 
experiment at 75°C lead to increased clarity of positive enhancements at both drug 
aromatic resonances, Figure 4.14. Additionally, both difference spectra showed 
enhancements of all resonances of the isobutyl substituent of the drug. Irradiation 
of the cyclodextrin H3 resonance also showed a positive enhancement of the H3 
resonance, and thus supports the orientation of the ibuprofen anion in the P- 
cyclodextrin already proposed to exist in D20  (Section 4.2) and dg-DMSO (Section 
4.6.3). In view of the almost universal enhancement of drug resonances we were, 
however, concerned that the effect of the increase in temperature, in addition to the 
desired change in molecular correlation time of the complex, might also be to 
promote permutations of its structure, to which activation barriers may be present 
at lower temperatures. A lowering of the sample temperature in the nOe difference 
experiment, which would have the opposed effect of increasing the molecular
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Figure 4.13 Part of the 400MHz !H spectrum of a 0.014M solution of ibuprofen
sodium in the presence of a mole equivalent of p-cyclodextrin in D20  at (i) 5°C,
(ii) 30°C and (iii) 75°C, showing the relative positions of the cyclodextrin H5 and
drug H2 resonances. C denotes cyclodextrin resonances
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correlation time of the complex, pushing it into the negative nOe regime, whilst 
simultaneously promoting complexation, was considered inappropriate. Thus, the 
possible reduction in temperature is limited by the freezing point of the aqueous 
solvent and additionally, at 5°C, it is observed that the cyclodextrin H5 resonance 
is increasingly obscured beneath that of the cyclodextrin H2 resonance, Figure 
4.13.
An alternative approach to increasing the molecular correlation time of the 
system was to examine complexation of ibuprofen sodium with p-cyclodextrin in a 
solvent of greater viscosity than D20. Such studies in d^DMSO, which has the 
added advantage of providing a lock signal more suited to the difference method 
[253], were, however, unsuccessful, owing to restrictions imposed by the overlap 
of the H3 and H6 resonances of the cyclodextrin, which therefore ruled out their 
selective saturation in an nOe difference experiment. Irradiation of low and high 
field aromatic resonances of ibuprofen sodium was however able to confirm 
assignment of these resonances in the presence of p-cyclodextrin (Section 4.3), 
through the observation of positive nOe enhancements of the H3 and isobutyl HI" 
and H2" signals respectively. In contrast, small negative nOes were found for the 
aromatic and isobutyl HI" and H2" resonances of ibuprofen sodium upon 
irradiation of the cyclodextrin H5 signal, but in the absence of data relating to 
irradiation of the cyclodextrin H3 and H6 resonances, interpretation of these nOes 
in terms of the structure of the p-cyclodextrin complex is unclear. Differences in 
sign of nOes of the ibuprofen sodium ]H resonances may be associated with their 
arising in the free and complexed states.
A further approach was to measure the nOe in the rotating frame, the 
advantages of which in the study of mini-molecules have already been described in 
Chapter 3. The 2D ROESY experiment was chosen in preference to the ID ROE 
difference method, since the selective inversion required for the latter was
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considered inappropriate for application to the partially obscured resonances 
observed in the spectrum of a 1:1 mole ratio solution of p-cyclodextrin and 
ibuprofen sodium in D20, and with other guest substrates examined in this work.
4.7.2 Studies with the ROESY Experiment
The spin-lock field introduces considerable difficulties in the practical 
implementation of the ROESY experiment Thus, this field must have the same 
frequency as, and be phase coherent with, the initial 90° excitation pulse and the 
receiver and must therefore be generated through the transmitter channel 
[253,287]. Although this requirement has the advantage that the decoupler channel 
remains available for solvent suppression purposes, where necessary, the high 
power levels typically used in excitation through the transmitter channel are 
incompatible with the continual application of the spin-lock over mixing times of 
the order of hundreds of milliseconds. Such incompatibility may be circumvented 
by two simple modifications of the basic ROESY experiment, denoted here 
VPHROEH and VPHROESYH, according to their usage in JEOL spectrometer 
software.
1. The VPHROESYH Sequence
90° ‘l
spin-lock mixing period 
Figure 4.15 The VPHROESYH sequence
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The VPHROESYH sequence, Figure 4.15 is based on the original 
experiment of Bothner-By et al. [260]. A reduced power level, which represents a 
compromise between the requirements of uniform excitation by the initial 90° 
pulse and the continual application of the spin-lock field, is used throughout.
2. The VPHROEH Sequence
90° 'p *P *P *P tp tp
ll >d <d >d >d td
spin-lock mixing period n
Figure 4.16 The VPHROEH sequence
An alternative approach which allows the use of raised power levels is the 
VPHROEH sequence, Figure 4.16, derived from the work of Kessler et al. [261]. 
The spin-lock field is here applied intermittently as a series of pulses of duration tp 
separated by short delays of duration td, where the duty cycle, tp/td, is typically of 
the order of 10%. The resulting field has a strength tp/Ctp+tJ of the corresponding 
continuous field [265].
In order to suppress interference from competing TOCSY pathways, 
Kessler et al. [261] advocate that tp should correspond to a pulse angle 
significantly different from 180°, and themselves used tp equivalent to a 32° pulse. 
The subsequent theoretical studies of Bax [265] have suggested however that this 
method offers no advantage in terms of the reduction of TOCSY correlations over 
the VPHROESYH experiment.
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More advanced experiments requiring the use of rapid power level 
switching [253] or the use of z-filters [288,289] have been described, but were not 
considered to offer significant advantages over the VPHROEH and VPHROESYH 
methods.
Initial studies with the ROESY experiment examined a 1:1 mole ratio 
solution of ibuprofen sodium and P-cyclodextrin in D20 . Spectrometer 
manufacturer’s literature recommended the use of the VPHROEH sequence with a 
reduced power level setting corresponding to a spin-lock field of 0.5kHz for a 10% 
duty cycle. Under such conditions, however, the spin-lock field was not of 
sufficient strength to prevent the relative precession of those resonances furthest 
from the carrier (at 4.644ppm). This was apparent from the first slice in the 
imaginary data set, used to set the phase of the spectrum in the f2 frequency 
domain, for which it was not possible to simultaneously obtain all resonances in 
phase, Figure 4.17.
At maximum power this problem was eliminated as is apparent from the 
corresponding imaginary data slice, Figure 4.17. The 1.4kHz strength of the spin- 
lock field generated in this case remains low in comparison to the fields of l-5kHz 
generally preferred for use in the ROESY experiment [253], however, and the 
VPHROESYH sequence was therefore chosen for use in this work, since the 
continual application of the spin-lock field in this sequence allowed field strengths 
of a considerably greater magnitude to be achieved. Typically, field strengths of 
the order of 3.8-5.3kHz were used.
Figure 4.18 shows the ROESY spectrum of a 1:1 mole ratio mixture of 
ibuprofen sodium and p-cyclodextrin in D20  acquired under such conditions, with 
a mixing time of 400ms. The diagonal is phased positive double absorption and 
shown in black. A number of ROESY correlations of negative double absorption 
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Figure 4.17 Imaginary data slices taken from ROESY data sets recorded at 
400MHz on a 0.055M solution of ibuprofen sodium in the presence of a mole 
equivalent of p-cyclodextrin in DzO at 30°C. (i) VPHROEH sequence with spin- 
lock field of 0.5kHz, (ii) VPHROEH sequence with spin-lock field of 1.4kHz and
(iii) VPHROESYH sequence with spin-lock field of 5kHz. The mixing time is 
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Figure 4.18 400MHz ROESY spectrum of a 0.055M solution of ibuprofen sodium 
in the presence of a mole equivalent of p-cyclodextrin in D 20  at 30°C. C denotes 
cyclodextrin resonances
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intramolecular TOCSY correlations (positive double absorption, shown in black) 
within the cyclodextrin resonances may also be identified. These correlations are 
not unexpected, since the carrier position (in the centre of the spectrum) is little 
removed from these resonances [264]. Such positioning of the carrier is 
unavoidable, however, if spectral resolution is to be maintained.
The presence of such TOCSY interactions further suggests that the 
combined TOCSY-ROESY or ROESY-TOCSY correlation pathways may be a 
complicating feature in the interpretation of this spectrum. In order to distinguish 
the true from the false ROESY correlation it was therefore necessary to investigate 
the carrier offset dependence of the observed ROESY correlations [264]. Neuhaus 
and Williamson state that for Bj and static fields in the l-5kHz and 200-500MHz 
ranges respectively, significant changes in intensity of false ROESY correlations 
should be apparent when the carrier is moved by as little as a few hundred Hz 
[253].
In practice, the most noticeable change on repositioning the carrier 
frequency 300-400Hz to high and low field for the ibuprofen sodium/p- 
cyclodextrin system is seen for cross-peak A of Figure 4.18, which changes phase 
on moving the carrier to low field. The observation of this necessarily 
intramolecular TOCSY correlation indicates that in addition to a possible 
intermolecular ROESY correlation between the cyclodextrin and the aromatic ring 
of the included guest, there is a significant contribution to this cross-peak as a 
result of interaction between the H2' and H2 resonances of the drug molecule, the 
latter of which has already been shown to lie obscured in this region of the 
spectrum.
In general, however, although movement of the carrier appears to eliminate 
the TOCSY correlation to the cyclodextrin HI resonance, that between the H3 or 
H6 and H2, H4 or H5 resonances remains prominent throughout, which indicates
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that carrier off-sets in excess of the recommended value are required in this 
instance.
Indeed, when the carrier is off-set to high field of all !H resonances [246], 
corresponding to ;a shift of approximately 1800Hz, this TOCSY correlation is no- 
longer readily apparent although all other intermolecular ROESY correlations 
remain. There are, however, several difficulties associated with this extreme 
positioning of the carrier frequency. Firstly, the necessary increase in frequency 
width to incorporate all resonances within the spectral window leads to a marked 
decrease in resolution (here 31.25Hz). Additionally, this increase in spectral width 
requires an accompanying increase in the rate of sampling of the FID, which for a 
constant matrix size may lead to severe truncation of the FID. Thus, the ROESY 
spectrum measured under such conditions here was noisier and showed raised 
levels of sine wiggling, characteristic of such truncation [253], which made it 
difficult to deduce the complete elimination of cyclodextrin TOCSY interactions. 
Presumably, careful optimisation of window functions for transformation would 
alleviate this problem.
Lowering of power levels of the spin-lock field provides an alternative 
approach to the elimination of the TOCSY interaction in ROESY spectra [262]. 
Examination of the 1:1 mole ratio solution of ibuprofen sodium and p-cyclodextrin 
in D20  using the VPHROESYH sequence with the carrier returned to 4.644ppm, 
but with the spin-lock power lowered to as little as 1kHz, showed that the TOCSY 
interaction within the cyclodextrin resonances was still apparent, although 
considerably reduced in intensity.
That equivalent ROESY correlations are present in all spectra, including 
that with the carrier off-set to high-field where TOCSY interactions appear to have 
been eliminated, suggests that these correlations are true ROESY cross-peaks in 
contrast to those which might arise through a false ROESY/TOCSY pathway. 






H3" H3 and/or H6 
H5
H I” weak correlations?
H2' H3 and/or H6 
H5 and/or drug H2
H3' H3 and/or H6 
H5
Table 4.8 Assignment of correlations observed in 400MHz ROESY spectra of a 
0.055M solution of ibuprofen sodium in the presence of a mole equivalent of p- 
cyclodextrin in D20  at 30°C
Due to the overlapping nature of the cyclodextrin resonances in these 
spectra it was necessary to assume when assigning correlations that they arose only 
from those protons lining the cavity and its rim. It can also be seen from Table 4.8, 
however, that resolution in the 2D matrix was not sufficient to allow 
discrimination between the H3 and H6 resonances of the cyclodextrin. This 
indistinction can be seen more clearly from Figure 4.19 which compares resolution 
in the high resolution !H spectrum with a typical first imaginary data slice taken 
from one of the ROESY spectra described above. The ROESY experiment was 
therefore repeated with the matrix size doubled to its maximum possible size 
compatible with the spectrometer memory capabilities, giving a resolution of 
7.81Hz over a standard spectral width of 4000Hz, which then allowed 
discrimination of the cyclodextrin H3 and H6 resonances to be achieved, Figure 
4.19. Additionally, since preliminary studies also made use of a solution of 
comparatively high concentration of 0.055M in both host and guest, to facilitate 
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Figure 4.19 Comparison of resolution in 400MHz ]H spectra of a 1:1 mole ratio 
solution of ibuprofen sodium and p-cyclodextrin in D20  at 30°C. (i) high 
resolution spectrum (resolution = 0.24Hz), (ii) imaginary slice from ROESY data 
set (resolution = 15.6Hz) and (iii) imaginary slice from ROESY data set 
(resolution = 7.81Hz). C denotes cyclodextrin resonances
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experiment to ensure that correlations were not the result of some associative 
process possibly present at higher concentration. Expansion of this data set 
revealed that:
1. Correlations previously assigned to the cyclodextrin H3 and/or H6 resonances 
are composed of two cross peaks, one strong and one weak (see, for example, 
Figure 4.20). These were assigned respectively to the H6 and H3 protons.
2. Despite increased resolution in the ROESY spectrum, it was not possible to 
either confirm or eliminate the additional contribution of a ROESY correlation 
between the H2' resonance of ibuprofen sodium and that of the cyclodextrin H5 
signal to cross-peak A of Figures 4.18 and 4.20, which has already been assigned 
in part as arising from intramolecular correlation between the ibuprofen sodium H2 
and H2' resonances. Correlation of the ibuprofen sodium H2’ resonance to 
cyclodextrin H6 would, however, suggest the additional presence of such an 
interaction.
The interpretation of these correlations, which it is to be noted are not 
inconsistent with those observed in the high temperature nOe experiment, in terms 
of a unique structure of the p-cyclodextrin inclusion complex of ibuprofen sodium 
as has been previously suggested to exist in aqueous solution is not straight­
forward. The strong intensity of ROESY correlations of the aromatic resonances of 
ibuprofen sodium to the cyclodextrin H5 and H6 signals in comparison to those to 
H3 would suggest only partial insertion of the aromatic ring into the macrocyclic 
cavity, so that it lies close to the primary hydroxyl entrance. A similar 
interpretation of the correlations of the isobutyl H3" signal would then suggest an 
orientation of the ibuprofen sodium molecule in the P-cyclodextrin cavity 
equivalent to that previously proposed (Section 4.2 and Section 4.6.3). 
Interpretation of ROESY cross peak intensity without regard to its dependence on
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Figure 4.20 Expansion of part of the 400MHz ROESY spectrum of a 0.014M 
solution of ibuprofen sodium in the presence of a mole equivalent of p- 
cyclodextrin in D20  at 30°C. C denotes cyclodextrin resonances
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non-uniform excitation and resonance off-set effects must, however, be regarded 
with caution [253]. Additionally, it must be remembered that the H3 proton may 
necessarily lie geometrically further from any molecule within the cyclodextrin 
cavity, as a result of the greater diameter of the secondary hydroxyl entrance of 
this cavity.
The ROESY experiment was also used to investigate the complexation of 
p-cyclodextrin with other of the 2-arylpropionates. Overlap of the cyclodextrin H3, 
H5 and H6 resonances, both with each other and with the H2 resonance of the 
guest substrate, was found to be a recurring difficulty in the interpretation of these 
spectra. Additionally, poor resolution of aromatic signals of some substrates in the 
presence of P-cyclodextrin further complicated interpretation.
A 1:1 mole ratio solution of sodium 2-(4-chlorophenyl)propionate and p- 
cyclodextrin in D20  was examined using the ROESY experiment to enable 
unequivocal assignment of the aromatic resonances of the salt, in addition to 
providing structural information in relation to the inclusion complex.
A COSY-45 experiment of this solution showed that the H2 resonance of 
the salt was obscured below the cyclodextrin H2 resonance but was conveniently 
separated from the H3, H5 and H6 resonances of the cyclodextrin which are of 
interest here. The cyclodextrin H3 and H6 resonances were, however, overlapping 
and indistinguishable in the resulting ROESY spectrum acquired using the 
VPHROESYH sequence and a spin-lock field of 3.8kHz over a mixing period of 
400ms, Figure 4.21.
A number of correlations were observed in this spectrum. Thus, cross- 
peaks were identified which were consistent with intramolecular ROESY 
correlations between the H2 resonance of the 2-arylpropionate and its aromatic and 
H3 groups. Additionally, intramolecular ROESY and TOCSY correlations were 
observed within the cyclodextrin resonances. The correlations of greatest interest 
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Figure 4.21 Comparison of resolution in 400MHz spectra of a 1:1 mole ratio 
solution of sodium 2-(4-chlorophenyl)propionate and P-cyclodextrin in DzO at 
30°C. Part of (i) high resolution spectrum (resolution = 0.24Hz), (ii) imaginary 
slice from ROESY data set (resolution = 7.81Hz) and (iii) imaginary slice from 
folded ROESY data set (resolution = 3.90Hz). C denotes cyclodextrin resonances
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cross-peaks were observed between the aromatic resonances of the guest and the 
H5 and H3 and/or H6 resonances of the host and between the methyl resonance of 
the former and the H3 and/or H6 resonance of the cyclodextrin.
A ROESY spectrum acquired under identical conditions but with a mixing 
time of 800ms reproduced these correlations. Furthermore slices taken through 
these spectra showed an increase in their intensity with mixing time in comparison 
to diagonal peaks and suggests that longer mixing times in the ROESY experiment 
may be generally beneficial in terms of enhanced sensitivity in the study of the 
complexes of p-cyclodextrin. In contrast, at a shorter mixing time of 200ms a 
reduced intensity of these correlations was observed, and indicated that mixing 
times of this order of magnitude, which have been used by other authors [285] in 
the examination of cyclodextrin complexes, may not be ideal for the examination 
of those complexes studied in this work.
Resolution of the aromatic H2' and H3' resonances of sodium 2-(4- 
chlorophenyl)propionate was not achieved in these spectra, despite the use of the 
largest 2D matrix compatible with the memory capability of the spectrometer. 
Thus, whilst ROESY correlations between the aromatic resonances of the salt and 
those of the cyclodextrin clearly supported inclusion of the aromatic ring into the 
macrocyclic cavity, no further structural information in respect of the complex was 
established, and additionally assignment of the aromatic resonances of the guest 
was not confirmed. It was therefore necessary to repeat the ROESY experiment 
with folding of the H3 resonance in order to achieve sufficient resolution in the 2D 
matrix to distinguish the H2' and H3f resonances of the salt, Figure 4.21. For 
maximal reduction in the spectral window upon folding, it was necessary to move 
the carrier frequency to low field by approximately 340Hz. Large TOCSY 
correlations were still however apparent within the non-glycosidic group of 
cyclodextrin resonances. Furthermore, it was not possible to clearly discern 
ROESY correlations to the aromatic region of the sodium 2-(4-
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chlorophenyl)propionate molecule, despite an 8-fold increase in the number of 
scans used to acquire the data set in comparison to earlier experiments. Imperfect 
filter cut-off was clearly not the cause of this loss in cross-peak intensity, since 
filter width was twice that of the spectral window. Small distortions in baseline as 
a result of non-optimal settings of delays prior to acquistion present a more 
probable cause.
Folding of the H3 resonance of the guest substrate was also required in 
studies of complexation of a 1:1 mole ratio solution of flurbiprofen sodium and p- 
cyclodextrin in D20 , again to achieve adequate resolution of the aromatic 
resonances of the guest together with partial resolution of the H3 and H6 
resonances of the cyclodextrin. In this case, the H2 resonance of the flurbiprofen 
sodium molecule was well resolved from all cyclodextrin resonances even in the 
absence of spectral folding, Figure 4.22.
Thus, a standard ROESY experiment acquired with a spectral width of 
4000Hz using the VPHROESYH sequence with a spin-lock field of 5kHz and a 
mixing time of 400ms revealed correlations with the same broad classification as 
was described for the solution of sodium 2-(4-chlorophenyl)propionate and p- 
cyclodextrin in D20 , namely: ROESY correlations of the H2 resonance of 
flurbiprofen sodium with its H3 and aromatic H21 and H6' resonances, ROESY and 
TOCSY correlations within the cyclodextrin resonances and intermolecular 
ROESY correlations between the aromatic resonances of the guest and the H5 and 
H3 and/or H6 resonances of the cyclodextrin and between the H3 signal of the 
guest and the H3 and/or H6 resonances of the cyclodextrin. Cross-peaks were 
observed between the cyclodextrin resonances and each of the three peaks into 
which the aromatic region of the flurbiprofen sodium molecule was coarsely 
resolved, Figure 4.23, these peaks incorporating (i) the H2", (ii) the H5\ H3", H4" 
and (iii) H2' and H6' resonances (Figure 4.22). In order to eliminate the possible 
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Figure 4.22 Comparison of resolution in 400MHz !H spectra of a 0 .014M solution
of flurbiprofen sodium in the presence of a mole equivalent of P-cyclodextrin in
D20  at 30°C. (i) high resolution spectrum (resolution = 0.24Hz), (ii) imaginary
slice from ROESY data set (resolution = 7.81 Hz) and (iii) imaginary slice from

















Figure 4.23 Expanded regions of 400MHz ROESY spectra of a 0.014M solution 
of flurbiprofen sodium in the presence of a mole equivalent of p-cyclodextrin in 
D20  at 30°C. (i) resolution = 7.81Hz and (ii) folded with resolution = 3.88Hz. C 
denotes cyclodextrin resonances
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correlations, the- carrier frequency was moved by 500Hz to high and low field of its 
initial positions which represents the maximum shift compatible with 
simultaneously maintaining resolution and all resonances within the spectral width. 
TOCSY correlations within the cyclodextrin resonances remained prominent in 
each of these spectra, however, and do not therefore allow the presence of false 
ROESY cross peaks to be ruled out.
These TOCSY correlations remain in the folded spectrum, which allowed 
distinction of both aromatic resonances of flurbiprofen sodium and the H3 and H6 
resonances of the cyclodextrin (Figure 4.22). Intermolecular ROESY correlations 
are, however, again weak despite a 4-fold increase in the number of scans versus 
the non-folded experiments, and was again thought to be a consequence of baseline 
distortions. Cross-peaks which can be distinguished indicate correlation of all 
aromatic resonances to the H3, H6 and presumably H5 resonances of the 
cyclodextrin, that of H5 lying partially obscured beneath that of cyclodextrin H2, 
Figure 4.23. Additional correlations to the cyclodextrin H2 or H4 resonance must 
be the result of combined TOCSY-ROESY interaction pathways, and suggests that 
other cross-peaks may similarly be false. Despite this inability to distinguish the 
true ROESY correlation from the false, it remains possible to conclude that both 
aromatic rings of the guest substrate penetrate the p-cyclodextrin cavity. Thus, 
false ROESY cross-peaks of resonances of one ring as a result of true correlation 
of the other are ruled out since the shortest !H coupling pathway between the two 
rings is over 5 bonds, which effectively prohibits TOCSY interactions between the 
two. It is noted that no intra-aromatic ROESY correlation which would support the 
existence of a dimeric structure for the flurbiprofen sodium/p-cyclodextrin system, 
similar to that observed in the solid state, was apparent in this spectrum.
It has also been suggested that dimerisation may be an important feature of 
the complexation of naproxen sodium with P-cyclodextrin. A 1:1 mole ratio 
solution of naproxen sodium and P-cyclodextrin in D2Q examined using the
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ROESY experiment similarly failed to show ROESY correlations within the 
naproxen sodiuim signals, however, which would support such a proposal. A 
number of intermolecular ROESY correlations were, however, present in this 
spectrum, which was acquired using a spin-lock field of 4kHz over a mixing period 
of 400ms. Figure 4.24 shows an expanded region of it together with assignments 
for each ROESY correlation.
It can be seen from these assignments that resolution in this matrix was 
insufficient to allow distinction between a number of signals. Thus, whilst 
aromatic HI' and H3' resonances of the naproxen sodium molecule were clearly 
resolved, those of H8' and H4’ and H5' and H7' were partially overlapping in the 
high resolution JH spectrum and were not distinguished here. Additionally, a 
COSY-45 experiment revealed that the H2 resonance of this molecule was 
obscured beneath the cyclodextrin H3 and H6 resonances. Even so, Figure 4.24 
shows that correlations of the aromatic HI' and H3' protons to it are readily 
discernible from those of other aromatic naproxen sodium resonances to the 
cyclodextrin H3 and H6 resonances either side of it.
The inteipretation of these intermolecular ROESY correlations in terms of 
a unique structure of the p-cyclodextrin complex of naproxen sodium is not 
possible. Disregarding correlations assigned to the aromatic H4' and H8' 
resonances which could not be unequivocally assigned to either or both of these 
resonances, the weak correlation of HI' to the cyclodextrin H5 resonance only, 
together with the correlation of the aromatic resonances of H5' and/or H7' with the 
cyclodextrin H3 and H5 resonance suggests an orientation of the guest molecule in 
the p- cyclodextrin cavity opposed to that proposed to exist in d^DMSO (Section 
4.6.3). Additional cross-peaks observed between aromatic H5' and/or H7' and to 
the cyclodextrin H6 resonances are not, however, consistent with this model. The 
presence of false ROESY correlations was thought to offer a possible explanation 
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Figure 4.24 Expanded region of a 400MHz ROESY spectrum of a 0.014M 
solution of naproxen sodium in the presence of a mole equivalent of p-cyclodextrin 
in D20  at 30°C. Intermolecular ROESY correlations are illustrated in the figure. C 
denotes resonances of the cyclodextrin
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resonances of the P-cyclodextrin molecule. Test ROESY experiments on a 
concentrated 1:1 mole ratio solution of naproxen sodium and p-cyclodextrin in 
D20  (0.055M in each reagent) were therefore carried out, using maximal 
transmitter off-sets to high and low field which allowed resolution in the 2D matrix 
to be maintained. Although the magnitude of the cyclodextrin TOCSY interaction 
was visibly reduced when the carrier was placed down field at approximately 
5.9ppm, the failure to eliminate it completely prevented the presence of false 
ROESY cross-peaks to be ruled out. Increased separation of the H5' and H7' 
resonances of naproxen sodium for this more concentrated solution in these spectra 
did, however, indicate that correlations to the cyclodextrin H3,H5 and H6 
resonances may be associated with each of the H5’ and H7’ resonances.
4.8 Application of Measurements of 13C to the Complexation of P-Cyclodextrin 
with some 2-Arvlpropionates in D?Q
Measurement of 13C TjS of cyclodextrins in the presence of a guest 
substrate in aqueous solution have been used by several authors to provide 
information regarding the structure and dynamics of the resulting inclusion 
complex [290-292]. The simplest interpretation of these values in terms of the 
motional characteristics of the complex requires that relaxation be dominated by 
the dipolar mechanism through some number N of directly attached protons and 
that molecular tumbling may be described by an isotropic correlation time, tc In 
the extreme narrowing limit, Tj may then be related to tc according to,
J - a t e  (4.7)
NT!
In practice, where complexation is not complete, the observed Tj is a 
population averaged sum of the T! for the free and complexed states.
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It was thought that the motional characteristics of a chiral guest might have 
important consequences in terms of chiral discrimination by a cyclodextrin host. 
Measurements of 13C TjS for the sodium 2-arylpropionate complexes of p- 
cyclodextrin were therefore undertaken.
The low concentrations of the solutions ideally used in this work to avoid 
complex association ruled out use of the classical inversion-recovery sequence for 
measurement of 13C longitudinal relaxation times in a practicable experiment run 
time. Two recent methods intended for faster Tj measurements, namely the 
DESPOT and SUFIR methods described in Chapter 3, were therefore considered. 
The SUFIR method was considered the simplest and most appropriate of the two; 
its use requires only determination of the 13C 180° pulse width, whereas the 
DESPOT sequence further requires determination of a pulse offset, which 
describes the deviation from proportionality of the pulse width and pulse angle. 
Additionally, the DESPOT sequence suffers with complications regarding the use 
of the lock circuitry of the spectrometer associated with the use of a homospoil 
pulse. Effective operation of the deuterium lock mechanism was considered 
essential for the long experiment times 13C Tj measurements require.
4.8.1 Implementation of the SUFIR sequence on a JEOL NMR Spectrometer
The SUFIR method has been relatively little used, and was not therefore 
available as a standard experimental sequence in the JEOL spectrometer software. 
The pulse sequence was therefore generated using the PEGS (Pulse Editing 
Graphics Software) program and is shown in Figure 4.25.
There are several important features of the sequence to be noted:
1. Continuous broad-band decoupling is achieved by use of the WAUGH 
sequence [293]. Heteronuclear decoupling eliminates cross-relaxation between 13C
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P u l s e  s e q u e n c e  n a m e .  SUFIR
EXPCH - {P>2)NHP5UFIRrtfl(C90).W2(C240),T-AC»PD,DU-l
(I 0 I II 21 31 41 51 61 71 8 l 9110111112113114 115116 117118119I2CI21I22I23I 24
TIHE LINE II I I I I I I I I I I I I I I I I I I I I I I I I
OB.GATE WT I w i l w i l w i lDT  DL T1 AC PD I W1 | W? | W1 10 f DL T1 AC PD I W t | W 1 j W 1 IDT DL T1 AC PD
OB.phase x x | p j |p4|___________|7I p i |P21pi I___________|x x |P31pa |___________(x
RESET  I |_____________________|  1___ I I I I______
R C V . G A T E  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I I
SAMPLING ____________________________ I |________________________________________________________________ | 1__________
P u l s e  s e q u e n c e  name.  SUFIR 
EXPCM = {P 2} NHP SUF IR :W 1( C9 0) , W2 (C2 40 ) ,T =AC +P D,D U= 1
G a t e  a s s i g n m e n t
















L o c a l  s y m b o l
T 1 T y p e  : S U s e  : 1 L i s t  : 1
R e p e a t  : 1
1 : 1 . 0  USEC
X T y p e  : S U s e  : 1 L i s t  : 1
R e p e a t  : 1
1 : 0 DEG
Figure 4.25 PEGS representation of the SUFIR experiment (continued overleaf)
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Type : M 
R e p e a t  : 1
0 DEG 
90  DEG 
90  DEG 
0 DEG
P2 Type  : M
R e p e a t 1
90  DEG 
180 DEG 
130  DEG 
90 DEG
P3 Typ e  : M
R e p e a t  :
1 : 90  DEG
P4 T y p e  : H 
R e p e a t  : 4
1 :
2 :
2 7 0  DEG 
90  DEG
PUPHA Type  : P




APHAS Ty p e  : A




U s e L i s t  : 16
0 DEG 
90  DEG 
90  DEG 
0 DEG
U s e L i s t  : 16
90 DEG 
130 DEG 
130  DEG 
90  DEG
U s e 1 L i s t  : 16
U se L i s t  : 16
U s e  : 1 L i s t  : 16
U s e  : 1 L i s t  : 16
iPHAS Typ e  : G U s e  : 1 L i s t  : 32
R e p e a t  : 1
A r e p e a t  : 1 @
1 : 0 DEG








V a r i a b l e  p a r a m e t e r  
PLX = PI1  
CNVRT = - 1 . 0 0 0 0
Figure 4.25 PEGS representation of the SUFIR experiment (continued from 
previous page)
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and *H nuclei which would otherwise cause*, deviation from mono-exponential 
behaviour of the measured [244,294].
2. Preparation of the spin system requires the use of a single DUMMY sequence.
3. To ensure constancy of the time delay t between pulses, the central period is 
divided in the same manner as the two delays during which acquisition is canied 
out. This division into deadtime (DT), delay (DL), acquisition time (AC) and pulse 
delay (PD) requires the use of the RESET function (which resets the observation 
transmitter phase to 0°) as a dummy event.
4.8.2 Testing of the SUFIR Sequence
The SUFIR sequence was tested on a number of samples for which the 13C 
Tj value from a classical inversion-recovery sequence was also measured. Test 
samples were chosen randomly, but were such that high sample concentrations 
were readily achieved to allow rapid measurement. Processing of inversion- 
recovery data is described in Chapter 5, and was achieved using calculation 
routines within the spectrometer software. A simple BASIC program, Figure 4.26, 
run on a BBC Archimedes computer allowed rapid calculation of Tj values from 
peak height measurements in the SUFIR method. The results are summarised in 
Tables 4.9 to 4.12. Tt values are given only for resonances which are clearly 
resolved and for which the necessary criteria for each experiment were satisfied; 
namely for the inversion-recovery experiment that Tj was less than a fifth of the 
largest value of the variable parameter t, and for the SUFIR method, that t/Tj lay in 
the range 0.5-3. Otherwise, entries are absent from these tables where calculation 
of T! was not possible, since S2>Sj (see equation 3.11). This relationship between 
Sj and S2 was thought to be a result of errors in peak intensity measurement where 
S2 is little changed from Sj. In general, agreement between the inversion-recovery 
and SUFIR methods is good.
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10 REM T 1 C A L C :A !SIMPLE PROGRAM FOR CALCULATING
15 REM T 1 VALUES FROM THE SUFIR EXPERIMENT
20 REM CAROL MARCHANT 23-08-91
22 REM LINES 2610 AND 2660 ADDED 09-09-91
25 REM ENSURE PRINTER IS LOADED AND ON-LINE
30 REM BEFORE COMMENCING
40 ♦IGNORE
50 PRINT "PLEASE ENTER SAMPLE CODE"
100 INPUT CODE$
150 PRINT "PLEASE ENTER DFILE NAME"
200 INPUT DFILE$
250 PRINT "PLEASE ENTER TAU VALUE"
300 INPUT TAU
350 PRINT "PLEASE ENTER MXINTS1 VALUE"
400 INPUT MXINTS1
410 PRINT "PLEASE ENTER NGAIN1 VALUE"
420 INPUT NGAIN1
450 PRINT "PLEASE ENTER MXINTS2 VALUE"
500 INPUT MXINTS2





600 PRINT "PLEASE ENTER PEAK POSITION"
650 INPUT PEAK
700 PRINT "PLEASE ENTER S1 FOR THE CHOSEN PEAK" 
750 INPUT S1




1000 IF PRELN>0 THEN GOTO 2250 
1050 VDU2
1100 PRINT "SAMPLE ";CODE$
1150 PRINT "DFILE ";DFILE$
1200 PRINT "PEAK ";PEAK
1250 PRINT "TAU ";TAU
1300 PRINT."MXINTS1 ";MXINTS1
1350 PRINT "MXINTS2 ";MXINTS2
1850 PRINT "S1 " ;S1
1900 PRINT "S2 ";S2
1950 PRINT "(1-S2/S1) ";PRELN
Figure 4.26 BASIC program for calculation of Tj values resulting from the SUFIR 
experiment from peak intensity data (continued overleaf)
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2400 PRINT "SAMPLE ";CODE$
2450 PRINT "DFILE ";DFILE$
2500 PRINT "PEAK "; PEAK
2550 PRINT "TAU ";TAU
2600 PRINT "MXINTS1 " ;MXINTS1
2610 PRINT "NGAIN1 ";NGAIN1
2650 PRINT "MXINTS2 ";MXINTS2
2660 PRINT "NGAIN2 NGAIN2
3250 PRINT "S1 ";S1
3300 PRINT "S2 " ;S2
3350 PRINT "T1 " ;T1
3370 PRINT "TAU/T1 ";TAU_T1 RATIO
3400 VDU1,10
3450 V D U 1 ,10
3500 VDU1 ,10
3550 VDU3
3600 PRINT "DO YOU HAVE MORE PEAKS IN THIS DATA SET"
3650 PRINT "PLEASE ENTER Y TO CONTINUE"
3700 INPUT CONTINUES
3750 IF CONTINUE$="Y" THEN GOTO 600
3800 PRINT "DO YOU HAVE MORE DATA FROM ANOTHER DATA SET
3850 PRINT "PLEASE ENTER Y FOR A NEW DATA SET"
3900 INPUT NEWSETS
3950 IF NEWSET$="Y”THEN GOTO 50
4000 PRINT "END"
Figure 4.26 BASIC program for calculation of Tj values resulting from the SUFIR 








29.2 4.5 3.9(1.4) 4.4(2.4)
26.4 3.8 3.4(1.6) 4.0(2.6)
19.0 4.8 4.6(1.2) 4.7(2.2)
18.4 5.0 5.4(1.0) 5.5(1.9)
8.5 6.2 4.7(1.2) 5.3(2.0)
Table 4.9 270MHz 13C Tj measurements using the inversion-recovery and SUFIR 







129.5 2.9 2.8(0.7) 2.9(1.9)
120.9 2.1 2.1(0.9) 2.2(2.5)
115.2 2.9 2.9(0.7) 2.9(1.9)
Table 4.10 270MHz 13C Tj measurements using the inversion-recovery and 







Cl 0.16 _ 0.18(1.6)
C4 0.17 - 0.16(1.7)
C3 0.17 - 0.18(1.6)
C5 0.17 0.20(2.7) 0.15(1.9)
C2 0.17 0.21(2.7) 0.16(1.8)
C6 0.10 - 0.11(2.5)
Table 4.11 270MHz 13C Tj measurements using the inversion-recovery and 
SUFIR methods for a concentrated solution of y-cyclodextrin in DzO. Resonances 
were assigned by comparison with 13C data for aqueous solutions of a - and p- 








127.6 3.2 3.0(1.8) 2.9(1.0)
126.4 2.0 1.9(2.9) 1.9(1.5)
124.8 3.1 3.0(1.8) 3.1(1.0)
69.1 2.8 2.5(2.1) 2.6(1.1)
24.5 1.2 - 1.2(2.5)
Table 4.12 270MHz 13C Tj measurements using the inversion-recovery and 
SUFIR methods for a concentrated solution of sec-phenethyl alcohol in CDC13
The sec-phenethyl alcohol sample was also used to investigate the 
reproducibility of the SUFIR method and its sensitivity to small errors in pulse 
width settings, since as a result of the poor sensitivity of 13C NMR it is often 
difficult to measure the pulse width with great accuracy.
Table 4.13 shows the results of consecutive measurements on the same 
sample under identical conditions and shows the method to be essentially 
reproducible.
Additionally, the effects of small variations in the 13C pulse in a range 
corresponding to a 180° pulse width of 15-19|is, compared with the measured 
value of 17|is, are shown in Table 4.14. These results confirm that the SUFIR 
method is not adversely affected by small errors in measurement of the 13C pulse 
width.
These observations together confirm the accuracy and robustness of the 
SUFIR method in the measurement of 13C Tj, and support the validity of the 
application of the method to the P-cyclodextrin complexes of the sodium 2- 
arylpropionates studied in this work.
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8/ppm Tj/s (t/Tj) using the SUFIR method with t=5.5s 
experiment 1 experiment 2 experiment 3
127.6 3.0(1.8) 2.9(1.8) 3.0(1.8)
126.4 1.9(2.9) 2.1(2.7) 1.9(2.8)
124.8 3.0(1.8) 3.2(1.7) 3.0(1.8)
69.1 2.5(2.1) 2.5 (2.2) 2.8(1.9)
Table 4.13 Investigations of the reproducibility of the SUFIR method in the 
measurement of 270MHz 13C T! for a concentrated solution of sec-phenethyl 
alcohol in CDC13


































Table 4.14 Investigations of the sensitivity of the SUFIR method to small errors in 
pulse width in the measurement of 270MHz 13C T, for a concentrated solution of 
sec-phenethyl alcohol in CDC13. The 180° pulse width was mis-set from its 
measured value of 17fis.
4.8.3 » C T , Measurements of the Complexation of B-Cvclodextrin with Ibuprofen 
Sodium in DX> using the SUFIR Sequence
Preliminary studies with the SUFIR sequence have compared 13C T x 
measurements of ibuprofen sodium in the presence and absence of a mole 
equivalent of p-cyclodextrin in D20 . The solutions examined were of a 
comparatively high concentration (0.17M) in ibuprofen sodium to reduce initial 
experimental run times.
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13C NMR data for ibuprofen sodium, referenced to a solution of DSS in 
D20 , are given in Table 4.15. Resonances were assigned predominantly from a 
heteronuclear correlation experiment. Carbons C l' and C4' were assigned from 
weak correlations to the H3 and HI" groups respectively in a long-range 












Table 4.15 270MHz 13C{!H } data and assignments for a 0.17M solution of 
ibuprofen sodium in DzO
A heteronuclear correlation experiment of a 1:1 mole ratio solution of 
ibuprofen sodium and P-cyclodextrin in D20  was also required to verify that the 
relative chemical shifts of these resonances were unchanged in the presence of p- 
cyclodextrin. An attempt to identify the resonances of carbons C l' and C4' in this 
case using the FLOCK experiment and the J coupling parameters of the ibuprofen 
sodium sample was, however, unsuccessful, perhaps as a  result o f enhanced rates 
of relaxation in the presence of the cyclodextrin [255]. Thus, it was unclear 
whether the single correlation which was observed between the lower field of these 
two resonances and H2' in this spectrum was the result of a 2 or 3 bond coupling 
pathway. The C l' and C4' resonances then remain unassigned.
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As in JH NMR spectroscopy, changes in chemical shift and chiral (or in the 
case of the isobutyl C3" signal possibly prochiral) splittings of the ibuprofen 
sodium 13C resonances are observed in the presence of a mole equivalent of p- 
cyclodextrin. These are summarised in Table 4.16.
13C resonance change in chemical shift/ppm chiral splitting/ppm
Cl -0.9,-1.0 0.1








Table 4.16 Changes in chemical shift and chiral splittings of 270MHz 13C{ JH} 
resonances of a 0.17M solution of ibuprofen sodium in the presence of a mole 
equivalent of p-cyclodextrin in D20
Splittings are all within the range of 0.1-0.2ppm and in the case of the C3 
resonance and the unassigned CT or C4' resonance are sufficient for baseline 
resolution to be achieved without recourse to the use of resolution enhancement 
functions. Their exploitation in the determination of optical purity is, however, 
hampered by the difficulties associated with quantitation in 13C NMR 
spectroscopy.
13C Tj measurements for an aqueous solution of ibuprofen sodium were 
achieved using the SUFIR method. Two experiments with t delays of 
approximately 1.7s and 10s were found to be necessary to cover the range of TjS 
within the substrate molecule. The results of these experiments are shown in Table 
4.17. Entries are again absent from this table where calculation of Tj was not 
possible, either because, as above, S2 > Sb or because either S! and/or S2 was of 
negligible peak intensity.
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Table 4.17 270MHz 13C T, for a 0.17M solution of ibuprofen sodium in DzO 
measured using the SUFIR method. Calculated values for which t/T, lies outside of 
its optimal range are given in parentheses
Cross-correlation effects, and consequent deviation from mono-exponential 
longitudinal relaxation [244,294], presumably account for a significant difference 
in the calculated Tj value for the C3 resonance from each experiment, since 
reasonable agreement is observed for other resonances where more than one 
determination of Tj was possible, even where the ratio of t/T! lies outside its 
optimal range. Clearly, therefore, it must be considered essential when using the 
SUFIR method to carry out at least two determinations of T, for each resonance 
using different t values, to ensure reproducibility of the calculated T, and to 
establish mono-exponential relaxation, which is an important assumption of the 
SUFIR method.
As is generally the case, relaxation of the quaternary 13C nuclei was found 
to be significantly slower than that of other resonances, since the absence of 
directly attached protons reduces the efficiency of the dipolar relaxation 
mechanism. A further consequence of this absence is that nOe enhancement of the 
intensity of these resonances is also eliminated, and as a result of their small size, 
peak intensities, and therefore T, values, for these nuclei are difficult to measure
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with great accuracy. Although improvements in the signal-to-noise ratio of these 
quaternary signals may be anticipated with greater signal averaging, it is to be 
noted that for the solution of ibuprofen sodium examined here quaternary signals 
remained weak despite an approximately 9 hour acquisition period.
For a solution of ibuprofen sodium in the presence of a mole equivalent of 
p-cyclodextrin in D20 , three SUFIR experiments were carried out to accommodate 
the range of 13C Tj of host and guest. Results are summarised in Table 4.18. For 
shorter relaxation times, it was found necessary to halve the number of sampling 
points, leading to a reduction in spectral resolution, in order to achieve time delays 
which were sufficiently small.






Cl 8.0(1.25) _ .
6.1(1.65) - -
C l' orC4’ [3.3(3.07)] - -
C l' or C4' [2.1(4.73)] 2.3(0.75) _
C3' - [0.5(3.13)] 0.5(0.57)
C2' 2.6(3.81) 0.6(2.78) 0.5(0.56)
C2 - [0.5(3.71)] -
Cl" - - 0.3(0.85)
C2" - 0.7(2.45) -
C3" - 0.8(2.12) -
- 0.8(2.09) -
C3 - [0.5(3.68)] -
[2.9(3.49)] 0.7(2.35) -
Table 4.18 270MHz 13C Tj for a 0.17M solution of ibuprofen sodium in the 
presence of a mole equivalent of p-cyclodextrin in D20  using the SUFIR method. 
Calculated values for which t/Tj lies outside of its optimal range are given in 
parentheses
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It is difficult to draw conclusive comparisons between Tj values given in 
Tables 4.17 and 4,18, since additional work is certainly required to establish their 
reproducibility. There are several points which may be made however. Thus, there 
appears to be a general reduction in 13C Tl of drug resonances upon the addition of 
p-cyclodextrin, which for non-quaternary carbons may, from equation 4.7, be 
associated with an increase in tc and a slowing of molecular reorientation. 
Measurement of solution viscosity would allow distinction between the 
contributions of drug inclusion and an increase in solution viscosity to this effect 
[290]. Accurate determination of the degree of complexation of ibuprofen sodium 
in the presence of cyclodextrin is furthermore required for detailed inteipretation.
Relaxation times for the 13C resonances of p-cyclodextrin lie within the 
range 0.1-0.2s and are of the anticipated order of magnitude [291]. 13C Tj for the 
uncomplexed P-cyclodextrin macrocycle were not measured here, primarily 
because the limited solubility of the cyclodextrin does not allow preparation of 
solutions of the concentration achieved in the presence of ibuprofen sodium. 
Additionally, little change in the dynamics of the macrocycle was expected on 
formation of the inclusion complex, as has been observed in the presence of other 
substrates [291].
4.9 Conclusion
The work reported here was directed towards greater understanding of the 
complexing and chiral discriminatory properties of the cyclodextrins. NMR 
spectroscopic methods have been used to examine the interaction of p-cyclodextrin 
with a series of 2-arylpropionates. Analysis of chemical shift and coupling 
constant data in D20  and d^DMSO allowed a common structure for the 
cyclodextrin with several of these guest substrates to be proposed. Whilst it was 
generally assumed in this interpretation that complexation of substrate and 
cyclodextrin was the result of interaction of a single molecule of each species, in
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the case of flurbiprofen sodium results suggested that complexation in aqueous 
solution involved interaction of the guest with more than one molecule of 
cyclodextrin. Job plot studies in DzO confirmed a 1:1 stoichiometry of host and 
guest in the complex in all cases and lead to the proposal of a dimeric structure for 
the complex formed between flurbiprofen sodium and P-cyclodextrin. Chemical 
shift data from the continuous variation plot were insufficiently sensitive to the 
complexation process to distinguish the monomeric and dimeric inclusion complex 
directly, and illustrate a significant short-coming of the method. In general, 
previous reports have been inclined to overlook the possible formation of other 
than monomeric structures in NMR Job plot experiments, but in view of the 
undoubted tendency to association exhibited by the cyclodextrin macrocycle in the 
presence of certain substrates this remains an area for future study.
Measurement of the nuclear Overhauser effect for a more direct approach 
to information relating to the structure of the cyclodextrin complex was also 
undertaken. NOe difference spectroscopy was found to be unsuitable as a result of 
the inherently small size of the nOe, which is a consequence of the molecular 
correlation time of the inclusion complex. The ROESY experiment was thought to 
offer a promising alternative to the nOe difference experiment, since in this 
method positive nOes of a reasonable magnitude are observed regardless of 
molecular correlation time. Additionally, the 2D method eliminated the need to 
achieve selective perturbation of resonances as is required in ID nOe experiments, 
and which was difficult to achieve here as a result of resonance overlap, the extent 
of which depended on the guest substrate. A disadvantage of the method resulted 
from the necessary reduction in spectral resolution in the 2D data matrix, which 
restricted interpretation, particularly through a failure to distinguish H3, H5 and 
H6 resonances of the cyclodextrin in certain cases. The H2 resonance of the guest 
substrate was also commonly obscured beneath resonances of the cyclodextrin and 
compounded this difficulty.
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Distinction! between the true and false ROESY cross-peaks in ROESY 
spectra also proved difficult, since for maximal resolution, the carrier necessarily 
lay close to the cyclodextrin resonances and promoted the TOCSY interactions 
which form the basis of the false ROESY cross-peak. Movement of the earner 
position and a lowering of spin-lock power were largely unsuccessful in 
eliminating this problem and unequivocal interpretation of the resulting spectra in 
terms of unique structures of the cyclodextrin inclusion complexes of the 2- 
arylpropionates was not possible. We believe, therefore, that until variations of the 
ROESY experiment which allow the selective elimination of TOCSY pathways 
have been derived, application of this method to the study of the structure of the 
cyclodextrin inclusion complex is limited. Previous studies which have made use 
of the ROESY experiment in the elucidation of cyclodextrin complex structure 
have made little reference to the distinction of the true and false ROESY cross- 
peak. Additionally, fortuitous resolution of cyclodextrin resonances, which 
facilitated spectral interpretation in these cases, is noted.
Preliminary studies with the SUFIR method allowed measurement of 13C 
Tj values in a time considerably shorter than the classical inversion-recovery 
method would require. Application to the study of cyclodextrin inclusion 
complexation suggests that the method may be useful in providing additional 
structural and dynamic information relating to the complex.
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A p p e n d i x  4 .1
400MHz !H NMR Data and Assignments for the Sodium Salts of some 2- 



























The assignments of H3' and H2' in the free drug were confirmed by a !H 
nOe difference experiment. Irradiation of the H2 and H3 resonances both lead to 
the observation of a positive nOe at the high field aromatic signal. Additionally, 
irradiation of the high field aromatic doublet gave a positive nOe at H2, whilst no 
enhancements were observed upon irradiation of the low field aromatic signal.
Assignment of aromatic resonances in the presence of P-cyclodextrin was 
not achieved. Two dimensional ROESY experiments aimed at their distinction 
through correlation to the H2 and H3 groups were unsuccessful. Additionally, the 
monitoring of shifts in aromatic signals through the analysis of Job plot data was 
prohibited by the strong coupling of these resonances exhibited at the lower field at 
which these plots were carried out (270MHz versus 400MHz).
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3. Sodium 2-(4-ni trophenyl)propionate










Job plot data confirm that no change in relative position of the H2' and H3‘ 
resonances is observed in the presence of p-cyclodextrin. Aromatic resonances for 
the free salt are readily assigned from the large down-field shift associated with a 
phenyl proton ortho to a nitro substituent.
4. Ibuprofen Sodium
The aromatic resonances for ibuprofen sodium were assigned by an nOe 
difference experiment. Irradiation of the high field aromatic doublet gave a 
positive nOe at the isobutyl H2" resonance, whilst irradiation of the low field 
signal gave an enhancement at H2. Correspondingly, irradiation at H2 gave a 
positive nOe at the low field aromatic resonance.
The assignment of these resonances in the complexed state was achieved 
from ROESY data. Clear correlations between the H3 resonance of the drug and 
the low field aromatic signal and the isobutyl H I" group and the high field 
aromatic signal were observed in spectra used in the elucidation of the structure of 































Assignment of the naproxen sodium resonances, based on coupling 
constants and the up-field shift associated with aromatic protons ortho to an -OMe 
substituent, was confirmed by a combination of nOe difference and decoupling 
spectroscopy. Irradiation of the methoxy resonance in a nOe difference 
experiment gave positive nOe enhancements at H5' and H 7\ Irradiation of the H2 
resonance then gave positive enhancements of H I’ and H3\ Decoupling of the H7' 
resonance caused the collapse of H8' to a singlet and completed assignment.
Job plot spectra and a COSY-45 experiment supported the assignment of 













Assignment of drug resonances was confirmed by a COSY-45 experiment 
with folding of the H3 resonance for improved spectral resolution. Aromatic 
proton resonances H2" and H3" were readily identified from their integral. COSY
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cross-peaks between H2" and H3" and H4" identified the latter so that the 
remaining triplet resonance could be identified as H5\ Correlation of the H5’ 
resonance with that of H6' gave the H21 resonance by default.
Assignment of aromatic resonances in the presence of a mole equivalent of 
p-cyclodextrin was complicated by broadening and overlap of signals. The H2" 
doublet was, however, clearly visible, and although exact chemical shifts could not 
be determined, the position of the overlapping H2' and H6' resonances were 
identified from Job plot spectra. Other resonances remain unassigned despite the 
use of COSY-45 spectroscopy.
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Appendix 4.2
400MHz *H NMR Data and Assignments for the Sodium Salts of some 2- 































































Reagents used in this work were supplied as follows: (+)-camphor 
(Aldrich); 2-(4-chlonophenyl)propionic acid (Janssen, MW=184.62); cumene 
(Aldrich); a-cyclodextrin (Wacker, MW=972.86); p-cyclodextrin (Aldrich, 
MW=1135.01); y-cyclodextrin (Wacker or Fluka, MW=1297.15); deuterated water 
(Goss or Merck); deuterochloroform (Merck); 2,6- dimethyl-p-cyclodextrin 
(Fluka, MW=1331.40); 2,2-dimethyl-2-silapentane-5- sulfonate (Aldrich); dg- 
dimethylsulfoxide (Merck); flurbiprofen (Boots, MW=244.27); ibuprofen (Boots, 
MW=206.29); (R)-ibuprofen (Boots, MW=206.29); (S)-ibuprofen (Boots, 
MW=206.29); ibuprofen sodium (R P Scherer, MW=228.27); methanol, SLR 
grade (Fisons); P-methylphenethylamine (Aldrich); naproxen sodium (Sigma, 
MW=252.25); scc-phenethyl alcohol (Aldrich); phenol, AR grade (Fisons); 2-(4- 
nitrophenyl)propionic acid (Aldrich, MW=195.18); 2-phenylpropionic acid 
(Aldrich, MW=150.18); sodium chloride, AR grade (Fisons); sodium deuteroxide, 
30% solution in D20  (Aldrich); sodium hydroxide pellets, AR grade (Fisons); 
sodium hydroxide, 0.1M Convol (BDH); sodium hydroxide, 0.1M Volucon (May 
and Baker); tween 80 (BDH)
All reagents were used as supplied, except in the case of methanol, which 
was distilled before use.
5.2 Preparation of the Salts of the 2-Arvlpropionic Acids
Ibuprofen and naproxen were supplied as the sodium salt. For all other 2- 
arylpropionic acids, the sodium salt was prepared by the following general 
procedure.
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Typically, 5 or 10 ml of a standardised Convol or Volucon solution of
0.1M sodium hydroxide prepared in distilled water was added to a mole equivalent 
of the appropriate 2-arylpropionic acid dissolved in 5- 10ml of distilled methanol. 
Following stirring and filtration through a plug of cotton wool, the solutions were 
taken to dryness on a rotary evaporator and dried under vacuum at a temperature of 
100-120°C for several hours. Salts of (R)-ibuprofen and (S)-ibuprofen were 
similarly prepared, but on a smaller scale as a result of the restricted availability of 
these compounds. Alternatively the sodium hydroxide solution was added directly 
to the 2-arylpropionic acid and taken to dryness prior to dissolution in distilled 
methanol.
5.3 Biological Fluid Studies with Ibuprofen
5.3.1 in vivo Studies with Ibuprofen
An oral dose of 400mg ibuprofen (Inoven™) was ingested with 
approximately 100ml of water by a healthy adult female. A urine sample was 
collected immediately and at approximately 4 hours and 8 3/4 hours thereafter and 
stored frozen until use.
Following defrosting to room temperature, 5ml aliquots of these samples 
were taken and 0.2ml of a 0.014M solution of DSS in distilled water added to 
them. These were then freeze-dried and reconstituted with 1ml DzO or an 
approximately 0.07M solution of NaOD in D20 , before being transferred directly 
to 5mm NMR tubes.
5.3.2 in vitro Studies with Ibuprofen Sodium
in vitro studies of the discrimination of the enantiomers of ibuprofen 
sodium in human urine with DMCD were carried out using a urine sample 
collected from a healthy adult female. 1ml aliquots of this sample were freeze-
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dried, either immediately following collection or after freezer storage, and 
reconstituted with 0.65ml of either D20, a 1 mg/ml (0.0Q44M) solution of 
ibuprofen sodium in D20 , or of a 1 mg/ml solution of ibuprofen sodium in D20  to 
which the appropriate weight of DMCD had been added. Reconstituted samples 
were transferred directly to 5mm NMR tubes.
5.4 in vivo Studies with Flurbiprofen
1. Two male Wistar rats of approximately 380g were starved over-night prior to 
oral dosing with 0.38ml of either a 1% solution of tween 80 or an approximately 
lOmg/ml suspension of flurbiprofen in a 1% solution of tween 80. The rats were 
kept in individual metabolism cages and allowed access to food and water. Urine 
samples were collected at approximately 0-7 1/2 and 7 1/2- 24 hours and stored 
frozen. Additionally, 1ml blood samples were taken at approximately 1 1/4 hours 
after dosing under an ether anaesthetic, but were not used in the work reported 
here.
0.3 or 0.4ml of these urine samples were taken following defrosting and 
100p.l of a 0.007M solution of DSS in D20  added to them. Samples were then 
freeze-dried and reconstituted with 0.4 or 0.5ml of an approximately 0.07M 
solution of NaOD in D20. Reconstituted control rat urine was subsequently spiked 
with 0.1ml of a 0.029M solution of flurbiprofen in approximately 0.07M NaOD in 
D20 , followed by 0.1ml of a 0.11M solution of DMCD also prepared in 0.07M 
NaOD in D20.
2. Two male Wistar rats of approximately 300g were starved over-night and orally 
dosed with 0.9ml of either distilled water or a 16.6mg/ml aqueous solution of 
flurbiprofen, converted to its salt in situ by addition of an equivalent of sodium 
hydroxide prepared as an aqueous solution. Animals were kept in individual 
metabolism cages following dosing and allowed access to food and water. Urine
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samples were collected at approximately 0-7 and 7-24 hours and stored frozen 
prior to use.
5.5 Preparation of Non-biological NMR Samples
Non-biological samples for NMR analysis were commonly prepared by 
weighing of the sodium 2-arylpropionate and/or cyclodextrin and subsequent 
addition of an approprite volume of deuterated solvent. Routinely, solutions were 
of a concentration 0.014M in host and/or guest, so that for 0.8ml of solution 1.9- 
2.9mg of guest substrate and 12.5mg of, for example, p-cyclodextrin were 
required. In studies of the effects of the presence of ionic salts on cyclodextrin 
complexation, solutions of sodium 2-arylpropionate and p-cyclodextrin prepared in 
this manner were then added quantitatively to an appropriate amount of the salt 
sodium chloride. Solutes generally dissolved readily on shaking, except in the case 
of dissolution of p-cyclodextrin in D20 , where warming was sometimes required. 
Samples were generally filtered through a plug of cotton wool into 5mm NMR 
tubes.
Alternatively, solutions were prepared by volumetric addition of a 
quantitative solution of the cyclodextrin or sodium 2-arylpropionate in the 
deuterated solvent of choice to the other preweighed reagent.
Job plot studies were carried out by the quantitative mixing of individual, 
approximately 0.0078M, solutions of the sodium 2-arylpropionate and P- 
cyclodextrin in D20  in volumes of 0.25 and 0.75ml, 0.33 and 0.67ml, 0.50 and 
0.50ml, 0.67 and 0.33ml and 0.75 and 0.25ml respectively. In this case, solutions 
were not filtered during transfer to 5mm NMR tubes.
Test samples for the SUF1R sequence were not prepared quantitatively, but 
were all of high concentration.
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5.6 NMR Methorils
NMR spectra were routinely acquired on a JEOL JNM GX40O FT NMR 
spectrometer, sited in the Department of Chemistry, University of Bristol, and 
operating at a frequency of 399.65MHz for and 54.10MHz for 170 . The 
spectrometer was equipped with a 5mm dedicated proton or tunable probe and a 
NM-GVT3 variable temperature controller.
Spectra were acquired at 30°C (-1°C), except where stated , following an 
equilibration period of at least 10 minutes.
!H data were collected over a spectral width of 4000Hz following 
application of a pulse of 1.5p.s, corresponding to a pulse angle of approximately 8° 
or 18° depending on the probe in use. 32K data points were transformed using a 
0.12Hz exponential broadening factor combined with a trapezoidal apodization 
function* (T1=0%, T2=0%, T3=90%, T4=100%) to give a final resolution of
The trapezoidal window function is here described in terms of four time 
parameters, T1-T4, which are expressed as a percentage of the acquisition time. 
These parameters define the co-ordinates of the four comers of the desired 
trapezium-shaped transformation function.
magnitude of trapezoidal 
window function
(T2.1) (T3.1)1
(T i.cn (T 4.0)0
T1 T2 T3 T4
acquisition time
Figure 5.1 Parameters describing the trapezoidal window function
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0.24Hz. Typically, 64 scans were collected using a pulse delay of 1 or 2s. Spectra 
were referenced to the residual solvent resonance.
Solvent suppression was achieved, where necessary, under equivalent 
conditions using the homogated decoupling sequence and an increased pulse delay 
of 5s, to ensure adequate saturation of the solvent resonance during this period. 
Continuous homonuclear decoupling spectra were similarly acquired with a delay 
of 5s following application of a pulse corresponding to a pulse angle of 
approximately 40°.
NOe difference spectra were similarly acquired over a spectral width of 
4000Hz by interleaving the collection of 16 scans at each irradiation point 
following a pulse typically corresponding to an angle of approximately 45°. The 
pulse delay for such experiments was again increased to 5s. 16K data points were 
collected, zero-filled and transformed using a 2Hz exponential broadening factor 
combined with a trapezoidal apodization function (T1=0%, T2=0%, T3=90%, 
T4=100%) prior to spectral subtraction, giving a resolution of 0.24Hz. Typically, 
64-384 scans were collected for each iiTadiation point.
Homonuclear 2D data sets were generally collected in matrices of size 
1024 x 256 points and zero-filled in ^  prior to transformation, which for a standard 
spectral width of 4000Hz gave a resolution of 7.81Hz in each dimension. Typically 
8 scans per slice were collected, using a pulse delay of Is.
COSY-45 spectra were acquired in the absolute value mode and were 
transformed using a sine-bell window function.
ROESY spectra were acquired in the phase-sensitive mode using either a 
continuous spin-locking period, or an intermittent field of 10%> duty cycle and 
composed of pulses corresponding to an angle of approximately 30°. Typically, 
this field was of strength 3.8-5.3kHz, and applied for a period of 400ms. 
Transformation was achieved using a trapezoidal apodization function (T1=0%,
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T2=0%, T3=70%, T4=100%) in each dimension. Preliminary spectra were 
acquired with a reduced 2D matrix size of 512 x 128 points.
nO I*! measurements were made using the inversion-recovery sequence 
and processed with the spectrometer software. Data were the result of the 
accumulation of 512 scans at each of 6 values of the variable time delay t, and the 
method of least squares was used to calculate Tj (equation 3.2) using an 
exponential weighting function. Data points in these calculations were rejected 
where the change in peak intensity was less than 20% of its maximum possible 
value. Spectra were collected over a frequency width of 50000Hz using a pulse 
delay of 0.05s. 8K data points were acquired and transformed using an exponential 
broadening factor of 1.5Hz combined with a trapezoidal apodization function 
(T1=0%, T2=0%, T3=90%, T4=100%) to give a resolution of 3.05Hz.
Alternatively, spectra were acquired on a JEOL JNM GX270 FT NMR 
spectrometer, sited in the School of Pharmacy and Pharmacology, University of 
Bath, and operating at a frequency of 270.05MHz for ]H and 67.80MHz for 13C. 
The spectrometer was equipped with a 5mm dual 13C/]H or tunable probe, but had 
no temperature control capabilities. Solutions were therefore necessarily examined 
at ambient temperature.
For ]H spectra typically 256 scans were acquired using a 5jis pulse, 
corresponding to an angle of approximately 28° and a pulse delay of 0.541s. 32K 
data points were collected over a spectral width of 3001.2Hz and were transformed 
using a 0.1Hz exponential broadening factor in conjunction with a trapezoidal 
apodization function (T1=0%, T2=0%, T3=90%, T4=100%) to give a resolution of
0.18Hz. Spectra were referenced to the residual solvent resonance or to DSS where 
added.
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13C spectra were acquired using a pulse of 4ps equivalent to an angle of 
approximately 45° and a pulse delay of 0.213s. Continuous broad-band ]H 
decoupling was achieved using the WAUGH sequence . 16K data points were 
collected over a spectral width of 18050.5Hz corresponding to a resolution of 
2.2Hz and were transformed using an exponential broadening factor of 1.1Hz 
combined with a trapezoidal apodization function (T1=0%, T2=0%, T3=90%, 
T4=100%). Spectra were referenced to the residual solvent resonance, or where 
this was inappropriate, to a sample of DSS in D20 . The number of transients 
collected was largely dependent on sample concentration.
13C-!H heteronuclear correlation experiments were recorded using a matrix 
size of 1024 x 128 points, and assuming a Uqj value of approximately 139Hz. 64 
scans per slice were acquired with a pulse delay of 2s, and data sets zero-filled in 
the fj domain prior to transformation with a 4Hz exponential broadening factor in 
f2 combined with a trapezoidal window function (T1=0%, T2=10%, T3=70%, 
T4=100%) in both dimensions. Resolution in the fj and f2 domains was 19.38Hz x
11.7Hz and 35.25Hz x 11.7Hz for ibuprofen sodium in the presence and absence of 
a mole equivalent of p-cyclodextrin respectively.
Long-range ^C-’H heteronuclear correlation experiments were acquired 
using the FLOCK experiment, the pulse sequence for which was provided by 
Martin Kipps, ICI Plant Protection Division, Bracknell. 112 scans per slice were 
collected for a matrix of 2048 x 128 points, using a pulse delay of Is, and 
assuming JJCH and 2JCH of approximately 139Hz and 8Hz respectively. Data were 
zero-filled in fj prior to transformation with a 4Hz exponential broadening factor 
in f2 combined with a trapezoidal window function (T1=0%, T2=10%, T3=70%, 
T4=100%) in both dimensions, to give a final resolution of 9.69Hz x 11.7Hz.
13C Tj measurements were made using either the inversion-recovery or 
SUFIR methods. Broad-band JH decoupling was obtained in all cases using the 
WAUGH sequence. Spectra were acquired over a spectral width of 18050.5Hz and
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typically collected into 16K data points and transformed using an exponential 
broadening factor of 1.1 Hz combined with a trapezoidal apodization function 
(T1=0%, T2=0%, T3=90%, T4=100%) to give a resolution of 2.2Hz.
Determinations using the inversion-recovery method were the result of 8- 
128 scans for each of 8-10 values of the variable parameter t. Processing was 
achieved in a manner analogous to that described for measurements of nO T x.
Tr values from peak intensity measurements resulting from the SUFIR 
experiment were calculated on a BBC Archimedes Computer (Chapter 4). For test 
samples 8-128 scans were typically collected. Tj measurements of ibuprofen 
sodium samples were the result of 800-1100 scans.
19F data presented in this thesis were kindly recorded by Martin Kipps, ICI 
Plant Protection Division, Bracknell. For non- biological samples, spectra were 
acquired on a JEOL JNM GSX270 FT NMR spectrometer, operating at 
254.05MHz for 19F. Broad-band proton-decoupled spectra were the result of the 
accumulation of 16 scans. 16K data points were acquired over a spectral width of 
3001.2Hz giving a resolution of 0.37Hz. Fourier transformation was achieved 
using an exponential broadening factor of 0.2Hz combined with a trapezoidal 
apodization function (T1=0%, T2=0%, T3=90%, T4=100%).
19F spectra for biological samples were acquired on a JEOL JNM GX400, 
operating at 376.05MHz for 19F. 16K data points were acquired over a spectral 
width of 7530.1Hz. Data were zero-filled and transformed using an exponential 
broadening factor of 0.2Hz combined with a trapezoidal apodization function 
(T1=0%, T2=0%, T3=90%, T4=100%) to give a resolution of 0.46Hz. Spectra 
were recorded in either the proton-coupled or selective proton-decoupled mode, 
and were the result of the collection of 256 scans for urine samples spiked with 
flurbiprofen, or of 9000 scans for samples containing metabolized drug. Spectra
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